EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or more cardiometabolic risk factor(s) and the absence of harmful alcohol intake. The spectrum of MASLD in...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of hepatology Ročník 81; číslo 3; s. 492 - 542
Hlavní autori:	Tacke, Frank, Horn, Paul, Wai-Sun Wong, Vincent, Ratziu, Vlad, Bugianesi, Elisabetta, Francque, Sven, Zelber-Sagi, Shira, Valenti, Luca, Roden, Michael, Schick, Fritz, Yki-Järvinen, Hannele, Gastaldelli, Amalia, Vettor, Roberto, Frühbeck, Gema, Dicker, Dror
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier B.V 01.09.2024
Predmet:	Humans Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - therapy Obesity - complications
ISSN:	0168-8278, 1600-0641, 1600-0641
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or more cardiometabolic risk factor(s) and the absence of harmful alcohol intake. The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD. Case-finding strategies for MASLD with liver fibrosis, using non-invasive tests, should be applied in individuals with cardiometabolic risk factors, abnormal liver enzymes, and/or radiological signs of hepatic steatosis, particularly in the presence of type 2 diabetes (T2D) or obesity with additional metabolic risk factor(s). A stepwise approach using blood-based scores (such as FIB-4) and, sequentially, imaging techniques (such as transient elastography) is suitable to rule-out/in advanced fibrosis, which is predictive of liver-related outcomes. In adults with MASLD, lifestyle modification – including weight loss, dietary changes, physical exercise and discouraging alcohol consumption – as well as optimal management of comorbidities – including use of incretin-based therapies (e.g. semaglutide, tirzepatide) for T2D or obesity, if indicated – is advised. Bariatric surgery is also an option in individuals with MASLD and obesity. If locally approved and dependent on the label, adults with non-cirrhotic MASH and significant liver fibrosis (stage ≥2) should be considered for a MASH-targeted treatment with resmetirom, which demonstrated histological effectiveness on steatohepatitis and fibrosis with an acceptable safety and tolerability profile. No MASH-targeted pharmacotherapy can currently be recommended for the cirrhotic stage. Management of MASH-related cirrhosis includes adaptations of metabolic drugs, nutritional counselling, surveillance for portal hypertension and HCC, as well as liver transplantation in decompensated cirrhosis.
AbstractList	Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or more cardiometabolic risk factor(s) and the absence of harmful alcohol intake. The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD. Case-finding strategies for MASLD with liver fibrosis, using non-invasive tests, should be applied in individuals with cardiometabolic risk factors, abnormal liver enzymes, and/or radiological signs of hepatic steatosis, particularly in the presence of type 2 diabetes (T2D) or obesity with additional metabolic risk factor(s). A stepwise approach using blood-based scores (such as FIB-4) and, sequentially, imaging techniques (such as transient elastography) is suitable to rule-out/in advanced fibrosis, which is predictive of liver-related outcomes. In adults with MASLD, lifestyle modification - including weight loss, dietary changes, physical exercise and discouraging alcohol consumption - as well as optimal management of comorbidities - including use of incretin-based therapies (e.g. semaglutide, tirzepatide) for T2D or obesity, if indicated - is advised. Bariatric surgery is also an option in individuals with MASLD and obesity. If locally approved and dependent on the label, adults with non-cirrhotic MASH and significant liver fibrosis (stage ≥2) should be considered for a MASH-targeted treatment with resmetirom, which demonstrated histological effectiveness on steatohepatitis and fibrosis with an acceptable safety and tolerability profile. No MASH-targeted pharmacotherapy can currently be recommended for the cirrhotic stage. Management of MASH-related cirrhosis includes adaptations of metabolic drugs, nutritional counselling, surveillance for portal hypertension and HCC, as well as liver transplantation in decompensated cirrhosis. Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or more cardiometabolic risk factor(s) and the absence of harmful alcohol intake. The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD. Case-finding strategies for MASLD with liver fibrosis, using non-invasive tests, should be applied in individuals with cardiometabolic risk factors, abnormal liver enzymes, and/or radiological signs of hepatic steatosis, particularly in the presence of type 2 diabetes (T2D) or obesity with additional metabolic risk factor(s). A stepwise approach using blood-based scores (such as FIB-4) and, sequentially, imaging techniques (such as transient elastography) is suitable to rule-out/in advanced fibrosis, which is predictive of liver-related outcomes. In adults with MASLD, lifestyle modification - including weight loss, dietary changes, physical exercise and discouraging alcohol consumption - as well as optimal management of comorbidities - including use of incretin-based therapies (e.g. semaglutide, tirzepatide) for T2D or obesity, if indicated - is advised. Bariatric surgery is also an option in individuals with MASLD and obesity. If locally approved and dependent on the label, adults with non-cirrhotic MASH and significant liver fibrosis (stage ≥2) should be considered for a MASH-targeted treatment with resmetirom, which demonstrated histological effectiveness on steatohepatitis and fibrosis with an acceptable safety and tolerability profile. No MASH-targeted pharmacotherapy can currently be recommended for the cirrhotic stage. Management of MASH-related cirrhosis includes adaptations of metabolic drugs, nutritional counselling, surveillance for portal hypertension and HCC, as well as liver transplantation in decompensated cirrhosis.Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or more cardiometabolic risk factor(s) and the absence of harmful alcohol intake. The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD. Case-finding strategies for MASLD with liver fibrosis, using non-invasive tests, should be applied in individuals with cardiometabolic risk factors, abnormal liver enzymes, and/or radiological signs of hepatic steatosis, particularly in the presence of type 2 diabetes (T2D) or obesity with additional metabolic risk factor(s). A stepwise approach using blood-based scores (such as FIB-4) and, sequentially, imaging techniques (such as transient elastography) is suitable to rule-out/in advanced fibrosis, which is predictive of liver-related outcomes. In adults with MASLD, lifestyle modification - including weight loss, dietary changes, physical exercise and discouraging alcohol consumption - as well as optimal management of comorbidities - including use of incretin-based therapies (e.g. semaglutide, tirzepatide) for T2D or obesity, if indicated - is advised. Bariatric surgery is also an option in individuals with MASLD and obesity. If locally approved and dependent on the label, adults with non-cirrhotic MASH and significant liver fibrosis (stage ≥2) should be considered for a MASH-targeted treatment with resmetirom, which demonstrated histological effectiveness on steatohepatitis and fibrosis with an acceptable safety and tolerability profile. No MASH-targeted pharmacotherapy can currently be recommended for the cirrhotic stage. Management of MASH-related cirrhosis includes adaptations of metabolic drugs, nutritional counselling, surveillance for portal hypertension and HCC, as well as liver transplantation in decompensated cirrhosis.
Author	Wai-Sun Wong, Vincent Gastaldelli, Amalia Roden, Michael Frühbeck, Gema Ratziu, Vlad Tacke, Frank Dicker, Dror Schick, Fritz Bugianesi, Elisabetta Yki-Järvinen, Hannele Zelber-Sagi, Shira Valenti, Luca Horn, Paul Francque, Sven Vettor, Roberto
Author_xml	– sequence: 1 givenname: Frank surname: Tacke fullname: Tacke, Frank – sequence: 2 givenname: Paul surname: Horn fullname: Horn, Paul – sequence: 3 givenname: Vincent surname: Wai-Sun Wong fullname: Wai-Sun Wong, Vincent – sequence: 4 givenname: Vlad surname: Ratziu fullname: Ratziu, Vlad – sequence: 5 givenname: Elisabetta surname: Bugianesi fullname: Bugianesi, Elisabetta – sequence: 6 givenname: Sven surname: Francque fullname: Francque, Sven – sequence: 7 givenname: Shira surname: Zelber-Sagi fullname: Zelber-Sagi, Shira – sequence: 8 givenname: Luca surname: Valenti fullname: Valenti, Luca – sequence: 9 givenname: Michael surname: Roden fullname: Roden, Michael – sequence: 10 givenname: Fritz surname: Schick fullname: Schick, Fritz – sequence: 11 givenname: Hannele surname: Yki-Järvinen fullname: Yki-Järvinen, Hannele – sequence: 12 givenname: Amalia surname: Gastaldelli fullname: Gastaldelli, Amalia – sequence: 13 givenname: Roberto surname: Vettor fullname: Vettor, Roberto – sequence: 14 givenname: Gema surname: Frühbeck fullname: Frühbeck, Gema – sequence: 15 givenname: Dror surname: Dicker fullname: Dicker, Dror
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38851997$$D View this record in MEDLINE/PubMed
BookMark	eNqFkc1uEzEUhS1URNPCC7BAXpbFhGt7Mj-ITZX-gBRUJGBtee7coQ4z42A7lbJjwxP0DXkSPEq66aJIVzqSdb5j3XtO2NHoRmLstYC5AFG8W8_Xt7SZS5D5HNIo8YzNRAGQQZGLIzZLpiqrZFkds5MQ1gCgoM5fsGNVVQtR1-WM_bk8_7r6-_s-ycVebviyt6NF0_Mv3mC0SPx6a1tKrxS4G3m8JT6Y0fyggcbIXccHiqZxvUXe7kK3HRPlxsyE4NCaSC0PkUx0KYv39o48b20gE4iffU7fX7x9yZ53pg_06qCn7PvV5bflx2x1c_1peb7KMFdSZMYsEIGMwRKgwLqTi7woi6pWUjbTSqIh6BSYshY1UqOwxK7oCkBZUScbdcrO9rkb735tKUQ92IDU92Yktw1aQbGoK5lLkaxvDtZtM1CrN94Oxu_0w-mSodob0LsQPHUabTTT4tEb22sBempJr_XUkp5a0pBGTdnyEfqQ_iT0YQ9ROtCdJa8DWhqRWusJo26dfRp__wjHQ80_afc_-B8w58C4
CitedBy_id	crossref_primary_10_1016_j_bpsgos_2025_100488 crossref_primary_10_1111_eci_14368 crossref_primary_10_1038_s41392_024_02104_8 crossref_primary_10_1016_j_jhep_2025_08_017 crossref_primary_10_25122_jml_2024_0342 crossref_primary_10_3350_cmh_2025_0045 crossref_primary_10_1007_s42000_024_00625_z crossref_primary_10_1038_s41598_025_06617_2 crossref_primary_10_1038_s41598_024_75274_8 crossref_primary_10_1055_a_2438_4383 crossref_primary_10_1111_eci_70074 crossref_primary_10_1097_HC9_0000000000000806 crossref_primary_10_1097_HC9_0000000000000807 crossref_primary_10_1016_j_jhep_2025_08_023 crossref_primary_10_1111_apt_70084 crossref_primary_10_1161_CIRCIMAGING_124_017376 crossref_primary_10_1016_j_jlr_2025_100887 crossref_primary_10_1007_s10067_025_07364_5 crossref_primary_10_1038_s41392_024_02072_z crossref_primary_10_1002_jcsm_13854 crossref_primary_10_3389_fnut_2025_1582861 crossref_primary_10_1111_liv_16218 crossref_primary_10_1096_fj_202501007R crossref_primary_10_1007_s42399_025_02054_4 crossref_primary_10_1038_s41423_025_01308_4 crossref_primary_10_1089_thy_2025_0245 crossref_primary_10_1111_liv_16220 crossref_primary_10_3389_fnut_2025_1518082 crossref_primary_10_1016_j_jdiacomp_2025_109147 crossref_primary_10_1016_j_jhep_2024_06_026 crossref_primary_10_1080_17474124_2025_2530605 crossref_primary_10_1136_gutjnl_2025_335598 crossref_primary_10_1177_13860291251376519 crossref_primary_10_1080_07853890_2025_2551813 crossref_primary_10_1111_ctr_70039 crossref_primary_10_3390_nu17162677 crossref_primary_10_1111_dom_16065 crossref_primary_10_1159_000546574 crossref_primary_10_1007_s00261_025_05008_5 crossref_primary_10_1136_flgastro_2025_103110 crossref_primary_10_1007_s00535_025_02287_z crossref_primary_10_1016_j_metabol_2024_156128 crossref_primary_10_3390_nu16132027 crossref_primary_10_1016_S2468_1253_24_00310_8 crossref_primary_10_1016_j_jnutbio_2025_110069 crossref_primary_10_1152_ajpgi_00381_2024 crossref_primary_10_1080_17843286_2025_2466011 crossref_primary_10_1016_j_jhep_2025_01_014 crossref_primary_10_1111_eci_70059 crossref_primary_10_1210_clinem_dgaf094 crossref_primary_10_3390_nu17183020 crossref_primary_10_1007_s13679_025_00646_8 crossref_primary_10_1016_j_metabol_2024_156015 crossref_primary_10_1038_s41591_025_03722_7 crossref_primary_10_1016_j_diabres_2024_111969 crossref_primary_10_1016_j_jhep_2025_08_007 crossref_primary_10_4062_biomolther_2025_037 crossref_primary_10_1002_jgh3_70137 crossref_primary_10_1016_j_aohep_2025_101789 crossref_primary_10_1186_s12876_025_04264_5 crossref_primary_10_1186_s12933_024_02572_w crossref_primary_10_1186_s12933_025_02700_0 crossref_primary_10_1186_s12876_025_04079_4 crossref_primary_10_26442_00403660_2025_08_203302 crossref_primary_10_1080_17474124_2024_2444554 crossref_primary_10_1016_S2213_8587_24_00318_8 crossref_primary_10_3390_ijms26188928 crossref_primary_10_1007_s00535_025_02285_1 crossref_primary_10_1016_j_eprac_2025_04_014 crossref_primary_10_1111_hiv_13697 crossref_primary_10_1016_j_numecd_2025_104266 crossref_primary_10_1016_j_biopha_2025_118542 crossref_primary_10_1016_j_semerg_2025_102555 crossref_primary_10_20517_mtod_2025_65 crossref_primary_10_1016_j_metabol_2024_156028 crossref_primary_10_1136_bmj_r1101 crossref_primary_10_1016_S2468_1253_24_00313_3 crossref_primary_10_1111_hepr_70001 crossref_primary_10_3390_ph18091276 crossref_primary_10_3390_cimb47080618 crossref_primary_10_4103_ijem_ijem_457_24 crossref_primary_10_4093_dmj_2024_0541 crossref_primary_10_1111_liv_16133 crossref_primary_10_1210_clinem_dgaf155 crossref_primary_10_20517_mtod_2024_108 crossref_primary_10_1136_gutjnl_2025_335542 crossref_primary_10_1097_HC9_0000000000000609 crossref_primary_10_1097_HC9_0000000000000728 crossref_primary_10_1007_s42000_025_00708_5 crossref_primary_10_1007_s15004_024_0810_z crossref_primary_10_1111_liv_70280 crossref_primary_10_1177_17562848241276334 crossref_primary_10_1371_journal_pone_0325066 crossref_primary_10_3390_livers5030033 crossref_primary_10_1111_liv_70281 crossref_primary_10_1139_cjpp_2025_0038 crossref_primary_10_4254_wjh_v17_i8_107873 crossref_primary_10_1111_liv_70165 crossref_primary_10_1016_S1634_6939_25_49520_9 crossref_primary_10_1111_liv_70164 crossref_primary_10_4254_wjh_v17_i8_108606 crossref_primary_10_1002_mnfr_70134 crossref_primary_10_1097_HC9_0000000000000718 crossref_primary_10_3390_ijms26031288 crossref_primary_10_1016_j_tem_2025_01_002 crossref_primary_10_4330_wjc_v17_i2_103845 crossref_primary_10_62751_2713_0177_2025_6_2_09 crossref_primary_10_1016_j_metabol_2024_156044 crossref_primary_10_3390_livers4040038 crossref_primary_10_1038_s41401_024_01466_7 crossref_primary_10_1515_cclm_2025_0615 crossref_primary_10_1016_j_metabol_2024_156047 crossref_primary_10_1016_j_phymed_2025_156806 crossref_primary_10_1007_s41971_025_00222_w crossref_primary_10_1111_hepr_14241 crossref_primary_10_1111_liv_70191 crossref_primary_10_1016_j_numecd_2025_104284 crossref_primary_10_1007_s13679_025_00637_9 crossref_primary_10_1007_s11739_025_03967_7 crossref_primary_10_1016_j_jhep_2025_02_014 crossref_primary_10_1111_liv_70075 crossref_primary_10_1016_j_jhep_2025_02_018 crossref_primary_10_1093_eurheartj_ehaf314 crossref_primary_10_1053_j_gastro_2024_12_039 crossref_primary_10_1186_s12916_025_04017_x crossref_primary_10_1016_j_semerg_2025_102530 crossref_primary_10_1111_liv_16103 crossref_primary_10_1152_ajpendo_00178_2025 crossref_primary_10_1097_MOG_0000000000001083 crossref_primary_10_1016_j_jhep_2024_06_034 crossref_primary_10_3390_metabo15080510 crossref_primary_10_4103_PMRR_PMRR_159_24 crossref_primary_10_1111_dom_16196 crossref_primary_10_1016_j_cgh_2025_06_036 crossref_primary_10_1016_j_jhep_2025_07_021 crossref_primary_10_3390_jcm14176148 crossref_primary_10_1016_j_jceh_2025_103114 crossref_primary_10_1038_s41575_024_01022_y crossref_primary_10_1111_liv_70062 crossref_primary_10_1016_j_jhep_2025_07_026 crossref_primary_10_1016_j_bbalip_2025_159666 crossref_primary_10_1111_liv_70063 crossref_primary_10_1016_j_bbrc_2025_151498 crossref_primary_10_1016_j_jceh_2025_103119 crossref_primary_10_1111_liv_16114 crossref_primary_10_1038_s41423_025_01307_5 crossref_primary_10_1007_s00330_025_11774_z crossref_primary_10_1080_17474124_2025_2502549 crossref_primary_10_1111_liv_16240 crossref_primary_10_1016_j_jhep_2025_07_019 crossref_primary_10_1016_j_jbc_2024_107876 crossref_primary_10_1016_j_jlr_2025_100857 crossref_primary_10_1186_s12944_025_02515_8 crossref_primary_10_3390_jcm13247719 crossref_primary_10_1016_j_cgh_2025_06_025 crossref_primary_10_1016_j_tjnut_2025_01_025 crossref_primary_10_3724_abbs_2025183 crossref_primary_10_1016_j_jhep_2025_03_034 crossref_primary_10_1111_liv_70010 crossref_primary_10_1111_liv_70131 crossref_primary_10_1080_00365521_2025_2536585 crossref_primary_10_1097_CM9_0000000000003616 crossref_primary_10_1177_20406223251358659 crossref_primary_10_1111_liv_70017 crossref_primary_10_1002_14651858_CD014850 crossref_primary_10_1111_liv_70139 crossref_primary_10_3389_fmed_2024_1499013 crossref_primary_10_1111_jdi_14398 crossref_primary_10_3390_jcm14072441 crossref_primary_10_1097_HC9_0000000000000649 crossref_primary_10_1038_s44355_025_00033_z crossref_primary_10_1097_MD_0000000000040836 crossref_primary_10_1016_j_phrs_2024_107532 crossref_primary_10_3390_cancers17050722 crossref_primary_10_1016_j_jhepr_2025_101363 crossref_primary_10_1016_j_atherosclerosis_2025_120495 crossref_primary_10_1016_j_cgh_2025_06_011 crossref_primary_10_1016_j_jhepr_2025_101480 crossref_primary_10_1111_liv_70240 crossref_primary_10_1016_j_clnu_2025_05_013 crossref_primary_10_3390_cancers17050842 crossref_primary_10_3748_wjg_v31_i22_106937 crossref_primary_10_1186_s12916_025_04320_7 crossref_primary_10_20517_mtod_2024_144 crossref_primary_10_14710_jnc_v14i2_48176 crossref_primary_10_1007_s40618_025_02631_3 crossref_primary_10_1007_s00535_024_02154_3 crossref_primary_10_1016_j_jdiacomp_2024_108875 crossref_primary_10_1002_psp4_13275 crossref_primary_10_1007_s11901_025_00692_9 crossref_primary_10_1016_j_metabol_2024_156080 crossref_primary_10_1080_19490976_2025_2541035 crossref_primary_10_1016_j_metabol_2024_156082 crossref_primary_10_1097_HC9_0000000000000756 crossref_primary_10_1016_j_jhepr_2025_101369 crossref_primary_10_1016_j_clnu_2025_05_009 crossref_primary_10_1007_s11357_025_01816_1 crossref_primary_10_1007_s11695_025_07810_y crossref_primary_10_1016_j_jhep_2025_03_017 crossref_primary_10_1111_liv_70271 crossref_primary_10_7759_cureus_86963 crossref_primary_10_1097_JS9_0000000000002654 crossref_primary_10_12677_acm_2025_1551592 crossref_primary_10_1016_j_freeradbiomed_2025_05_420 crossref_primary_10_7759_cureus_75993 crossref_primary_10_12677_acm_2025_1551598 crossref_primary_10_1111_liv_70035 crossref_primary_10_1016_j_ajt_2025_03_005 crossref_primary_10_1016_S1155_1976_25_46793_X crossref_primary_10_1016_j_redox_2025_103809 crossref_primary_10_3389_fcvm_2025_1609071 crossref_primary_10_3892_br_2025_1939 crossref_primary_10_7759_cureus_76716 crossref_primary_10_1007_s12672_025_02518_y crossref_primary_10_1093_ckj_sfaf260 crossref_primary_10_1097_HC9_0000000000000747 crossref_primary_10_1002_ejhf_3677 crossref_primary_10_1097_JCMA_0000000000001266 crossref_primary_10_1016_j_diabet_2025_101684 crossref_primary_10_1016_j_diabet_2025_101680 crossref_primary_10_1016_j_clinre_2025_102629 crossref_primary_10_1016_j_jacc_2025_02_035 crossref_primary_10_1016_S2468_1253_25_00187_6 crossref_primary_10_1016_j_clnesp_2025_04_026 crossref_primary_10_3390_ijms251910795 crossref_primary_10_1111_ijpo_70017 crossref_primary_10_2337_dc24_2075 crossref_primary_10_3350_cmh_2024_1165 crossref_primary_10_1097_HC9_0000000000000618 crossref_primary_10_1038_s41598_025_89690_x crossref_primary_10_3390_medicina61061102 crossref_primary_10_1016_j_jhepr_2025_101388 crossref_primary_10_1007_s11739_025_03880_z crossref_primary_10_1097_HC9_0000000000000561 crossref_primary_10_1016_j_jhepr_2025_101450 crossref_primary_10_1186_s43162_025_00470_5 crossref_primary_10_4103_sjg_sjg_199_25 crossref_primary_10_1016_j_jhep_2025_05_002 crossref_primary_10_1016_j_gastha_2025_100630 crossref_primary_10_2337_dci25_0008 crossref_primary_10_2147_JIR_S499396 crossref_primary_10_1055_a_2542_9930 crossref_primary_10_3390_nu17091580 crossref_primary_10_1186_s13098_025_01808_3 crossref_primary_10_1038_s41423_025_01313_7 crossref_primary_10_1038_s41598_025_10871_9 crossref_primary_10_1016_j_jhepr_2025_101337 crossref_primary_10_53435_funj_00999 crossref_primary_10_1016_j_jhep_2025_05_016 crossref_primary_10_3390_nu17010178 crossref_primary_10_1096_fj_202403088R crossref_primary_10_1038_s41419_025_07940_2 crossref_primary_10_3390_ijms26072959 crossref_primary_10_1016_j_lfs_2025_123665 crossref_primary_10_1055_a_2548_0108 crossref_primary_10_3389_fendo_2025_1623136 crossref_primary_10_3390_ph18091321 crossref_primary_10_1136_gutjnl_2025_334981 crossref_primary_10_1016_j_cgh_2025_07_011 crossref_primary_10_1126_sciadv_adv3201 crossref_primary_10_26442_00403660_2025_08_203365 crossref_primary_10_1016_j_gastha_2025_100747 crossref_primary_10_3748_wjg_v31_i4_101436 crossref_primary_10_1016_j_jhep_2024_10_023 crossref_primary_10_1097_HC9_0000000000000678 crossref_primary_10_1016_j_clinre_2025_102573 crossref_primary_10_1016_j_ejim_2025_01_030 crossref_primary_10_1186_s12933_024_02399_5 crossref_primary_10_1016_j_jhepr_2025_101351 crossref_primary_10_1016_j_jrras_2025_101647 crossref_primary_10_1016_j_molmet_2024_102090 crossref_primary_10_1016_j_jceh_2025_103187 crossref_primary_10_1002_lci2_70019 crossref_primary_10_1016_j_clnu_2025_07_014 crossref_primary_10_1016_j_jhep_2025_05_026 crossref_primary_10_1111_liv_70231 crossref_primary_10_1016_j_clnu_2025_07_019 crossref_primary_10_3390_nu17081328 crossref_primary_10_1016_j_clinre_2025_102543 crossref_primary_10_1007_s11695_025_08246_0 crossref_primary_10_3138_canlivj_2025_0017 crossref_primary_10_3390_nu16203505 crossref_primary_10_26442_00403660_2025_08_203339 crossref_primary_10_1016_j_lanepe_2025_101320 crossref_primary_10_1016_j_jhepr_2025_101358 crossref_primary_10_1002_ejhf_3639 crossref_primary_10_1002_lci2_70021 crossref_primary_10_1016_j_medcle_2025_107044 crossref_primary_10_3390_nu16234225 crossref_primary_10_1507_endocrj_EJ25_0047 crossref_primary_10_1039_D5FO02970H crossref_primary_10_1136_gutjnl_2025_334725 crossref_primary_10_1038_s41598_025_89496_x crossref_primary_10_1111_hiv_70079 crossref_primary_10_3390_nu16203524 crossref_primary_10_1097_PAP_0000000000000483 crossref_primary_10_1001_jamanetworkopen_2025_16367 crossref_primary_10_1111_liv_70226 crossref_primary_10_1111_liv_70104 crossref_primary_10_1111_liv_70225 crossref_primary_10_4330_wjc_v16_i9_502 crossref_primary_10_1111_liv_70109 crossref_primary_10_3748_wjg_v30_i39_4329 crossref_primary_10_1111_hepr_14190 crossref_primary_10_1016_j_jhepr_2025_101589 crossref_primary_10_3390_nu17010085 crossref_primary_10_1002_ehf2_15330 crossref_primary_10_3390_children11101230 crossref_primary_10_1016_j_ijcard_2025_133174 crossref_primary_10_1016_j_cgh_2025_01_047 crossref_primary_10_1016_j_ajpc_2025_101272 crossref_primary_10_1007_s12325_025_03238_z crossref_primary_10_1097_MCG_0000000000002234 crossref_primary_10_1097_HEP_0000000000001342 crossref_primary_10_33920_MED_12_2503_05 crossref_primary_10_1093_jcag_gwae057 crossref_primary_10_1038_s41598_024_77307_8 crossref_primary_10_1210_endrev_bnaf018 crossref_primary_10_1007_s13300_025_01738_3 crossref_primary_10_1016_j_jhepr_2025_101419 crossref_primary_10_14309_ctg_0000000000000806 crossref_primary_10_1016_j_jhepr_2025_101535 crossref_primary_10_1016_j_dld_2024_12_003 crossref_primary_10_1002_lci2_86 crossref_primary_10_1053_j_gastro_2025_02_044 crossref_primary_10_1097_HEP_0000000000001356 crossref_primary_10_1016_j_eprac_2025_07_017 crossref_primary_10_1007_s11377_025_00878_z crossref_primary_10_1038_s41598_025_17396_1 crossref_primary_10_14309_ajg_0000000000003657 crossref_primary_10_3892_mmr_2024_13375 crossref_primary_10_1016_j_dld_2025_08_092 crossref_primary_10_1016_j_gastha_2025_100668 crossref_primary_10_1111_apt_18169 crossref_primary_10_3389_fnut_2025_1606482 crossref_primary_10_1080_14656566_2024_2374463 crossref_primary_10_1093_eurjpc_zwae306 crossref_primary_10_4254_wjh_v17_i3_102286 crossref_primary_10_1007_s10620_025_08912_4 crossref_primary_10_1016_j_phymed_2025_157050 crossref_primary_10_1038_s41572_025_00599_1 crossref_primary_10_4254_wjh_v17_i3_104580 crossref_primary_10_37349_edd_2025_100590 crossref_primary_10_5493_wjem_v14_i4_98543 crossref_primary_10_1053_j_gastro_2025_02_034 crossref_primary_10_1097_HC9_0000000000000583 crossref_primary_10_3390_biomedicines13061346 crossref_primary_10_3390_biomedicines13082004 crossref_primary_10_1080_00365521_2025_2555911 crossref_primary_10_7717_peerj_19377 crossref_primary_10_1016_j_jare_2025_09_033 crossref_primary_10_1111_liv_70311 crossref_primary_10_1007_s12265_025_10699_8 crossref_primary_10_3390_antiox14080956 crossref_primary_10_1007_s11428_025_01309_x crossref_primary_10_1016_j_jhep_2025_04_028 crossref_primary_10_1111_apt_70306 crossref_primary_10_1007_s11033_024_10088_5 crossref_primary_10_1111_1751_2980_13325 crossref_primary_10_1016_j_medcle_2025_106951 crossref_primary_10_1016_j_metabol_2025_156296 crossref_primary_10_1016_j_jhepr_2025_101437 crossref_primary_10_1186_s13098_025_01577_z crossref_primary_10_1016_S2468_1253_25_00097_4 crossref_primary_10_3390_nu17182972 crossref_primary_10_1016_j_medcli_2025_106951 crossref_primary_10_1016_S0140_6736_24_01811_7 crossref_primary_10_1186_s12986_025_00897_1 crossref_primary_10_1055_a_2592_6109 crossref_primary_10_1016_j_jhep_2024_11_043 crossref_primary_10_1097_MCG_0000000000002140 crossref_primary_10_17235_reed_2025_11545_2025 crossref_primary_10_1016_j_jhep_2024_11_049 crossref_primary_10_1038_s41598_025_06151_1 crossref_primary_10_3389_fnut_2025_1594192 crossref_primary_10_1161_CIRCRESAHA_125_325602 crossref_primary_10_1016_j_freeradbiomed_2025_02_017 crossref_primary_10_1016_j_jhep_2025_04_035 crossref_primary_10_1016_j_ajpc_2025_101000 crossref_primary_10_1038_s41423_025_01324_4 crossref_primary_10_3748_wjg_v31_i20_105346 crossref_primary_10_1111_jdi_70050 crossref_primary_10_3748_wjg_v31_i4_99312 crossref_primary_10_3390_biomedicines13092292 crossref_primary_10_1016_j_jhepr_2025_101421 crossref_primary_10_1002_brb3_70222 crossref_primary_10_1038_s41591_025_03654_2 crossref_primary_10_1186_s12876_024_03584_2 crossref_primary_10_1002_fsn3_70904 crossref_primary_10_1136_bmjopen_2024_092731 crossref_primary_10_7759_cureus_84803 crossref_primary_10_1016_j_jhep_2024_09_024 crossref_primary_10_1111_dom_16533 crossref_primary_10_1186_s12933_025_02716_6 crossref_primary_10_12968_hmed_2024_0655 crossref_primary_10_1080_13543784_2025_2473062 crossref_primary_10_1016_j_dsx_2025_103209 crossref_primary_10_1016_j_obpill_2024_100154 crossref_primary_10_1210_clinem_dgae744 crossref_primary_10_1111_apt_18137 crossref_primary_10_3390_nu17182914 crossref_primary_10_1002_bmc_70200 crossref_primary_10_2147_JIR_S533707 crossref_primary_10_4254_wjh_v17_i7_106795 crossref_primary_10_1007_s42000_025_00701_y crossref_primary_10_1016_j_metabol_2025_156391 crossref_primary_10_1186_s12967_025_06464_9 crossref_primary_10_1016_S0140_6736_25_01042_6 crossref_primary_10_1111_jvh_70004 crossref_primary_10_7759_cureus_77146 crossref_primary_10_1210_jendso_bvae218 crossref_primary_10_1016_j_prp_2025_156192 crossref_primary_10_1016_j_obpill_2024_100142 crossref_primary_10_1016_j_clinre_2025_102612 crossref_primary_10_1111_apt_70335 crossref_primary_10_4330_wjc_v16_i10_580 crossref_primary_10_1016_j_lanepe_2025_101272 crossref_primary_10_31832_smj_1684457 crossref_primary_10_1016_j_acra_2025_04_009 crossref_primary_10_3389_fendo_2025_1558194 crossref_primary_10_3389_fnut_2025_1478165 crossref_primary_10_1097_HEP_0000000000001400 crossref_primary_10_3390_ijms26178633 crossref_primary_10_37349_edd_2025_100577 crossref_primary_10_1080_13543784_2024_2441865 crossref_primary_10_1155_sci_6699571 crossref_primary_10_4254_wjh_v17_i7_107668 crossref_primary_10_1097_MCG_0000000000002210 crossref_primary_10_37349_emed_2025_1001334 crossref_primary_10_1097_CP9_0000000000000106 crossref_primary_10_1161_CIRCULATIONAHA_124_070535 crossref_primary_10_1016_j_ajpath_2025_05_009 crossref_primary_10_1111_apt_70107 crossref_primary_10_3389_fmed_2024_1451133 crossref_primary_10_3390_nu16223876 crossref_primary_10_3892_br_2025_2036 crossref_primary_10_1016_S0140_6736_25_01384_4 crossref_primary_10_3390_nu17182932 crossref_primary_10_1016_j_peptides_2025_171380 crossref_primary_10_1056_NEJMra2412865 crossref_primary_10_1111_apt_18273 crossref_primary_10_3350_cmh_2024_0823 crossref_primary_10_4093_dmj_2025_0644 crossref_primary_10_1186_s41043_024_00714_0 crossref_primary_10_1038_s41387_024_00339_6 crossref_primary_10_1007_s00330_025_11944_z crossref_primary_10_1016_j_ejim_2025_02_014 crossref_primary_10_1097_CM9_0000000000003629 crossref_primary_10_1080_1744666X_2025_2514605 crossref_primary_10_1136_flgastro_2024_102705 crossref_primary_10_1016_j_jare_2025_01_014 crossref_primary_10_1111_jdi_14402 crossref_primary_10_1016_j_jhepr_2025_101508 crossref_primary_10_1111_dom_70117 crossref_primary_10_1016_j_jhepr_2025_101507 crossref_primary_10_4254_wjh_v17_i4_104622 crossref_primary_10_3390_jcm14010143 crossref_primary_10_1177_08465371251357447 crossref_primary_10_1177_08465371251357446 crossref_primary_10_1177_08465371251357444 crossref_primary_10_1016_j_ejim_2025_07_025 crossref_primary_10_1016_j_jhep_2024_08_017 crossref_primary_10_3389_fphar_2025_1521416 crossref_primary_10_1016_j_cgh_2025_02_007 crossref_primary_10_1016_j_ejrad_2024_111749 crossref_primary_10_3390_ijms26094256 crossref_primary_10_21518_ms2025_216 crossref_primary_10_1111_liv_16057 crossref_primary_10_1016_S2468_1253_25_00092_5 crossref_primary_10_1111_dom_16333 crossref_primary_10_1111_liv_16055 crossref_primary_10_1002_advs_202411984 crossref_primary_10_24884_1609_2201_2025_104_1_59_64 crossref_primary_10_3389_fphar_2025_1648614 crossref_primary_10_1186_s13098_025_01802_9 crossref_primary_10_3390_biomedicines13071641 crossref_primary_10_3390_microorganisms13020241 crossref_primary_10_3390_diagnostics15131598 crossref_primary_10_1016_j_jhep_2024_08_020 crossref_primary_10_36290_vnl_2025_005 crossref_primary_10_1016_j_fitote_2025_106685 crossref_primary_10_1111_acer_70112 crossref_primary_10_4093_dmj_2025_0469 crossref_primary_10_1016_j_dld_2025_08_006 crossref_primary_10_1016_j_jhep_2024_08_005 crossref_primary_10_1186_s12967_025_06870_z crossref_primary_10_1016_j_jtha_2024_08_018 crossref_primary_10_1097_MEG_0000000000002964 crossref_primary_10_1016_j_jceh_2024_102427 crossref_primary_10_1111_dom_16109 crossref_primary_10_1038_s41575_025_01045_z crossref_primary_10_1093_eurjpc_zwaf004 crossref_primary_10_1111_apt_18444 crossref_primary_10_1097_MD_0000000000044527 crossref_primary_10_1080_07853890_2025_2486594 crossref_primary_10_1111_apt_70256 crossref_primary_10_2147_NSS_S511115 crossref_primary_10_3389_fmed_2025_1623808 crossref_primary_10_1136_egastro_2025_100187 crossref_primary_10_3350_cmh_2024_0737 crossref_primary_10_4093_dmj_2025_0220 crossref_primary_10_3389_fmed_2025_1609751 crossref_primary_10_1371_journal_pone_0316158 crossref_primary_10_1016_j_metabol_2025_156325 crossref_primary_10_1038_s41598_025_04121_1 crossref_primary_10_1590_s0004_2803_24612025_117 crossref_primary_10_31146_1682_8658_ecg_230_10_11_35 crossref_primary_10_1016_j_dld_2025_05_023 crossref_primary_10_2174_0118715303326392241022050205 crossref_primary_10_1093_joccuh_uiaf038 crossref_primary_10_1093_eurjpc_zwaf396 crossref_primary_10_1136_bmjgast_2025_001771 crossref_primary_10_3390_nu17020244 crossref_primary_10_1089_met_2024_0168 crossref_primary_10_2337_dci24_0094 crossref_primary_10_1038_s41575_025_01089_1 crossref_primary_10_1136_egastro_2025_100196 crossref_primary_10_3389_fonc_2025_1565692 crossref_primary_10_1186_s12876_025_04087_4 crossref_primary_10_1016_j_diabres_2025_112151 crossref_primary_10_1016_S2213_8587_25_00141_X crossref_primary_10_1155_ije_6430023 crossref_primary_10_1007_s11332_025_01445_3 crossref_primary_10_1038_s41598_025_08434_z crossref_primary_10_3389_fnut_2025_1644014 crossref_primary_10_1007_s00535_025_02270_8 crossref_primary_10_14309_ajg_0000000000003493 crossref_primary_10_1007_s12072_025_10870_y crossref_primary_10_1016_j_cegh_2025_102041 crossref_primary_10_3389_fendo_2025_1619003 crossref_primary_10_12968_gasn_2024_0120R3 crossref_primary_10_1007_s10620_024_08799_7 crossref_primary_10_31435_ijitss_3_47__2025_3493 crossref_primary_10_1016_j_cgh_2025_02_018 crossref_primary_10_1148_radiol_243780 crossref_primary_10_1016_j_cgh_2025_02_014 crossref_primary_10_1016_j_cgh_2025_02_017 crossref_primary_10_3348_jksr_2025_0024 crossref_primary_10_1002_nbm_70077 crossref_primary_10_1093_schbul_sbaf123 crossref_primary_10_1111_dom_16568 crossref_primary_10_1111_apt_18346 crossref_primary_10_1016_j_freeradbiomed_2025_04_005 crossref_primary_10_1002_14651858_CD015524_pub2 crossref_primary_10_1155_jdr_5555842 crossref_primary_10_3390_diagnostics14182041 crossref_primary_10_3390_gastroent15040071 crossref_primary_10_1016_j_jceh_2025_102512 crossref_primary_10_1016_j_piel_2025_02_015 crossref_primary_10_1016_j_ajhg_2025_06_014 crossref_primary_10_1080_17474124_2025_2468297 crossref_primary_10_1080_19490976_2025_2539448 crossref_primary_10_1002_fsn3_70627 crossref_primary_10_1136_bmjopen_2024_087307 crossref_primary_10_3748_wjg_v31_i10_103716 crossref_primary_10_1016_j_cjca_2025_04_012 crossref_primary_10_1016_j_jhep_2024_07_011 crossref_primary_10_1016_S2468_1253_25_00128_1 crossref_primary_10_1080_00365521_2025_2553284 crossref_primary_10_1152_ajpcell_00951_2024 crossref_primary_10_1111_apt_18413 crossref_primary_10_1111_apt_18412 crossref_primary_10_1111_apt_70044 crossref_primary_10_1111_apt_70286 crossref_primary_10_1002_jpen_2722 crossref_primary_10_3748_wjg_v31_i32_110333 crossref_primary_10_1111_apt_70281 crossref_primary_10_1111_dom_16496 crossref_primary_10_4330_wjc_v17_i7_107751 crossref_primary_10_1016_S2468_1253_25_00226_2 crossref_primary_10_14309_ajg_0000000000003594 crossref_primary_10_1080_19490976_2025_2508951 crossref_primary_10_1016_j_tem_2025_03_006 crossref_primary_10_1016_j_molmed_2025_08_006 crossref_primary_10_33160_yam_2025_05_009 crossref_primary_10_3389_fnut_2024_1426551 crossref_primary_10_1016_j_jhep_2024_07_026 crossref_primary_10_4254_wjh_v17_i4_102978 crossref_primary_10_1002_jgh3_70277 crossref_primary_10_1093_ofid_ofaf369 crossref_primary_10_1186_s12986_025_01000_4 crossref_primary_10_15829_1560_4071_2025_6541 crossref_primary_10_2337_dc25_S004 crossref_primary_10_1007_s11901_025_00698_3 crossref_primary_10_3390_vetsci12030220 crossref_primary_10_1097_MD_0000000000042303 crossref_primary_10_1038_s41467_025_63351_z crossref_primary_10_1111_apt_70178 crossref_primary_10_3390_ijms26125427 crossref_primary_10_1111_apt_70051 crossref_primary_10_1080_00365521_2025_2544305 crossref_primary_10_1111_apt_70174 crossref_primary_10_1002_ueg2_70055 crossref_primary_10_3390_jpm15080357 crossref_primary_10_1002_jgh3_70281 crossref_primary_10_15829_1560_4071_2025_6538 crossref_primary_10_1097_HEP_0000000000001243 crossref_primary_10_3390_ijms26094077 crossref_primary_10_7759_cureus_90861 crossref_primary_10_1172_JCI189953 crossref_primary_10_3389_fnut_2025_1534604 crossref_primary_10_1016_S2468_1253_25_00095_0 crossref_primary_10_1093_toxsci_kfaf116 crossref_primary_10_3389_fendo_2024_1474384 crossref_primary_10_1038_s44355_024_00017_5 crossref_primary_10_2147_DMSO_S528569 crossref_primary_10_1007_s00535_025_02214_2 crossref_primary_10_1016_j_lansea_2025_100644 crossref_primary_10_1016_j_sleh_2025_07_007 crossref_primary_10_1021_acsomega_5c02274 crossref_primary_10_1111_apt_70063 crossref_primary_10_1111_dom_70071 crossref_primary_10_3390_biomedicines13040855 crossref_primary_10_1016_j_aohep_2025_101907 crossref_primary_10_3390_jcm14103422 crossref_primary_10_1097_HEP_0000000000001376 crossref_primary_10_1016_j_cjca_2025_06_075 crossref_primary_10_1016_j_aohep_2025_101900 crossref_primary_10_1038_s41598_025_18172_x crossref_primary_10_4254_wjh_v17_i7_107837 crossref_primary_10_1007_s12072_025_10795_6 crossref_primary_10_3390_ijms26052226 crossref_primary_10_1186_s12933_025_02764_y crossref_primary_10_1016_j_jdiacomp_2025_109045 crossref_primary_10_3350_cmh_2024_0431 crossref_primary_10_1111_apt_70198 crossref_primary_10_31146_1682_8658_ecg_229_9_96_109 crossref_primary_10_3350_cmh_2024_0315 crossref_primary_10_1002_jum_16703 crossref_primary_10_1111_dom_16361
Cites_doi	10.1038/s41575-018-0010-0 10.1016/j.jhep.2018.09.024 10.1503/cmaj.191707 10.1111/joim.12719 10.1016/j.jhep.2023.06.003 10.1002/hep.32145 10.1038/s41598-020-78342-x 10.1016/S2468-1253(19)30383-8 10.1016/S0140-6736(10)61272-X 10.1016/j.jhep.2022.10.010 10.1016/j.cgh.2019.04.062 10.1016/j.jhep.2021.02.034 10.1186/s12916-019-1321-x 10.1016/S0140-6736(23)01174-1 10.1097/MEG.0000000000002517 10.1161/CIR.0000000000001031 10.1016/j.jhep.2023.03.014 10.1016/j.jhep.2023.07.033 10.1016/j.jhep.2016.08.023 10.1038/s41416-018-0007-z 10.1053/j.gastro.2013.06.057 10.1016/j.jhep.2021.12.004 10.1016/j.jhep.2023.04.003 10.1016/j.cgh.2018.12.031 10.1097/TP.0000000000001794 10.1001/jamaoncol.2016.3147 10.1016/j.ijsu.2022.106752 10.1016/j.molmet.2021.101351 10.1186/s12889-021-10991-7 10.1038/s42255-023-00812-z 10.1038/s41591-022-01861-9 10.1016/j.cgh.2019.07.058 10.1002/hep.32294 10.1053/j.gastro.2021.07.049 10.1080/14728222.2021.2018418 10.1016/j.jhep.2020.02.027 10.1016/j.jhep.2019.04.019 10.1016/j.jhep.2022.04.040 10.1148/radiol.2021204288 10.1016/j.ebiom.2023.104747 10.1038/s41575-021-00472-y 10.1016/j.jhep.2018.06.024 10.14309/ajg.0000000000001726 10.1016/j.jhep.2022.07.020 10.1016/j.jhep.2023.03.040 10.1186/s12937-021-00694-5 10.1002/hep.28431 10.3390/nu11102442 10.1136/gutjnl-2022-327672 10.1007/s11695-022-06011-1 10.1016/j.ebiom.2022.104392 10.1002/hep4.1794 10.1002/hep.32204 10.1093/advances/nmy040 10.1016/j.cgh.2020.07.023 10.1136/bmjopen-2021-049767 10.1001/jama.2024.1447 10.1016/j.cmet.2022.12.001 10.1002/hep.27097 10.1007/s00535-011-0431-9 10.1053/j.gastro.2024.03.017 10.1002/hep.31108 10.1016/j.cgh.2020.09.044 10.1002/hep.29848 10.1002/hep.26156 10.1111/apt.17424 10.1371/journal.pone.0074558 10.1002/hep.30664 10.1002/hsr2.352 10.1111/add.13757 10.2337/dc18-0165 10.2337/dc20-2151 10.1136/gutjnl-2020-322572 10.1111/j.1465-3362.2009.00052.x 10.1097/MD.0000000000010214 10.1093/ije/dyz146 10.1053/j.gastro.2022.08.045 10.1001/jamanetworkopen.2022.35003 10.3389/fnut.2021.702802 10.1097/TP.0000000000002361 10.3390/ijerph10083409 10.1093/ajcn/nqaa332 10.1056/NEJMoa0907929 10.1016/S0140-6736(05)67528-9 10.1007/s00261-021-03269-4 10.1016/j.cgh.2018.11.030 10.1056/NEJM199712113372401 10.1002/hep.30967 10.3810/pgm.2012.07.2574 10.1016/j.jceh.2022.11.006 10.1016/j.jhep.2022.09.019 10.1136/bmj.c1240 10.1111/apt.14112 10.1016/j.jhep.2022.10.023 10.1016/j.cgh.2012.09.025 10.1007/s10620-015-4000-6 10.1016/j.cgh.2021.09.042 10.1016/j.metabol.2020.154204 10.1016/S2213-8587(22)00070-5 10.1021/jm4019299 10.1016/j.jhep.2015.10.009 10.1073/pnas.1506113113 10.1002/hep.21669 10.1053/j.gastro.2023.04.025 10.1002/hep.31251 10.1002/hep.30330 10.1111/liv.14818 10.14309/ajg.0000000000000340 10.1016/j.jhep.2019.04.013 10.1017/S0007114520000914 10.1016/j.jhep.2019.09.018 10.1016/j.jhep.2018.01.015 10.1056/NEJMoa1506930 10.1161/CIRCULATIONAHA.109.192644 10.1016/j.jhep.2019.05.008 10.1016/j.jhep.2023.04.031 10.1056/NEJMoa060326 10.1016/j.cgh.2011.07.007 10.1016/j.cgh.2021.09.041 10.1016/j.jhep.2019.06.021 10.7326/0003-4819-159-12-201312170-00729 10.1016/j.cld.2013.09.006 10.1002/hep.30163 10.1136/bmj.c912 10.1016/S2468-1253(20)30252-1 10.1016/j.jhep.2012.03.024 10.1016/j.cgh.2023.12.033 10.1016/j.cgh.2020.04.017 10.1002/hep.32633 10.1016/S2468-1253(23)00270-4 10.1002/hep.30858 10.1016/j.cgh.2020.06.045 10.1007/s10620-015-3821-7 10.1016/j.jhep.2016.12.025 10.1016/S0140-6736(18)31310-2 10.7326/M22-1787 10.1016/j.jhep.2017.11.030 10.1093/aje/kws252 10.1097/TP.0000000000002147 10.1007/s00125-023-06053-9 10.1016/S0140-6736(18)31875-0 10.1038/s41598-019-39998-2 10.1097/HC9.0000000000000183 10.14309/ajg.0000000000001059 10.1038/s41430-020-0563-1 10.1016/j.jhep.2021.05.008 10.1053/j.gastro.2004.02.015 10.1111/apt.17385 10.1002/hep.22367 10.1016/j.cgh.2020.04.084 10.1111/j.1365-2036.2004.02025.x 10.1002/hep.31622 10.1016/j.jhep.2011.04.022 10.1136/gutjnl-2020-322976 10.1016/j.cgh.2015.07.019 10.1002/hep.32545 10.1158/1055-9965.EPI-20-1201 10.14309/ajg.0000000000000715 10.1111/apt.14261 10.1186/s12902-022-01015-5 10.1097/MEG.0000000000002158 10.1136/gutjnl-2020-323106 10.1016/j.jhep.2023.01.030 10.1002/hep.31843 10.1016/j.jhep.2014.02.030 10.1016/j.jhep.2021.08.012 10.1002/ijc.26338 10.7326/0003-4819-137-1-200207020-00006 10.1056/NEJMoa2117872 10.1016/j.jhep.2024.01.014 10.1002/hep.24418 10.1186/s12872-023-03580-6 10.1053/j.gastro.2022.06.023 10.1016/j.cgh.2021.07.010 10.1053/j.gastro.2018.01.064 10.1016/j.clnu.2018.11.030 10.1136/gutjnl-2022-328689 10.1016/j.jhep.2022.01.016 10.1111/apt.12569 10.1016/j.jhep.2015.11.004 10.1002/lt.24958 10.1016/j.jhep.2016.04.023 10.1016/j.jhep.2010.08.030 10.1053/j.gastro.2022.06.073 10.1056/NEJMoa2304286 10.1002/hep.31014 10.1371/journal.pone.0221683 10.1016/j.jhep.2023.05.013 10.1016/j.cgh.2021.05.002 10.1111/ajt.15706 10.1053/j.gastro.2018.09.021 10.1161/CIRCRESAHA.119.314944 10.1111/liv.15185 10.1016/j.jhep.2021.12.031 10.1210/clinem/dgab795 10.1002/hep4.1313 10.1016/j.cgh.2014.04.014 10.1038/s41591-019-0379-5 10.1016/j.tem.2022.08.001 10.1016/j.jhep.2021.10.018 10.1097/MEG.0000000000000973 10.1016/j.alcohol.2020.07.010 10.1136/bmj.f10 10.1002/ijc.33367 10.1016/j.cgh.2023.03.042 10.1002/hep.21763 10.2337/dc23-1937 10.3748/wjg.v22.i32.7236 10.1172/JCI162513 10.1097/HC9.0000000000000108 10.1097/TP.0b013e31822e0bee 10.1016/j.ejca.2012.02.063 10.1016/j.jhep.2018.10.011 10.1007/s11695-022-06289-1 10.3748/wjg.v20.i36.12945 10.1016/j.jhep.2021.02.027 10.1016/j.jhep.2021.10.029 10.1002/jcsm.12039 10.1056/NEJMoa2309000 10.1016/j.jhep.2014.08.036 10.1001/jama.2021.19569 10.1016/j.jhep.2022.11.013 10.1007/s00125-021-05625-x 10.14309/ajg.0000000000000994 10.2337/dc18-1569 10.1016/j.cell.2021.04.015 10.1002/lt.25338 10.1111/1753-0407.13086 10.1016/j.jhep.2021.04.044 10.1055/s-0041-1723751 10.1002/hep.31296 10.1097/TP.0000000000002433 10.1002/hep.29631 10.1002/hep.23280 10.1053/j.gastro.2015.04.005 10.1210/jc.2017-00867 10.1016/j.cgh.2021.09.021 10.1016/j.jhep.2022.08.030 10.1056/NEJMoa1509840 10.1002/hep.30590 10.1002/hep.28992 10.1097/TP.0000000000002175 10.1016/j.jhep.2020.02.020 10.1002/hep.27368 10.1002/hep.27199 10.1016/j.jhep.2021.06.036 10.1053/j.gastro.2020.12.023 10.1016/S2468-2667(18)30230-5 10.1016/S2213-8587(14)70120-2 10.1002/hep.29055 10.3390/jcm12093336 10.1080/19490976.2023.2226922 10.1016/S2468-1253(23)00068-7 10.1016/S0002-9343(96)00197-0 10.1002/hep.32358 10.1016/j.ejim.2023.07.039 10.1016/j.jhep.2013.08.011 10.1371/journal.pone.0263931 10.1016/j.cgh.2021.05.056 10.1002/oby.23503 10.14309/ajg.0000000000001883 10.1016/j.jhep.2022.10.030 10.1002/hep.21327 10.1016/j.eprac.2022.03.010 10.1016/j.cgh.2020.10.034 10.1002/lt.26560 10.1016/j.cgh.2018.11.033 10.1056/NEJMoa1712191 10.1016/j.jhep.2019.01.036 10.1111/apt.15989 10.1002/hep.22575 10.1016/j.jhep.2020.07.025 10.1038/ajg.2016.453 10.1056/NEJMe2314365 10.1002/hep.30857 10.1097/MD.0000000000006585 10.1016/j.jhep.2007.02.013 10.3389/fendo.2022.931519 10.1053/j.gastro.2018.03.038 10.1053/j.gastro.2020.06.006 10.1002/hep.30864 10.1111/ctr.13229 10.1016/S0140-6736(21)01701-3 10.1002/hep.26761 10.1136/gutjnl-2020-322786 10.1136/jech.2007.065607 10.1016/j.jhep.2020.11.024 10.1016/j.metabol.2020.154455 10.1136/gutjnl-2023-330110 10.1016/j.jhep.2023.04.025 10.1016/j.cgh.2012.10.001 10.1111/jgh.16266 10.1097/HEP.0000000000000323 10.1016/j.jhep.2017.09.016 10.1111/jgh.15363 10.1016/j.jhep.2004.10.005 10.1016/j.cgh.2019.04.061 10.1016/j.jhep.2023.03.023 10.1016/j.jhep.2018.05.019 10.1016/j.jhep.2023.02.004 10.1002/lt.25406 10.1016/j.jhep.2016.12.022 10.1016/j.nutres.2022.07.010 10.3390/genes14091811 10.1001/jama.2023.10875 10.1002/hep.28895 10.1038/tpj.2017.45 10.1097/HCO.0000000000001104 10.1007/s10620-022-07601-w 10.1007/s10620-022-07596-4 10.1001/jamanetworkopen.2019.12565 10.1186/s41747-022-00303-y 10.1016/j.jhep.2018.10.033 10.1136/gutjnl-2013-305718 10.1111/dom.13619 10.1053/jhep.2003.50346 10.1002/hep.25855 10.1016/j.jhep.2020.01.013 10.1016/j.cgh.2023.02.003 10.1111/apt.15331 10.1056/NEJMoa2029349 10.1016/j.jhep.2022.10.035 10.1016/j.jhep.2022.11.010 10.1093/ije/dyab174 10.1038/s41574-023-00898-1 10.1177/1756284819878046 10.1002/hep.23727 10.1097/GME.0000000000002133 10.1002/hep.30226 10.1111/jebm.12270 10.1016/S2468-1253(22)00317-X 10.1016/S2468-1253(23)00017-1 10.1016/j.cgh.2019.11.012 10.1016/j.cgh.2017.09.041 10.1007/s11695-017-2847-7 10.1159/000497124 10.1016/j.soard.2018.12.002 10.1097/LVT.0000000000000007 10.1111/jgh.14311 10.1053/j.gastro.2020.07.050 10.1111/j.1365-2036.2008.03869.x 10.1002/hep.31845 10.1002/hep4.1831 10.1016/S2468-1253(19)30184-0 10.1097/SLA.0b013e31818a01ef 10.1016/j.jhep.2023.07.014 10.1056/NEJMoa2036205 10.1111/liv.15335 10.1038/s41416-020-0741-x 10.1016/j.jhep.2015.10.006 10.1002/hep.29607 10.1002/hep.30076 10.1016/j.cgh.2017.04.016 10.1053/j.gastro.2021.03.003 10.2337/dc15-0575 10.1002/hep.32049 10.1111/jgh.16035 10.1016/S2468-1253(19)30320-6 10.1016/j.cgh.2023.04.024 10.4254/wjh.v10.i11.877 10.1016/j.jhep.2014.12.005 10.1016/j.jhep.2018.03.019 10.1053/j.gastro.2016.01.004 10.1056/NEJMoa2028395 10.21101/cejph.a6239 10.1053/j.gastro.2015.03.044 10.1016/j.cgh.2017.08.014 10.1111/joim.13343 10.1016/j.jhep.2022.03.031 10.1016/j.jhep.2018.08.011 10.1136/gutjnl-2020-323082 10.1001/jamanetworkopen.2023.3513 10.1002/hep.23527 10.1016/j.clnu.2022.06.037 10.1053/j.gastro.2014.04.046 10.1016/j.jhep.2021.11.012 10.1053/j.gastro.2020.12.003 10.1016/j.clnu.2021.12.014 10.1002/hep.29302 10.1016/j.jhep.2020.06.007 10.1002/hep.31309 10.1371/journal.pmed.1001680 10.1016/j.cgh.2011.01.023 10.1016/j.cgh.2021.11.001 10.1002/hep.30418 10.1002/hep.21496 10.1016/S2213-8587(19)30187-1 10.1002/lt.26074 10.1053/j.gastro.2018.08.024 10.1016/j.jhep.2023.08.018 10.1111/apt.14990 10.1007/s00125-022-05769-4 10.1053/j.gastro.2008.06.047 10.1002/lt.25637 10.1053/jhep.2002.33713 10.1016/S2468-1253(21)00308-3 10.1111/apt.17308 10.1002/hep.32207 10.1053/j.gastro.2020.01.043 10.1111/apt.13505 10.1097/MEG.0000000000001105 10.1016/j.eclinm.2023.102310 10.1016/S0140-6736(19)33041-7 10.1016/j.clnu.2018.12.022 10.1136/gutjnl-2021-324264 10.1136/gut.2011.242073 10.1111/ajt.13779 10.1016/S0140-6736(15)00803-X 10.1111/apt.17734 10.1371/journal.pone.0173499 10.1016/j.cgh.2021.01.023 10.1016/S2468-1253(23)00150-4 10.1038/s41591-020-1116-9 10.1016/j.clnu.2021.11.014 10.1016/j.jhep.2021.05.025 10.1002/lt.26219 10.1016/S2468-1253(23)00141-3 10.1038/s41591-023-02603-1 10.1210/jc.2015-1966 10.1016/j.jhep.2023.04.036 10.1111/liv.14279 10.7326/M15-1774 10.1002/lt.23936 10.1002/hep.510250120 10.1136/gutjnl-2022-327777 10.1002/hep.32047 10.1007/s00330-019-06072-4 10.2337/dc21-1335 10.1016/S2213-8587(23)00329-7 10.1016/j.cgh.2020.05.021 10.1016/S2468-1253(19)30181-5 10.1038/s41575-023-00800-4 10.1016/j.jhep.2022.04.003 10.1016/j.nut.2013.05.016 10.1371/journal.pone.0147237 10.1007/s00330-020-07223-8 10.1097/MEG.0000000000002641 10.1055/s-0038-1677517 10.7570/jomes23031 10.1053/j.gastro.2019.09.008 10.1007/s00464-020-07555-y 10.1016/j.jhep.2019.04.011 10.1136/gutjnl-2023-330269 10.1016/j.drudis.2012.05.012 10.1016/j.cgh.2021.12.043 10.1016/j.gastha.2023.07.018 10.1038/s41591-023-02539-6 10.1016/j.cgh.2020.12.016 10.1016/j.jhep.2024.03.023 10.1016/j.jhep.2023.07.004 10.1097/HEP.0000000000000004 10.1038/ajg.2011.327 10.1053/j.gastro.2016.01.032 10.1002/mrm.20825 10.1002/hep.31655 10.14309/ajg.0000000000002222 10.1111/j.1600-6143.2012.04318.x 10.1111/acer.14271 10.1053/j.jvca.2021.07.020 10.1002/hep.29329 10.1016/j.aohep.2020.08.071 10.1002/hep.31158 10.1053/j.gastro.2009.01.053 10.1016/j.soard.2017.09.528 10.1016/S0140-6736(22)00847-9 10.1007/s12072-015-9679-0 10.1053/j.gastro.2023.06.027 10.1093/ajcn/nqaa380 10.1007/s11154-023-09796-3 10.1053/j.gastro.2023.01.040 10.1016/j.clnu.2023.03.021 10.1016/S0140-6736(21)00536-5 10.1016/j.jhep.2022.03.026 10.1016/S2468-1253(23)00443-0 10.1016/S0140-6736(14)61933-4 10.1038/ajg.2016.517 10.1056/NEJMoa2401755 10.1055/s-2002-30102 10.1002/hep.30368 10.1007/s00125-017-4340-1 10.1001/jama.2023.12618 10.1016/S2468-1253(20)30077-7 10.1111/apt.14937 10.1016/S0140-6736(19)32517-6 10.1016/j.cld.2023.01.002 10.1002/hep.20092 10.1017/S0007114519003301 10.1016/j.jhep.2021.12.022 10.1016/j.jhep.2019.12.022 10.1016/S0140-6736(23)00634-7 10.1007/s12072-022-10414-8 10.1111/j.1440-1746.2011.06951.x 10.1016/j.cgh.2020.08.061 10.1016/j.jhep.2022.11.025 10.1136/gutjnl-2021-324191 10.1016/j.jhep.2019.08.019 10.1038/s41591-023-02553-8 10.1016/j.cgh.2014.07.037 10.2337/dc22-2048 10.1002/hep.30362 10.1053/j.gastro.2004.08.052 10.1002/hep.29660 10.7150/thno.40249 10.2337/dc19-0641 10.1017/S0007114522003956 10.1097/MD.0000000000014918 10.1053/j.gastro.2017.08.012 10.1042/bj3480607 10.1016/j.metabol.2023.155642 10.1002/hep.23312 10.1210/clinem/dgac660 10.1007/s10620-016-4044-2 10.1016/S2213-8587(22)00003-1 10.1186/s13000-022-01247-y 10.1016/j.jhep.2018.03.018
ContentType	Journal Article
Contributor	Wai-Sun Wong, Vincent Gastaldelli, Amalia Roden, Michael Frühbeck, Gema Ratziu, Vlad Tacke, Frank Dicker, Dror Schick, Fritz Bugianesi, Elisabetta Yki-Järvinen, Hannele Zelber-Sagi, Shira Valenti, Luca Horn, Paul Francque, Sven Vettor, Roberto
Contributor_xml	– sequence: 1 givenname: Frank surname: Tacke fullname: Tacke, Frank – sequence: 2 givenname: Paul surname: Horn fullname: Horn, Paul – sequence: 3 givenname: Vincent surname: Wai-Sun Wong fullname: Wai-Sun Wong, Vincent – sequence: 4 givenname: Vlad surname: Ratziu fullname: Ratziu, Vlad – sequence: 5 givenname: Elisabetta surname: Bugianesi fullname: Bugianesi, Elisabetta – sequence: 6 givenname: Sven surname: Francque fullname: Francque, Sven – sequence: 7 givenname: Shira surname: Zelber-Sagi fullname: Zelber-Sagi, Shira – sequence: 8 givenname: Luca surname: Valenti fullname: Valenti, Luca – sequence: 9 givenname: Michael surname: Roden fullname: Roden, Michael – sequence: 10 givenname: Fritz surname: Schick fullname: Schick, Fritz – sequence: 11 givenname: Hannele surname: Yki-Järvinen fullname: Yki-Järvinen, Hannele – sequence: 12 givenname: Amalia surname: Gastaldelli fullname: Gastaldelli, Amalia – sequence: 13 givenname: Roberto surname: Vettor fullname: Vettor, Roberto – sequence: 14 givenname: Gema surname: Frühbeck fullname: Frühbeck, Gema – sequence: 15 givenname: Dror surname: Dicker fullname: Dicker, Dror
Copyright	2024 The Author(s) Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.
Copyright_xml	– notice: 2024 The Author(s) – notice: Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.
CorporateAuthor	European Association for the Study of the Liver (EASL) European Association for the Study of Diabetes (EASD) European Association for the Study of Obesity (EASO)
CorporateAuthor_xml	– name: European Association for the Study of Diabetes (EASD) – name: European Association for the Study of Obesity (EASO) – name: European Association for the Study of the Liver (EASL)
DBID	6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.jhep.2024.04.031
DatabaseName	ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1600-0641
EndPage	542
ExternalDocumentID	38851997 10_1016_j_jhep_2024_04_031 S0168827824003295
Genre	Journal Article Practice Guideline
GroupedDBID	--- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LZ1 M27 M41 MJL MO0 N9A O-L O9- OAUVE OC. ON0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UV1 WUQ X7M YOC Z5R ZGI ~G- ~HD 6I. AACTN AAFTH AFCTW AFKWA AJOXV AMFUW RIG 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c4321-aa5cc0eaac7006c9f25467689322b88511be0f30a7919ceb3c7cf6f60c28ef2b3
ISSN	0168-8278 1600-0641
IngestDate	Sun Nov 09 11:02:59 EST 2025 Mon Jul 21 05:51:32 EDT 2025 Sat Nov 29 02:17:18 EST 2025 Tue Nov 18 21:27:36 EST 2025 Sat Aug 24 15:41:32 EDT 2024 Tue Oct 14 19:36:55 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Language	English
License	This is an open access article under the CC BY-NC license. Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c4321-aa5cc0eaac7006c9f25467689322b88511be0f30a7919ceb3c7cf6f60c28ef2b3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23
OpenAccessLink	https://www.clinicalkey.com/#!/content/1-s2.0-S0168827824003295
PMID	38851997
PQID	3065982421
PQPubID	23479
PageCount	51
ParticipantIDs	proquest_miscellaneous_3065982421 pubmed_primary_38851997 crossref_citationtrail_10_1016_j_jhep_2024_04_031 crossref_primary_10_1016_j_jhep_2024_04_031 elsevier_sciencedirect_doi_10_1016_j_jhep_2024_04_031 elsevier_clinicalkey_doi_10_1016_j_jhep_2024_04_031
PublicationCentury	2000
PublicationDate	September 2024 2024-09-00 20240901
PublicationDateYYYYMMDD	2024-09-01
PublicationDate_xml	– month: 09 year: 2024 text: September 2024
PublicationDecade	2020
PublicationPlace	Netherlands
PublicationPlace_xml	– name: Netherlands
PublicationTitle	Journal of hepatology
PublicationTitleAlternate	J Hepatol
PublicationYear	2024
Publisher	Elsevier B.V
Publisher_xml	– name: Elsevier B.V
References	Vallet-Pichard, Mallet, Nalpas (bib136) 2007; 46 Wolf, Rich, Marrero (bib249) 2021; 73 Myung, Ju, Cho (bib370) 2013; 346 Salmon-Gomez, Catalan, Fruhbeck (bib529) 2023; 24 Younossi, Paik, Stepanova (bib4) 2024; 80 Ratziu, Rinella, Neuschwander-Tetri (bib383) 2022; 76 Vallin, Guillaud, Boillot (bib515) 2014; 20 Lee, Han, Lee (bib483) 2022; 16 Abdelbasset, Tantawy, Kamel (bib321) 2019; 98 Wong, Chan, Choi (bib474) 2013; 11 Latva-Rasku, Honka, Kullberg (bib416) 2019; 42 Sookoian, Castaño, Pirola (bib89) 2014; 63 Argo, Patrie, Lackner (bib387) 2015; 62 Sjöholm, Carlsson, Svensson (bib438) 2022; 45 Marti-Aguado, Clemente-Sanchez, Bataller (bib113) 2022; 77 Yaskolka, Rinott, Tsaban (bib287) 2021; 70 Montano-Loza, Angulo, Meza-Junco (bib450) 2016; 7 Hajifathalian, Torabi Sagvand, McCullough (bib88) 2019; 70 Montano-Loza, Rodríguez-Perálvarez, Pageaux (bib510) 2023; 78 Ma, Yang, Li (bib111) 2019; 48 Harrison, Manghi, Smith (bib417) 2022; 28 . Jamialahmadi, Mancina, Ciociola (bib203) 2021; 160 Romero-Gomez, Lawitz, Shankar (bib406) 2023; 79 Sharma, Stine, Verbeek (bib484) 2022; 36 Ma, Yang, Simon (bib105) 2019; 70 Sripongpun, Kim, Mannalithara (bib145) 2023; 77 O’Gorman, Naimimohasses, Monaghan (bib318) 2020; 52 Harrison, Taub, Neff (bib362) 2023; 29 Vilar-Gomez, Vuppalanchi, Desai (bib430) 2019; 50 Askgaard, Grønbæk, Kjær (bib94) 2015; 62 Xiao, Ng, Chan (bib26) 2023; 13 Rynders, Thomas, Zaman (bib293) 2019; 11 VanWagner, Serper, Kang (bib513) 2016; 16 Ozturk, Olson, Samir (bib150) 2022; 47 Gunturu, Castillo-Larios, Bowers (bib506) 2022; 32 Wharton, Lau, Vallis (bib282) 2020; 192 Bhurwal, Rattan, Yoshitake (bib342) 2020; 29 Valenti, Pelusi, Bianco (bib20) 2021; 5 Bjelakovic, Nikolova, Gluud (bib369) 2013; 8 Selvaraj, Mózes, Jayaswal (bib157) 2021; 75 Pais, Fartoux, Goumard (bib232) 2017; 46 Henry, Paik, Austin (bib324) 2023; 57 Loomba, Huang, Sanyal (bib186) 2023; 72 Byrne, Targher (bib227) 2020; 72 Haas, Pirruccello, Friedman (bib205) 2021; 1 Dormandy, Charbonnel, Eckland (bib421) 2005; 366 Perumpail, Wong, Ahmed (bib236) 2015; 60 (bib139) 2021; 75 Bogumil, Park, Le Marchand (bib106) 2019; 3 (bib3) 2016; 64 Choi, Brouwer, Zanjir (bib10) 2020; 71 Kim, Tamaki, Imajo (bib172) 2022; 77 Scorletti, Creasy, Vujkovic (bib367) 2022; 117 Anastácio, Ferreira, de Sena Ribeiro (bib509) 2011; 92 Hinkson, Lally, Gibson (bib147) 2023; 57 Newsome, Sasso, Deeks (bib168) 2020; 5 Vilarinho, Ajmera, Zheng (bib208) 2021; 74 Properzi, O’Sullivan, Sherriff (bib298) 2018; 68 Mansour, Mohajeri-Tehrani, Samadi (bib343) 2021; 20 Ajmera, Cepin, Tesfai (bib49) 2023; 78 Pirmoazen, Khurana, El Kaffas (bib154) 2020; 10 Siddiqui, Harrison, Abdelmalek (bib256) 2018; 67 Hashida, Kawaguchi, Bekki (bib316) 2017; 66 Imajo, Honda, Kobayashi (bib159) 2022; 20 Eslam, Wong, Hashem (bib149) 2021; 116 Truong, Gornbein, Yang (bib357) 2023; 21 Huang, Wilson, Behling (bib53) 2023; 165 Dongiovanni, Romeo, Valenti (bib532) 2014; 20 Julian, Ballesta, Pera (bib63) 2022; 13 Deutsch, Ahlqvist, Udler (bib58) 2022; 65 Zhang, Yip, Wong (bib128) 2023; 72 “The Oxford Levels of Evidence 2”. Oxford Centre for Evidence-Based Medicine. [Available from Lai, Tandon, Bernal (bib446) 2021; 74 Prati, Taioli, Zanella (bib19) 2002; 137 Fakhry, Mhaskar, Schwitalla (bib440) 2019; 15 Owen, Doran, Halestrap (bib464) 2000; 348 Ratziu, Sanyal, Harrison (bib265) 2020; 72 Machann, Thamer, Schnoedt (bib165) 2006; 55 Hassan, Abdel-Wahab, Kaseb (bib48) 2015; 149 Wah Kheong, Nik Mustapha, Mahadeva (bib395) 2017; 15 (bib527) 2018; 69 Kernan, Viscoli, Furie (bib422) 2016; 374 Zhang, Gu, Bian (bib110) 2021; 113 Gastaldelli (bib221) 2022; 30 Kahl, Gancheva, Straßburger (bib415) 2020; 43 Khan, Foster, Chowdhury (bib466) 2012; 124 Sanyal, Chalasani, Kowdley (bib372) 2010; 362 Simon, Roelstraete, Khalili (bib18) 2021; 70 Marin-Alejandre, Cantero, Perez-Diaz-Del-Campo (bib286) 2021; 41 Harrison, Ratziu, Magnanensi (bib352) 2023; 79 Chikritzhs, Fillmore, Stockwell (bib80) 2009; 28 Hallsworth, Fattakhova, Hollingsworth (bib315) 2011; 60 Mosko, Nguyen (bib503) 2011; 9 Karlas, Petroff, Sasso (bib166) 2017; 66 Vilar-Gomez, Martinez-Perez, Calzadilla-Bertot (bib280) 2015; 149 Kelly, Pietranico-Cole, Larigan (bib349) 2014; 57 Lassailly, Caiazzo, Ntandja-Wandji (bib443) 2020; 159 Yasui, Hashimoto, Komorizono (bib234) 2011; 9 Malehmir, Pfister, Gallage (bib273) 2019; 25 Ma, Hennein, Liu (bib102) 2018; 155 Cusi, Isaacs, Barb (bib125) 2022; 28 Armstrong, Gaunt, Aithal (bib400) 2016; 387 Zelber-Sagi, Ivancovsky-Wajcman, Fliss Isakov (bib303) 2018; 68 Abul-Husn, Cheng, Li (bib200) 2018; 378 Lindor, Kowdley, Heathcote (bib373) 2004; 39 Khurshid, Al-Alusi, Churchill (bib328) 2023; 330 Hakim, Zhang, DeLisle (bib209) 2019; 70 Kim, Kim, Kim (bib180) 2013; 57 Anstee, Castera, Loomba (bib153) 2022; 76 Gastaldelli, Cusi, Fernandez Lando (bib404) 2022; 10 Sanyal, Anstee, Trauner (bib259) 2022; 75 Zhang, Harmsen, Mettler (bib432) 2014; 60 Toyoda, Fujii, Iwaki (bib536) 2023; 2 Castera, Garteiser, Laouenan (bib171) 2024 Asfari, Niyazi, Lopez (bib64) 2017; 29 Simon, Kim, Luo (bib115) 2020; 72 Ajmera, Kim, Yang (bib170) 2022; 163 Younossi, Ratziu, Loomba (bib381) 2019; 394 Peng, Li, Zhao (bib300) 2022; 22 Younossi, Stepanova, Ong (bib87) 2019; 17 Hassani, Mansoori, Hosseinzadeh (bib296) 2021; 36 Etemadi, Sinha, Ward (bib302) 2017; 357 Ren, Zhou, Zhang (bib445) 2022; 13 Andreeva, Egnell, Touvier (bib118) 2021; 29 Pais, Aron-Wisnewsky, Bedossa (bib442) 2022; 76 Xourafa, Korbmacher, Roden (bib216) 2024; 20 Stafylidou, Paschos, Katsoula (bib477) 2019; 17 Xiao, Zhu, Xiao (bib158) 2017; 66 Abeysekera, Valenti, Younossi (bib174) 2024; 9 Lin, Lee, Yip (bib184) 2024; 331 Ascha, Hanouneh, Lopez (bib101) 2010; 51 Luu, Behari, Goh (bib116) 2021; 30 Shang, Grip, Modica (bib17) 2024 Lichtenstein, Appel, Vadiveloo (bib310) 2021; 144 Nevens, Andreone, Mazzella (bib379) 2016; 375 Francque, Bedossa, Ratziu (bib425) 2021; 385 Yoo, Park, Cho (bib73) 2023; 12 Zhao, Zhang, Coday (bib112) 2023; 330 Goyal, Nohria, Goyal (bib427) 2020; 10 Vilar-Gomez, Nephew, Vuppalanchi (bib37) 2022; 75 Liu, Zhong, Tan (bib24) 2019; 9 Taylor, Taylor, Bayliss (bib121) 2020; 158 Liu, Balkwill, Reeves (bib44) 2010; 340 Zhang, Fu, Liu (bib469) 2023; 35 Ekstedt, Franzen, Mathiesen (bib43) 2006; 44 Younes, Caviglia, Govaere (bib182) 2021; 75 Pelusi, Ronzoni, Malvestiti (bib210) 2022; 42 Vilar-Gomez, Vuppalanchi, Gawrieh (bib309) 2023; 118 Ekstedt, Franzen, Mathiesen (bib470) 2007; 47 Sanyal, Abdelmalek, Suzuki (bib386) 2014; 147 Kim, An, Lim (bib252) 2017; 3 Åberg, Färkkilä, Männistö (bib83) 2020; 44 Wong, Ekstedt, Wong (bib119) 2023; 79 Tariq, Saharia, Nwokedi (bib508) 2023; 29 Aron-Wisnewsky, Minville, Tordjman (bib65) 2012; 56 Bradley, Cox, Palaniyappan (bib189) 2022; 6 Yip, Chan, Wong (bib465) 2021; 4 Zamora-Valdes, Watt, Kellogg (bib505) 2018; 68 Lin, Yip, Zhang (bib120) 2023; 77 Dongiovanni, Stender, Pietrelli (bib201) 2018; 283 Soldera, Camazzola, Rodriguez (bib492) 2018; 10 Reig, Gambato, Man (bib242) 2019; 103 Rich, Oji, Mufti (bib71) 2018; 16 Kim, Lo, Corey (bib109) 2022; 41 Zhang, Pan, Chen (bib117) 2020; 122 Ciardullo, Cannistraci, Muraca (bib229) 2023 Chen, Banini, Do (bib319) 2023; 14 Golabi, Otgonsuren, de Avila (bib35) 2018; 97 Sanyal, Castera, Wong (bib257) 2023; 21 Sanyal, Shankar, Yates (bib354) 2023; 29 Cherubini, Ostadreza, Jamialahmadi (bib197) 2023; 29 Angulo, Bugianesi, Bjornsson (bib176) 2013; 145 Wei, Lin, Huang (bib288) 2023; 6 Tapper, Hunink, Afdhal (bib133) 2016; 11 Bischoff, Ockenga, Eshraghian (bib456) 2023; 42 Tsochatzis, Watt, VanWagner (bib488) 2023; 78 Chitturi, George (bib467) 2002; 22 Ekstedt, Hagstrom, Nasr (bib32) 2015; 61 Åberg, Byrne, Pirola (bib75) 2023; 78 Nascimbeni, Lebray, Fedchuk (bib188) 2015; 13 van Kleef, Francque, Prieto-Ortiz (bib144) 2024 Anushiravani, Alswat, Dalekos (bib142) 2023; 35 Puri, Baillie, Wiest (bib385) 2007; 46 Athyros, Tziomalos, Gossios (bib389) 2010; 376 Patton, Heimbach, McCullough (bib500) 2021; 19 Orci, Sanduzzi-Zamparelli, Caballol (bib239) 2022; 20 Thomas, Vedel-Krogh, Nordestgaard (bib530) 2024; 39 Ajmera, Terrault, Harrison (bib533) 2017; 65 Stine, Munaganuru, Barnard (bib262) 2021; 19 Harrison, Rossi, Paredes (bib264) 2020; 71 Simon, Patorno, Schneeweiss (bib409) 2022; 20 Aminian, Al-Kurd, Wilson (bib439) 2021; 326 Ridderstråle, Andersen, Zeller (bib413) 2014; 2 Sinn, Kang, Cho (bib334) 2021; 33 Plank, Gane, Peng (bib457) 2008; 48 Fan, Papatheodoridis, Sun (bib535) 2020; 73 Wong, Vergniol, Wong (bib152) 2010; 51 Ezpeleta, Gabel, Cienfuegos (bib283) 2023; 35 Berzigotti, Garcia-Tsao, Bosch (bib45) 2011; 54 Sabag, Barr, Armour (bib317) 2022; 107 Loomba, Friedman, Shulman (bib33) 2021; 184 Crosby, Davis, Joshi (bib292) 2021; 8 Loomba, Yang, Su (bib96) 2013; 177 Nahra, Wang, Gadde (bib405) 2021; 44 Isokuortti, Zhou, Peltonen (bib220) 2017; 60 Azhie, Sheth, Hammad (bib521) 2021; 27 Morris, Jung, Kim (bib524) 2019; 25 Kim, Vazquez-Montesino, Li (bib311) 2020; 72 Simpson, Hermon, Liu (bib95) 2019; 4 Singh, Allen, Wang (bib62) 2015; 13 Jaroenlapnopparat, Charoenngam, Ponvilawan (bib67) 2023; 30 Holmer, Lindqvist, Petersson (bib294) 2021; 3 De Vincentis, Tavaglione, Jamialahmadi (bib207) 2022; 20 Staufer, Huber-Schonauer, Strebinger (bib76) 2022; 77 Kim, Murag, Cholankeril (bib322) 2021; 19 Wong, Wong, Chan (bib333) 2018; 69 (bib78) 2022; 400 Harrison, Fecht, Brunt (bib434) 2009; 49 Verna, Phipps, Halazun (bib486) 2023; 29 (bib497) 2016; 64 Sharpton, Terrault, Posselt (bib504) 2019; 25 Corey, Klebanoff, Tramontano (bib134) 2016; 61 Fatourou, Tsochatzis (bib512) 2019; 4 Chun, Lee, Lee (bib323) 2023; 21 Thun, Peto, Lopez (bib79) 1997; 337 VanWagner, Ning, Allen (bib99) 2017; 153 Chen, Wang, Wang (bib531) 2012; 48 Zaharia, Strassburger, Strom (bib219) 2019; 7 He, Li, Guo (bib299) 2020; 124 Aberg, Helenius-Hietala, Puukka (bib84) 2018; 67 Cusi (bib363) 2024; 390 Simon, Henson, Osganian (bib274) 2019; 17 Haam, Kim, Kim (bib41) 2023; 32 Rosenberg, Voelker, Thiel (bib146) 2004; 127 Ratziu, Tacke (bib364) 2023; 79 Koutny, Aigner, Datz (bib39) 2023; 118 Jung, Loomba, Imajo (bib169) 2021; 70 Walker, El-Serag, Sada (bib248) 2016; 43 Mantovani, Petracca, Beatrice (bib30) 2022; 71 Alberti, Eckel, Grundy (bib42) 2009; 120 Brunt, Kleiner, Wilson (bib261) 2019; 70 Z Iwasa (10.1016/j.jhep.2024.04.031_bib452) 2013; 29 Muniraj (10.1016/j.jhep.2024.04.031_bib498) 2021; 160 Ye (10.1016/j.jhep.2024.04.031_bib329) 2020; 5 Galvin (10.1016/j.jhep.2024.04.031_bib517) 2019; 25 Wolf (10.1016/j.jhep.2024.04.031_bib249) 2021; 73 Montano-Loza (10.1016/j.jhep.2024.04.031_bib450) 2016; 7 Loomba (10.1016/j.jhep.2024.04.031_bib33) 2021; 184 Kanwal (10.1016/j.jhep.2024.04.031_bib244) 2018; 155 Traussnigg (10.1016/j.jhep.2024.04.031_bib377) 2019; 4 van Kleef (10.1016/j.jhep.2024.04.031_bib144) 2024 Rynders (10.1016/j.jhep.2024.04.031_bib293) 2019; 11 Chitturi (10.1016/j.jhep.2024.04.031_bib467) 2002; 22 Ozturk (10.1016/j.jhep.2024.04.031_bib150) 2022; 47 DiJoseph (10.1016/j.jhep.2024.04.031_bib325) 2023; 68 Abdel-Rahman (10.1016/j.jhep.2024.04.031_bib74) 2017; 10 Hughes (10.1016/j.jhep.2024.04.031_bib254) 2021; 19 Hayat (10.1016/j.jhep.2024.04.031_bib338) 2021; 20 Anstee (10.1016/j.jhep.2024.04.031_bib153) 2022; 76 Valenti (10.1016/j.jhep.2024.04.031_bib20) 2021; 5 Dunn (10.1016/j.jhep.2024.04.031_bib90) 2012; 57 Zelber-Sagi (10.1016/j.jhep.2024.04.031_bib291) 2022; 42 O’Gorman (10.1016/j.jhep.2024.04.031_bib318) 2020; 52 Rehm (10.1016/j.jhep.2024.04.031_bib82) 2017; 112 Stine (10.1016/j.jhep.2024.04.031_bib262) 2021; 19 Harrison (10.1016/j.jhep.2024.04.031_bib362) 2023; 29 Mosca (10.1016/j.jhep.2024.04.031_bib308) 2017; 66 (10.1016/j.jhep.2024.04.031_bib77) 2018; 392 Zamora-Valdes (10.1016/j.jhep.2024.04.031_bib505) 2018; 68 Marrero (10.1016/j.jhep.2024.04.031_bib97) 2005; 42 Pais (10.1016/j.jhep.2024.04.031_bib232) 2017; 46 Wong (10.1016/j.jhep.2024.04.031_bib152) 2010; 51 Alonso-Merino (10.1016/j.jhep.2024.04.031_bib348) 2016; 113 Huang (10.1016/j.jhep.2024.04.031_bib53) 2023; 165 Vilar-Gomez (10.1016/j.jhep.2024.04.031_bib37) 2022; 75 Holmer (10.1016/j.jhep.2024.04.031_bib294) 2021; 3 Kim (10.1016/j.jhep.2024.04.031_bib322) 2021; 19 Musso (10.1016/j.jhep.2024.04.031_bib518) 2014; 11 Pelusi (10.1016/j.jhep.2024.04.031_bib196) 2019; 9 Naveau (10.1016/j.jhep.2024.04.031_bib85) 1997; 25 Liu (10.1016/j.jhep.2024.04.031_bib107) 2021; 73 Hansen (10.1016/j.jhep.2024.04.031_bib290) 2023; 176 Herder (10.1016/j.jhep.2024.04.031_bib59) 2022; 65 Buzzetti (10.1016/j.jhep.2024.04.031_bib295) 2021; 6 Kalavalapalli (10.1016/j.jhep.2024.04.031_bib222) 2023; 108 Sharma (10.1016/j.jhep.2024.04.031_bib539) 2017 Elsaid (10.1016/j.jhep.2024.04.031_bib437) 2022; 5 Yip (10.1016/j.jhep.2024.04.031_bib465) 2021; 4 Kernan (10.1016/j.jhep.2024.04.031_bib422) 2016; 374 Haas (10.1016/j.jhep.2024.04.031_bib205) 2021; 1 Shang (10.1016/j.jhep.2024.04.031_bib17) 2024 Sanyal (10.1016/j.jhep.2024.04.031_bib122) 2021; 385 Liu (10.1016/j.jhep.2024.04.031_bib301) 2023; 130 Xourafa (10.1016/j.jhep.2024.04.031_bib216) 2024; 20 Malespin (10.1016/j.jhep.2024.04.031_bib281) 2022; 20 Khurshid (10.1016/j.jhep.2024.04.031_bib328) 2023; 330 Vilar-Gomez (10.1016/j.jhep.2024.04.031_bib280) 2015; 149 Lichtenstein (10.1016/j.jhep.2024.04.031_bib310) 2021; 144 Stafylidou (10.1016/j.jhep.2024.04.031_bib477) 2019; 17 Sarasin (10.1016/j.jhep.2024.04.031_bib238) 1996; 101 Newsome (10.1016/j.jhep.2024.04.031_bib397) 2023; 79 Sanyal (10.1016/j.jhep.2024.04.031_bib408) 2024 Harrison (10.1016/j.jhep.2024.04.031_bib350) 2024; 390 Kim (10.1016/j.jhep.2024.04.031_bib225) 2008; 48 Kleiner (10.1016/j.jhep.2024.04.031_bib260) 2019; 2 Loomba (10.1016/j.jhep.2024.04.031_bib403) 2021; 73 Hinkson (10.1016/j.jhep.2024.04.031_bib147) 2023; 57 Tsochatzis (10.1016/j.jhep.2024.04.031_bib489) 2019; 103 Chen (10.1016/j.jhep.2024.04.031_bib194) 2023; 164 Chen (10.1016/j.jhep.2024.04.031_bib339) 2019; 38 Behari (10.1016/j.jhep.2024.04.031_bib243) 2023; 7 Zhang (10.1016/j.jhep.2024.04.031_bib463) 2022; 76 Jamali (10.1016/j.jhep.2024.04.031_bib459) 2022; 117 Ebrahimi (10.1016/j.jhep.2024.04.031_bib9) 2023; 79 Vilar-Gomez (10.1016/j.jhep.2024.04.031_bib430) 2019; 50 Hu (10.1016/j.jhep.2024.04.031_bib479) 2021; 31 Wong (10.1016/j.jhep.2024.04.031_bib119) 2023; 79 Meena (10.1016/j.jhep.2024.04.031_bib454) 2023; 38 Chalasani (10.1016/j.jhep.2024.04.031_bib391) 2004; 126 Bril (10.1016/j.jhep.2024.04.031_bib217) 2023; 27 Hagstrom (10.1016/j.jhep.2024.04.031_bib23) 2022; 292 Selvaraj (10.1016/j.jhep.2024.04.031_bib157) 2021; 75 Malehmir (10.1016/j.jhep.2024.04.031_bib273) 2019; 25 Brown (10.1016/j.jhep.2024.04.031_bib412) 2021; 398 Angulo (10.1016/j.jhep.2024.04.031_bib176) 2013; 145 Hagstrom (10.1016/j.jhep.2024.04.031_bib177) 2019; 17 Harrison (10.1016/j.jhep.2024.04.031_bib70) 2021; 75 Zaharia (10.1016/j.jhep.2024.04.031_bib219) 2019; 7 White (10.1016/j.jhep.2024.04.031_bib241) 2012; 10 Properzi (10.1016/j.jhep.2024.04.031_bib298) 2018; 68 Mak (10.1016/j.jhep.2024.04.031_bib214) 2023; 78 Gibson (10.1016/j.jhep.2024.04.031_bib528) 2020; 123 Linden-Torres (10.1016/j.jhep.2024.04.031_bib344) 2022; 106 Khan (10.1016/j.jhep.2024.04.031_bib466) 2012; 124 de Franchis (10.1016/j.jhep.2024.04.031_bib473) 2022; 76 Berzigotti (10.1016/j.jhep.2024.04.031_bib455) 2017; 65 Kashiwagi (10.1016/j.jhep.2024.04.031_bib98) 2020; 89 Bhurwal (10.1016/j.jhep.2024.04.031_bib342) 2020; 29 Harrison (10.1016/j.jhep.2024.04.031_bib361) 2020; 73 Alkhouri (10.1016/j.jhep.2024.04.031_bib402) 2022; 77 Di Lorenzo (10.1016/j.jhep.2024.04.031_bib435) 2020; 34 Pillai (10.1016/j.jhep.2024.04.031_bib213) 2018; 18 Noureddin (10.1016/j.jhep.2024.04.031_bib132) 2020; 159 Frühbeck (10.1016/j.jhep.2024.04.031_bib224) 2019; 12 Cassinotto (10.1016/j.jhep.2024.04.031_bib155) 2021; 73 Alexander (10.1016/j.jhep.2024.04.031_bib275) 2019; 367 Reig (10.1016/j.jhep.2024.04.031_bib242) 2019; 103 Wong (10.1016/j.jhep.2024.04.031_bib474) 2013; 11 Israelsen (10.1016/j.jhep.2024.04.031_bib8) 2024; 9 Younes (10.1016/j.jhep.2024.04.031_bib182) 2021; 75 Bogumil (10.1016/j.jhep.2024.04.031_bib106) 2019; 3 Tsamalaidze (10.1016/j.jhep.2024.04.031_bib525) 2018; 28 Stine (10.1016/j.jhep.2024.04.031_bib312) 2023; 7 Zhang (10.1016/j.jhep.2024.04.031_bib432) 2014; 60 Xiao (10.1016/j.jhep.2024.04.031_bib158) 2017; 66 Dajti (10.1016/j.jhep.2024.04.031_bib480) 2023; 8 Wah Kheong (10.1016/j.jhep.2024.04.031_bib395) 2017; 15 Younossi (10.1016/j.jhep.2024.04.031_bib87) 2019; 17 Lee (10.1016/j.jhep.2024.04.031_bib483) 2022; 16 Lassailly (10.1016/j.jhep.2024.04.031_bib443) 2020; 159 Vanwagner (10.1016/j.jhep.2024.04.031_bib485) 2012; 56 Bril (10.1016/j.jhep.2024.04.031_bib390) 2017; 102 Thun (10.1016/j.jhep.2024.04.031_bib79) 1997; 337 Perumpail (10.1016/j.jhep.2024.04.031_bib236) 2015; 60 Ezpeleta (10.1016/j.jhep.2024.04.031_bib283) 2023; 35 Gunturu (10.1016/j.jhep.2024.04.031_bib506) 2022; 32 Eslam (10.1016/j.jhep.2024.04.031_bib149) 2021; 116 Owen (10.1016/j.jhep.2024.04.031_bib464) 2000; 348 Kim (10.1016/j.jhep.2024.04.031_bib253) 2019; 69 Bischoff (10.1016/j.jhep.2024.04.031_bib456) 2023; 42 Prati (10.1016/j.jhep.2024.04.031_bib19) 2002; 137 Bianco (10.1016/j.jhep.2024.04.031_bib206) 2021; 74 Pryke (10.1016/j.jhep.2024.04.031_bib127) 2023; 78 Zhang (10.1016/j.jhep.2024.04.031_bib104) 2022; 51 Imajo (10.1016/j.jhep.2024.04.031_bib159) 2022; 20 Yaskolka (10.1016/j.jhep.2024.04.031_bib287) 2021; 70 Hatziagelaki (10.1016/j.jhep.2024.04.031_bib346) 2022; 33 VanWagner (10.1016/j.jhep.2024.04.031_bib520) 2020; 20 Berzigotti (10.1016/j.jhep.2024.04.031_bib45) 2011; 54 Vilar-Gomez (10.1016/j.jhep.2024.04.031_bib309) 2023; 118 Anastácio (10.1016/j.jhep.2024.04.031_bib509) 2011; 92 Peng (10.1016/j.jhep.2024.04.031_bib300) 2022; 22 Isokuortti (10.1016/j.jhep.2024.04.031_bib220) 2017; 60 Sripongpun (10.1016/j.jhep.2024.04.031_bib145) 2023; 77 Bluher (10.1016/j.jhep.2024.04.031_bib407) 2024; 67 Chen (10.1016/j.jhep.2024.04.031_bib319) 2023; 14 Tzartzeva (10.1016/j.jhep.2024.04.031_bib250) 2018; 154 Tamaki (10.1016/j.jhep.2024.04.031_bib135) 2022; 132 Mantovani (10.1016/j.jhep.2024.04.031_bib29) 2023; 72 Cusi (10.1016/j.jhep.2024.04.031_bib419) 2016; 165 En Li Cho (10.1016/j.jhep.2024.04.031_bib16) 2023; 72 Younossi (10.1016/j.jhep.2024.04.031_bib284) 2023; 20 Nair (10.1016/j.jhep.2024.04.031_bib428) 2004; 20 Leuschner (10.1016/j.jhep.2024.04.031_bib374) 2010; 52 Golabi (10.1016/j.jhep.2024.04.031_bib35) 2018; 97 Watt (10.1016/j.jhep.2024.04.031_bib502) 2021; 27 Parikh (10.1016/j.jhep.2024.04.031_bib237) 2020; 115 Luu (10.1016/j.jhep.2024.04.031_bib116) 2021; 30 Kwok (10.1016/j.jhep.2024.04.031_bib156) 2014; 39 Rinella (10.1016/j.jhep.2024.04.031_bib126) 2023; 77 Kim (10.1016/j.jhep.2024.04.031_bib180) 2013; 57 Henry (10.1016/j.jhep.2024.04.031_bib324) 2023; 57 Pais (10.1016/j.jhep.2024.04.031_bib496) 2023; 79 Sabag (10.1016/j.jhep.2024.04.031_bib317) 2022; 107 Bagnardi (10.1016/j.jhep.2024.04.031_bib81) 2008; 62 Chikritzhs (10.1016/j.jhep.2024.04.031_bib80) 2009; 28 Rosso (10.1016/j.jhep.2024.04.031_bib198) 2023; 21 Fernandez (10.1016/j.jhep.2024.04.031_bib277) 2022; 17 Ioannou (10.1016/j.jhep.2024.04.031_bib240) 2021; 75 Stefan (10.1016/j.jhep.2024.04.031_bib51) 2022; 10 Armstrong (10.1016/j.jhep.2024.04.031_bib400) 2016; 387 Reddy (10.1016/j.jhep.2024.04.031_bib538) 2023; 165 Staufer (10.1016/j.jhep.2024.04.031_bib76) 2022; 77 Hassani (10.1016/j.jhep.2024.04.031_bib296) 2021; 36 (10.1016/j.jhep.2024.04.031_bib139) 2021; 75 Harrison (10.1016/j.jhep.2024.04.031_bib352) 2023; 79 Spengler (10.1016/j.jhep.2024.04.031_bib493) 2017; 101 Luu (10.1016/j.jhep.2024.04.031_bib108) 2021; 148 Zheng (10.1016/j.jhep.2024.04.031_bib212) 2023; 95 Ioannou (10.1016/j.jhep.2024.04.031_bib534) 2019; 71 Serra-Burriel (10.1016/j.jhep.2024.04.031_bib143) 2023; 402 Mantovani (10.1016/j.jhep.2024.04.031_bib226) 2022; 71 Mosko (10.1016/j.jhep.2024.04.031_bib503) 2011; 9 Mansour (10.1016/j.jhep.2024.04.031_bib343) 2021; 20 Gitto (10.1016/j.jhep.2024.04.031_bib519) 2018; 30 Borena (10.1016/j.jhep.2024.04.031_bib46) 2012; 131 Pirmoazen (10.1016/j.jhep.2024.04.031_bib154) 2020; 10 Fatourou (10.1016/j.jhep.2024.04.031_bib512) 2019; 4 Mozes (10.1016/j.jhep.2024.04.031_bib187) 2023; 8 Zhou (10.1016/j.jhep.2024.04.031_bib487) 2022; 104 Scorletti (10.1016/j.jhep.2024.04.031_bib367) 2022; 117 Kelly (10.1016/j.jhep.2024.04.031_bib349) 2014; 57 Jayakumar (10.1016/j.jhep.2024.04.031_bib269) 2019; 70 Ekstedt (10.1016/j.jhep.2024.04.031_bib470) 2007; 47 Kahl (10.1016/j.jhep.2024.04.031
References_xml	– volume: 64 start-page: 73 year: 2016 end-page: 84 ident: bib31 article-title: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes publication-title: Hepatology (Baltimore, Md) – volume: 146 year: 2023 ident: bib15 article-title: Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States publication-title: Metabolism – volume: 104 year: 2022 ident: bib487 article-title: Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: an updated meta-analysis and systematic review publication-title: Int J Surg – volume: 283 start-page: 356 year: 2018 end-page: 370 ident: bib201 article-title: Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver publication-title: J Intern Med – volume: 70 start-page: 133 year: 2019 end-page: 141 ident: bib269 article-title: Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib publication-title: J Hepatol – volume: 108 start-page: 1192 year: 2023 end-page: 1201 ident: bib222 article-title: Adipose tissue insulin resistance predicts the severity of liver fibrosis in patients with type 2 diabetes and NAFLD publication-title: J Clin Endocrinol Metab – year: 2024 ident: bib408 article-title: A phase 2 randomized trial of survodutide in MASH and fibrosis publication-title: N Engl J Med – volume: 24 start-page: 122 year: 2018 end-page: 139 ident: bib320 article-title: Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list publication-title: Liver Transpl – volume: 362 start-page: 1675 year: 2010 end-page: 1685 ident: bib372 article-title: Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis publication-title: N Engl J Med – volume: 38 start-page: 485 year: 2019 end-page: 521 ident: bib447 article-title: ESPEN guideline on clinical nutrition in liver disease publication-title: Clin Nutr – volume: 48 start-page: 557 year: 2008 end-page: 566 ident: bib457 article-title: Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial publication-title: Hepatology (Baltimore, Md) – volume: 9 year: 2019 ident: bib24 article-title: Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis publication-title: Sci Rep – volume: 78 start-page: 281 year: 2023 end-page: 292 ident: bib462 article-title: Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan publication-title: J Hepatol – volume: 71 start-page: 907 year: 2020 end-page: 916 ident: bib55 article-title: Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 12 year: 2022 ident: bib92 article-title: Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis publication-title: BMJ Open – volume: 20 start-page: 1382 year: 2022 ident: bib409 article-title: Glucagon-like peptide-1 receptor agonists and hepatic decompensation events in patients with cirrhosis and diabetes publication-title: Clin Gastroenterol Hepatol – volume: 79 start-page: 842 year: 2023 end-page: 852 ident: bib119 article-title: Changing epidemiology, global trends and implications for outcomes of NAFLD publication-title: J Hepatol – volume: 385 start-page: 956 year: 2015 end-page: 965 ident: bib380 article-title: Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial publication-title: Lancet – volume: 48 start-page: 696 year: 2018 end-page: 703 ident: bib230 article-title: Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases publication-title: Aliment Pharmacol Ther – volume: 61 start-page: 1547 year: 2015 end-page: 1554 ident: bib32 article-title: Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up publication-title: Hepatology (Baltimore, Md) – volume: 156 start-page: 88 year: 2019 end-page: 95 e5 ident: bib271 article-title: Factors associated with histologic response in adult patients with nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 177 start-page: 333 year: 2013 end-page: 342 ident: bib96 article-title: Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study publication-title: Am J Epidemiol – volume: 57 start-page: 1014 year: 2023 end-page: 1027 ident: bib27 article-title: Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities publication-title: Aliment Pharmacol Ther – volume: 34 start-page: 241 year: 2019 end-page: 248 ident: bib190 article-title: Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness publication-title: J Gastroenterol Hepatol – volume: 17 year: 2022 ident: bib277 article-title: Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: PLoS One – volume: 131 start-page: 193 year: 2012 end-page: 200 ident: bib46 article-title: Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults publication-title: Int J Cancer – volume: 10 start-page: 877 year: 2018 end-page: 886 ident: bib492 article-title: Cardiac stress testing and coronary artery disease in liver transplantation candidates: meta-analysis publication-title: World J Hepatol – volume: 10 start-page: 4277 year: 2020 end-page: 4289 ident: bib154 article-title: Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease publication-title: Theranostics – volume: 70 start-page: 5 year: 2019 end-page: 7 ident: bib5 article-title: Clinical practice guidelines of the European association for the study of the liver - advancing methodology but preserving practicability publication-title: J Hepatol – volume: 78 start-page: 914 year: 2023 end-page: 925 ident: bib424 article-title: Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase II randomized placebo-controlled trial (DESTINY-1) publication-title: J Hepatol – volume: 20 start-page: 2451 year: 2022 ident: bib160 article-title: Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis publication-title: Clin Gastroenterol Hepatol – volume: 3 year: 2021 ident: bib294 article-title: Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial publication-title: JHEP Rep – volume: 10 start-page: 245 year: 2017 end-page: 254 ident: bib74 article-title: Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies publication-title: J Evid Based Med – volume: 14 year: 2023 ident: bib319 article-title: Exercise does not independently improve histological outcomes in biopsy-proven non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Genes (Basel) – volume: 163 start-page: 764 year: 2022 end-page: 774 e1 ident: bib330 article-title: AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review publication-title: Gastroenterology – volume: 51 start-page: 454 year: 2010 end-page: 462 ident: bib152 article-title: Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 17 start-page: 65 year: 2022 ident: bib516 article-title: Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting publication-title: Diagn Pathol – volume: 4 start-page: e41 year: 2019 end-page: e48 ident: bib95 article-title: Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study publication-title: Lancet Public Health – volume: 36 start-page: 2616 year: 2022 end-page: 2627 ident: bib484 article-title: Management of patients with non-alcoholic steatohepatitis undergoing liver transplantation: considerations for the anesthesiologist publication-title: J Cardiothorac Vasc Anesth – volume: 79 start-page: 592 year: 2023 end-page: 604 ident: bib358 article-title: An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography publication-title: J Hepatol – volume: 8 year: 2021 ident: bib292 article-title: Ketogenic diets and chronic disease: weighing the benefits against the risks publication-title: Front Nutr – volume: 158 start-page: 200 year: 2020 end-page: 214 ident: bib192 article-title: Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease publication-title: Gastroenterology – volume: 71 start-page: 1141 year: 2019 end-page: 1151 ident: bib129 article-title: Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia publication-title: J Hepatol – volume: 41 start-page: 1532 year: 2021 end-page: 1544 ident: bib286 article-title: Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial publication-title: Liver Int – volume: 66 start-page: 1968 year: 2017 end-page: 1979 ident: bib490 article-title: A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: the CAR-OLT score publication-title: Hepatology (Baltimore, Md) – volume: 43 start-page: 621 year: 2016 end-page: 630 ident: bib248 article-title: Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer publication-title: Aliment Pharmacol Ther – volume: 20 start-page: 23 year: 2004 end-page: 28 ident: bib428 article-title: Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial publication-title: Aliment Pharmacol Ther – volume: 70 start-page: 962 year: 2021 end-page: 969 ident: bib218 article-title: Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals publication-title: Gut – volume: 4 start-page: 731 year: 2019 end-page: 741 ident: bib512 article-title: Management of metabolic syndrome and cardiovascular risk after liver transplantation publication-title: Lancet Gastroenterol Hepatol – volume: 112 start-page: 968 year: 2017 end-page: 1001 ident: bib82 article-title: The relationship between different dimensions of alcohol use and the burden of disease-an update publication-title: Addiction – volume: 20 start-page: 797 year: 2020 end-page: 807 ident: bib520 article-title: Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipients publication-title: Am J Transpl – volume: 70 start-page: 1913 year: 2019 end-page: 1927 ident: bib360 article-title: The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials publication-title: Hepatology (Baltimore, Md) – volume: 390 start-page: 497 year: 2024 end-page: 509 ident: bib350 article-title: A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis publication-title: N Engl J Med – volume: 34 start-page: 2332 year: 2020 end-page: 2358 ident: bib435 article-title: Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP publication-title: Surg Endosc – year: 2024 ident: bib144 article-title: Maf-5 predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction publication-title: Gastroenterology – volume: 29 start-page: 3564 year: 2019 end-page: 3573 ident: bib163 article-title: Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis publication-title: Eur Radiol – volume: 57 year: 2022 ident: bib398 article-title: GLP-1 physiology informs the pharmacotherapy of obesity publication-title: Mol Metab – volume: 79 start-page: 261 year: 2023 end-page: 262 ident: bib364 article-title: At the dawn of potent therapeutics for fatty liver disease - introducing the miniseries on promising pharmacological targets for NASH publication-title: J Hepatol – volume: 13 start-page: 363 year: 2013 end-page: 368 ident: bib507 article-title: Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease publication-title: Am J Transpl – volume: 20 start-page: 1064 year: 2014 end-page: 1071 ident: bib515 article-title: Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis publication-title: Liver Transpl – volume: 330 start-page: 247 year: 2023 end-page: 252 ident: bib328 article-title: Accelerometer-derived "weekend warrior" physical activity and incident cardiovascular disease publication-title: JAMA – volume: 12 start-page: 131 year: 2019 end-page: 136 ident: bib224 article-title: The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications publication-title: Obes Facts – volume: 64 start-page: 308 year: 2016 end-page: 315 ident: bib161 article-title: Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease publication-title: J Hepatol – volume: 62 start-page: 615 year: 2008 end-page: 619 ident: bib81 article-title: Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis publication-title: J Epidemiol Community Health – volume: 387 start-page: 679 year: 2016 end-page: 690 ident: bib400 article-title: Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study publication-title: Lancet – volume: 39 start-page: 86 year: 2019 end-page: 95 ident: bib331 article-title: NASH in lean individuals publication-title: Semin Liver Dis – volume: 29 start-page: 1418 year: 2013 end-page: 1421 ident: bib452 article-title: Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis publication-title: Nutrition – volume: 22 start-page: 95 year: 2022 ident: bib300 article-title: Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials publication-title: BMC Endocr Disord – volume: 76 start-page: 506 year: 2022 end-page: 517 ident: bib383 article-title: EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study publication-title: J Hepatol – volume: 71 start-page: 793 year: 2019 end-page: 801 ident: bib50 article-title: The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis publication-title: J Hepatol – volume: 78 start-page: 479 year: 2023 end-page: 492 ident: bib384 article-title: Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH publication-title: J Hepatol – volume: 29 start-page: 34 year: 2023 end-page: 47 ident: bib486 article-title: Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium publication-title: Liver Transpl – volume: 39 start-page: 166 year: 2016 end-page: 174 ident: bib436 article-title: Determinants of diabetes remission and glycemic control after bariatric surgery publication-title: Diabetes Care – volume: 44 start-page: 384 year: 2020 end-page: 403 ident: bib83 article-title: Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies publication-title: Alcohol Clin Exp Res – volume: 73 start-page: 1023 year: 2020 end-page: 1029 ident: bib191 article-title: Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease publication-title: J Hepatol – volume: 115 year: 2021 ident: bib278 article-title: The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Metabolism – volume: 87 year: 2023 ident: bib393 article-title: Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study publication-title: EBioMedicine – volume: 79 start-page: 829 year: 2023 end-page: 841 ident: bib496 article-title: A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials publication-title: J Hepatol – volume: 28 start-page: 441 year: 2009 end-page: 444 ident: bib80 article-title: A healthy dose of scepticism: four good reasons to think again about protective effects of alcohol on coronary heart disease publication-title: Drug Alcohol Rev – volume: 71 start-page: 313 year: 2019 end-page: 322 ident: bib482 article-title: Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study publication-title: J Hepatol – volume: 165 start-page: 1053 year: 2023 end-page: 10563 e6 ident: bib538 article-title: Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study publication-title: Gastroenterology – volume: 376 start-page: 1916 year: 2010 end-page: 1922 ident: bib389 article-title: Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis publication-title: Lancet – volume: 23 start-page: 554 year: 2023 ident: bib228 article-title: The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque publication-title: BMC Cardiovasc Disord – volume: 192 start-page: E875 year: 2020 end-page: E891 ident: bib282 article-title: Obesity in adults: a clinical practice guideline publication-title: CMAJ – volume: 77 start-page: 1797 year: 2023 end-page: 1835 ident: bib126 article-title: AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 57 start-page: 384 year: 2012 end-page: 391 ident: bib90 article-title: Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD) publication-title: J Hepatol – volume: 367 year: 2019 ident: bib275 article-title: Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults publication-title: BMJ – volume: 7 start-page: 684 year: 2019 end-page: 694 ident: bib219 article-title: Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study publication-title: Lancet Diabetes Endocrinol – volume: 50 start-page: 317 year: 2019 end-page: 328 ident: bib430 article-title: Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis publication-title: Aliment Pharmacol Ther – volume: 159 start-page: 1985 year: 2020 end-page: 1987 e4 ident: bib132 article-title: Nashnet. Screening for nonalcoholic fatty liver disease in persons with type 2 diabetes in the United States is cost-effective: a comprehensive cost-utility analysis publication-title: Gastroenterology – volume: 25 start-page: 538 year: 2019 end-page: 544 ident: bib504 article-title: Outcomes of sleeve gastrectomy in obese liver transplant candidates publication-title: Liver Transpl – volume: 19 start-page: 436 year: 2021 end-page: 445 ident: bib500 article-title: AGA clinical practice update on bariatric surgery in cirrhosis: expert review publication-title: Clin Gastroenterol Hepatol – volume: 124 start-page: 1 year: 2020 end-page: 13 ident: bib299 article-title: Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Br J Nutr – volume: 126 start-page: 1287 year: 2004 end-page: 1292 ident: bib391 article-title: Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity publication-title: Gastroenterology – volume: 63 start-page: 530 year: 2014 end-page: 532 ident: bib89 article-title: Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals publication-title: Gut – volume: 17 start-page: 988 year: 2012 end-page: 997 ident: bib378 article-title: Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis publication-title: Drug Discov Today – volume: 65 start-page: 281 year: 1968 end-page: 393 ident: bib7 article-title: [Principles and practice of mass screening for disease] publication-title: Bol Oficina Sanit Panam – volume: 69 start-page: 1075 year: 2019 end-page: 1086 ident: bib148 article-title: ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis publication-title: Hepatology (Baltimore, Md) – volume: 16 start-page: 198 year: 2018 end-page: 210 e2 ident: bib71 article-title: Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol – volume: 398 start-page: 262 year: 2021 end-page: 276 ident: bib412 article-title: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications publication-title: Lancet – volume: 77 start-page: 918 year: 2022 end-page: 930 ident: bib76 article-title: Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 113 start-page: E3451 year: 2016 end-page: E3460 ident: bib348 article-title: Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses publication-title: Proceedings of the National Academy of Sciences – volume: 101 start-page: 2288 year: 2017 end-page: 2296 ident: bib493 article-title: Liver transplantation in the obese cirrhotic patient publication-title: Transplantation – volume: 10 start-page: 393 year: 2022 end-page: 406 ident: bib404 article-title: Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial publication-title: Lancet Diabetes Endocrinol – volume: 60 start-page: 1792 year: 2014 ident: bib69 article-title: The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 8 start-page: 511 year: 2023 end-page: 522 ident: bib411 article-title: Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial publication-title: Lancet Gastroenterol Hepatol – volume: 8 start-page: 20 year: 2023 end-page: 30 ident: bib13 article-title: Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis publication-title: Lancet Gastroenterol Hepatol – volume: 69 start-page: 878 year: 2018 end-page: 885 ident: bib478 article-title: Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis publication-title: J Hepatol – volume: 164 start-page: 966 year: 2023 end-page: 977 e17 ident: bib194 article-title: PNPLA3 genotype and diabetes identify patients with nonalcoholic fatty liver disease at high risk of incident cirrhosis publication-title: Gastroenterology – volume: 76 start-page: 781 year: 2022 end-page: 787 ident: bib167 article-title: MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis publication-title: J Hepatol – volume: 118 start-page: 98 year: 2023 end-page: 107 ident: bib39 article-title: Relationships between education and non-alcoholic fatty liver disease publication-title: Eur J Intern Med – volume: 66 start-page: 1022 year: 2017 end-page: 1030 ident: bib166 article-title: Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis publication-title: J Hepatol – volume: 75 start-page: 46 year: 2021 end-page: 54 ident: bib306 article-title: Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial publication-title: J Hepatol – volume: 43 start-page: 298 year: 2020 end-page: 305 ident: bib415 article-title: Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial publication-title: Diabetes Care – volume: 20 start-page: 908 year: 2022 ident: bib159 article-title: Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 130 start-page: 996 year: 2023 end-page: 1004 ident: bib301 article-title: Association between ultra-processed foods consumption and risk of non-alcoholic fatty liver disease: a population-based analysis of NHANES 2011-2018 publication-title: Br J Nutr – volume: 59 start-page: 51 year: 2024 end-page: 63 ident: bib351 article-title: Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis publication-title: Aliment Pharmacol Ther – volume: 96 year: 2017 ident: bib131 article-title: Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients publication-title: Medicine (Baltimore) – volume: 73 start-page: 713 year: 2021 end-page: 725 ident: bib249 article-title: Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis publication-title: Hepatology (Baltimore, Md) – volume: 136 start-page: 1601 year: 2009 end-page: 1608 ident: bib394 article-title: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes publication-title: Gastroenterology – volume: 38 start-page: 2552 year: 2019 end-page: 2557 ident: bib339 article-title: A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease publication-title: Clin Nutr – volume: 75 start-page: 1491 year: 2022 end-page: 1506 ident: bib37 article-title: High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population publication-title: Hepatology (Baltimore, Md) – volume: 46 start-page: 1230 year: 2011 end-page: 1237 ident: bib233 article-title: Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey publication-title: J Gastroenterol – volume: 72 start-page: 742 year: 2020 end-page: 752 ident: bib347 article-title: Thyroid hormone signaling and the liver publication-title: Hepatology (Baltimore, Md) – volume: 35 start-page: 1284 year: 2023 end-page: 1288 ident: bib142 article-title: Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD publication-title: Eur J Gastroenterol Hepatol – volume: 6 year: 2024 ident: bib164 article-title: Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: a meta-analysis publication-title: JHEP Rep – volume: 11 year: 2016 ident: bib133 article-title: Cost-effectiveness analysis: risk stratification of nonalcoholic fatty liver disease (NAFLD) by the primary care physician using the NAFLD fibrosis score publication-title: PLoS One – volume: 42 start-page: 218 year: 2005 end-page: 224 ident: bib97 article-title: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma publication-title: J Hepatol – volume: 117 start-page: 1614 year: 2022 end-page: 1620 ident: bib459 article-title: Outcomes of exercise interventions in patients with advanced liver disease: a systematic review of randomized clinical trials publication-title: Am J Gastroenterol – volume: 71 start-page: 778 year: 2022 end-page: 788 ident: bib30 article-title: Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies publication-title: Gut – volume: 402 start-page: 988 year: 2023 end-page: 996 ident: bib143 article-title: Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study publication-title: Lancet – volume: 29 start-page: 2656 year: 2023 end-page: 2664 ident: bib354 article-title: Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis publication-title: Nat Med – volume: 66 year: 2023 ident: bib272 article-title: FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial publication-title: EClinicalMedicine – volume: 15 year: 2023 ident: bib336 article-title: Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies publication-title: Gut Microbes – volume: 38 start-page: 1917 year: 2023 end-page: 1925 ident: bib453 article-title: Nutritional therapy for persistent cognitive impairment after resolution of overt hepatic encephalopathy in patients with cirrhosis: a double-blind randomized controlled trial publication-title: J Gastroenterol Hepatol – volume: 20 start-page: 2393 year: 2022 ident: bib281 article-title: Weight loss and weight regain in usual clinical practice: results from the TARGET-NASH observational cohort publication-title: Clin Gastroenterol Hepatol – volume: 62 start-page: 190 year: 2015 end-page: 197 ident: bib387 article-title: Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial publication-title: J Hepatol – volume: 6 start-page: 903 year: 2021 end-page: 913 ident: bib25 article-title: Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis publication-title: Lancet Gastroenterol Hepatol – volume: 8 start-page: 714 year: 2023 end-page: 725 ident: bib140 article-title: Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study publication-title: Lancet Gastroenterol Hepatol – volume: 107 start-page: 862 year: 2022 end-page: 881 ident: bib317 article-title: The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis publication-title: J Clin Endocrinol Metab – volume: 20 year: 2021 ident: bib338 article-title: The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies publication-title: Ann Hepatol – volume: 78 start-page: 1199 year: 2023 end-page: 1215 ident: bib510 article-title: Liver transplantation immunology: immunosuppression, rejection, and immunomodulation publication-title: J Hepatol – volume: 14 year: 2019 ident: bib396 article-title: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial publication-title: PLoS One – volume: 144 start-page: e472 year: 2021 end-page: e487 ident: bib310 article-title: 2021 Dietary guidance to improve cardiovascular health: a scientific statement from the American heart association publication-title: Circulation – volume: 54 start-page: 555 year: 2011 end-page: 561 ident: bib45 article-title: Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis publication-title: Hepatology (Baltimore, Md) – volume: 30 start-page: 380 year: 2021 end-page: 387 ident: bib116 article-title: Composite score of healthy lifestyle factors and risk of hepatocellular carcinoma: findings from a prospective cohort study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 71 start-page: 495 year: 2020 end-page: 509 ident: bib371 article-title: Vitamin E improves transplant-free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis publication-title: Hepatology (Baltimore, Md) – volume: 48 start-page: 1863 year: 2019 end-page: 1871 ident: bib111 article-title: Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men publication-title: Int J Epidemiol – volume: 40 start-page: 355 year: 2020 end-page: 359 ident: bib66 article-title: Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis publication-title: Liver Int – volume: 41 start-page: 990 year: 2022 end-page: 1000 ident: bib451 article-title: Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement publication-title: Clin Nutr – volume: 150 start-page: 1160 year: 2016 end-page: 11670 e3 ident: bib471 article-title: Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis publication-title: Gastroenterology – volume: 27 start-page: 187 year: 2023 end-page: 210 ident: bib217 article-title: Metabolic syndrome and its association with nonalcoholic steatohepatitis publication-title: Clin Liver Dis – volume: 75 start-page: 1476 year: 2021 end-page: 1484 ident: bib240 article-title: Epidemiology and risk-stratification of NAFLD-associated HCC publication-title: J Hepatol – volume: 97 year: 2018 ident: bib35 article-title: Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) publication-title: Medicine (Baltimore) – volume: 69 start-page: 182 year: 2018 end-page: 236 ident: bib246 article-title: EASL clinical practice guidelines: management of hepatocellular carcinoma publication-title: J Hepatol – volume: 13 year: 2022 ident: bib445 article-title: Effects of bariatric endoscopy on non-alcoholic fatty liver disease: a comprehensive systematic review and meta-analysis publication-title: Front Endocrinol (Lausanne) – volume: 31 start-page: 2392 year: 2021 end-page: 2404 ident: bib479 article-title: Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis publication-title: Eur Radiol – volume: 10 start-page: 1342 year: 2012 ident: bib241 article-title: Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review publication-title: Clin Gastroenterol Hepatol – volume: 61 start-page: 1714 year: 2016 end-page: 1720 ident: bib392 article-title: Statins are underutilized in patients with nonalcoholic fatty liver disease and dyslipidemia publication-title: Dig Dis Sci – volume: 71 start-page: 983 year: 2022 end-page: 990 ident: bib263 article-title: Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease publication-title: Gut – volume: 20 start-page: 2462 year: 2022 end-page: 2473 e10 ident: bib28 article-title: A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 66 start-page: 142 year: 2017 end-page: 152 ident: bib316 article-title: Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review publication-title: J Hepatol – volume: 38 start-page: 518 year: 2003 end-page: 526 ident: bib137 article-title: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C publication-title: Hepatology (Baltimore, Md) – volume: 72 start-page: 1062 year: 2020 end-page: 1069 ident: bib115 article-title: Physical activity compared to adiposity and risk of liver-related mortality: results from two prospective, nationwide cohorts publication-title: J Hepatol – volume: 46 start-page: 85 year: 2017 end-page: 95 ident: bib332 article-title: Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients publication-title: Aliment Pharmacol Ther – volume: 48 start-page: 2137 year: 2012 end-page: 2145 ident: bib531 article-title: Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies publication-title: Eur J Cancer – volume: 5 start-page: 1824 year: 2021 end-page: 1832 ident: bib20 article-title: Definition of healthy ranges for alanine aminotransferase levels: a 2021 update publication-title: Hepatol Commun – volume: 69 start-page: 154 year: 2018 end-page: 181 ident: bib527 article-title: EASL clinical practice guidelines: management of alcohol-related liver disease publication-title: J Hepatol – volume: 41 start-page: 1913 year: 2022 end-page: 1931 ident: bib279 article-title: The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis publication-title: Clin Nutr – volume: 6 year: 2021 ident: bib295 article-title: Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis publication-title: Cochrane Database Syst Rev – volume: 46 start-page: 1081 year: 2007 end-page: 1090 ident: bib385 article-title: A lipidomic analysis of nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 42 start-page: 931 year: 2019 end-page: 937 ident: bib416 article-title: The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients publication-title: Diabetes Care – volume: 385 start-page: 1547 year: 2021 end-page: 1558 ident: bib425 article-title: A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH publication-title: N Engl J Med – volume: 340 year: 2010 ident: bib44 article-title: Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study publication-title: BMJ – volume: 30 start-page: 348 year: 2023 end-page: 354 ident: bib67 article-title: Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Menopause – volume: 330 start-page: 537 year: 2023 end-page: 546 ident: bib112 article-title: Sugar-sweetened and artificially sweetened beverages and risk of liver cancer and chronic liver disease mortality publication-title: JAMA – volume: 6 start-page: 52 year: 2022 ident: bib189 article-title: Variability of noninvasive MRI and biological markers in compensated cirrhosis: insights for assessing disease progression publication-title: Eur Radiol Exp – volume: 29 start-page: 2643 year: 2023 end-page: 2655 ident: bib197 article-title: Interaction between estrogen receptor-alpha and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women publication-title: Nat Med – volume: 25 start-page: 108 year: 1997 end-page: 111 ident: bib85 article-title: Excess weight risk factor for alcoholic liver disease publication-title: Hepatology (Baltimore, Md) – volume: 24 start-page: 809 year: 2023 end-page: 823 ident: bib529 article-title: Relevance of body composition in phenotyping the obesities publication-title: Rev Endocr Metab Disord – volume: 102 start-page: 1096 year: 2018 end-page: 1107 ident: bib514 article-title: Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation publication-title: Transplantation – volume: 71 start-page: 823 year: 2019 end-page: 833 ident: bib258 article-title: Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD publication-title: J Hepatol – volume: 117 start-page: 927 year: 2022 end-page: 930 ident: bib367 article-title: Dietary vitamin E intake is associated with a reduced risk of developing digestive diseases and nonalcoholic fatty liver disease publication-title: Am J Gastroenterol – volume: 14 start-page: 646 year: 2016 end-page: 649 ident: bib495 article-title: Listing practices for morbidly obese patients at liver transplantation centers in the United States publication-title: Exp Clin Transpl – volume: 32 start-page: 3600 year: 2022 end-page: 3604 ident: bib506 article-title: Combined sleeve gastrectomy with liver transplant in patients with obesity: a feasibility study publication-title: Obes Surg – volume: 1 year: 2021 ident: bib205 article-title: Machine learning enables new insights into genetic contributions to liver fat accumulation publication-title: Cell Genom – volume: 51 start-page: 1972 year: 2010 end-page: 1978 ident: bib101 article-title: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) – volume: 4 start-page: 781 year: 2019 end-page: 793 ident: bib377 article-title: Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial publication-title: Lancet Gastroenterol Hepatol – volume: 41 start-page: 1801 year: 2018 end-page: 1808 ident: bib414 article-title: Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial) publication-title: Diabetes Care – volume: 29 start-page: 172 year: 2009 end-page: 182 ident: bib429 article-title: Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis publication-title: Aliment Pharmacol Ther – volume: 165 start-page: 305 year: 2016 end-page: 315 ident: bib419 article-title: Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial publication-title: Ann Intern Med – volume: 159 start-page: 824 year: 2013 end-page: 834 ident: bib368 article-title: Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force publication-title: Ann Intern Med – volume: 46 start-page: 32 year: 2007 end-page: 36 ident: bib136 article-title: FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest publication-title: Hepatology (Baltimore, Md) – volume: 95 year: 2023 ident: bib212 article-title: Advancing diagnosis and management of liver disease in adults through exome sequencing publication-title: EBioMedicine – volume: 149 start-page: 119 year: 2015 end-page: 129 ident: bib48 article-title: Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma publication-title: Gastroenterology – volume: 125 start-page: 29 year: 2019 end-page: 40 ident: bib365 article-title: Relationship between serum alpha-tocopherol and overall and cause-specific mortality publication-title: Circ Res – volume: 27 start-page: 430 year: 2012 end-page: 441 ident: bib458 article-title: Late evening snack: exploiting a period of anabolic opportunity in cirrhosis publication-title: J Gastroenterol Hepatol – volume: 184 start-page: 2537 year: 2021 end-page: 2564 ident: bib33 article-title: Mechanisms and disease consequences of nonalcoholic fatty liver disease publication-title: Cell – volume: 894 start-page: 1 year: 2000 end-page: 253 ident: bib40 article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation publication-title: World Health Organ Tech Rep Ser – volume: 73 start-page: 175 year: 2021 end-page: 185 ident: bib107 article-title: Plant-based and animal-based low-carbohydrate diets and risk of hepatocellular carcinoma among US men and women publication-title: Hepatology (Baltimore, Md) – volume: 18 start-page: 157 year: 2014 end-page: 163 ident: bib11 article-title: The impact of obesity and metabolic syndrome on alcoholic liver disease publication-title: Clin Liver Dis – volume: 148 start-page: 2102 year: 2021 end-page: 2114 ident: bib108 article-title: Quality diet indexes and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study publication-title: Int J Cancer – volume: 79 start-page: 1110 year: 2023 end-page: 1120 ident: bib382 article-title: Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis publication-title: J Hepatol – volume: 77 start-page: 1335 year: 2023 end-page: 1347 ident: bib12 article-title: The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review publication-title: Hepatology (Baltimore, Md) – volume: 79 start-page: 758 year: 2023 end-page: 767 ident: bib352 article-title: NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: a prospective derivation and validation study publication-title: J Hepatol – volume: 28 start-page: 528 year: 2022 end-page: 562 ident: bib125 article-title: American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-sponsored by the American association for the study of liver diseases (AASLD) publication-title: Endocr Pract – volume: 68 start-page: 1741 year: 2018 end-page: 1754 ident: bib298 article-title: Ad libitum mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial publication-title: Hepatology (Baltimore, Md) – volume: 89 start-page: 1 year: 2020 end-page: 7 ident: bib98 article-title: Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease publication-title: Alcohol – volume: 103 year: 2019 ident: bib242 article-title: Should patients with NAFLD/NASH Be surveyed for HCC? publication-title: Transplantation – year: 2023 ident: bib247 article-title: EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis – volume: 17 start-page: 95 year: 2019 ident: bib56 article-title: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts publication-title: BMC Med – volume: 60 start-page: 110 year: 2014 end-page: 117 ident: bib231 article-title: Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team publication-title: J Hepatol – volume: 106 start-page: 24 year: 2022 end-page: 34 ident: bib344 article-title: Coffee consumption has no effect on circulating markers of liver function but increases adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials publication-title: Nutr Res – volume: 76 start-page: 469 year: 2022 end-page: 482 ident: bib463 article-title: Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 32 year: 2018 ident: bib491 article-title: Cardio-hepatic risk assessment by CMR imaging in liver transplant candidates publication-title: Clin Transpl – volume: 113 start-page: 391 year: 2021 end-page: 400 ident: bib305 article-title: Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial publication-title: Am J Clin Nutr – volume: 70 start-page: 172 year: 2019 end-page: 193 ident: bib449 article-title: EASL Clinical Practice Guidelines on nutrition in chronic liver disease publication-title: J Hepatol – volume: 30 start-page: 1549 year: 2022 end-page: 1563 ident: bib221 article-title: Measuring and estimating insulin resistance in clinical and research settings publication-title: Obesity (Silver Spring) – volume: 60 start-page: 3142 year: 2015 end-page: 3148 ident: bib236 article-title: Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience publication-title: Dig Dis Sci – volume: 20 start-page: 27 year: 2024 end-page: 49 ident: bib216 article-title: Inter-organ crosstalk during development and progression of type 2 diabetes mellitus publication-title: Nat Rev Endocrinol – volume: 32 start-page: 121 year: 2023 end-page: 129 ident: bib41 article-title: Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity publication-title: J Obes Metab Syndr – volume: 78 start-page: 501 year: 2023 end-page: 512 ident: bib100 article-title: Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort publication-title: J Hepatol – volume: 2 year: 2020 ident: bib526 article-title: NAFLD and liver transplantation: disease burden, current management and future challenges publication-title: JHEP Rep – volume: 77 start-page: 191 year: 2022 end-page: 205 ident: bib113 article-title: Cigarette smoking and liver diseases publication-title: J Hepatol – volume: 22 start-page: 169 year: 2002 end-page: 183 ident: bib467 article-title: Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs publication-title: Semin Liver Dis – volume: 27 start-page: 49 year: 2021 end-page: 57 ident: bib61 article-title: Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes publication-title: Nat Med – volume: 29 start-page: 422 year: 2023 end-page: 430 ident: bib508 article-title: Combined liver transplantation and sleeve gastrectomy: report of a brief-interval staged approach publication-title: Liver Transpl – volume: 393 start-page: 1597 year: 2019 end-page: 1608 ident: bib476 article-title: Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial publication-title: Lancet – volume: 68 start-page: 1239 year: 2018 end-page: 1246 ident: bib303 article-title: High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance publication-title: J Hepatol – volume: 75 start-page: 1235 year: 2022 end-page: 1246 ident: bib259 article-title: Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) – volume: 32 start-page: 1872 year: 2022 end-page: 1883 ident: bib441 article-title: Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis publication-title: Obes Surg – volume: 22 start-page: 7236 year: 2016 end-page: 7251 ident: bib151 article-title: Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease – Where do we stand? publication-title: World J Gastroenterol – volume: 301 start-page: 250 year: 2021 end-page: 262 ident: bib162 article-title: Quantification of liver fat content with CT and MRI: state of the art publication-title: Radiology – volume: 36 start-page: 1470 year: 2021 end-page: 1478 ident: bib296 article-title: Relationship between dietary patterns and non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: J Gastroenterol Hepatol – volume: 8 start-page: 704 year: 2023 end-page: 713 ident: bib187 article-title: Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis publication-title: Lancet Gastroenterol Hepatol – volume: 59 start-page: 1406 year: 2014 end-page: 1414 ident: bib68 article-title: Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) – volume: 113 start-page: 1265 year: 2021 end-page: 1274 ident: bib110 article-title: Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study publication-title: Am J Clin Nutr – volume: 73 start-page: 1368 year: 2020 end-page: 1378 ident: bib535 article-title: aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis publication-title: J Hepatol – volume: 51 start-page: 679 year: 2010 end-page: 689 ident: bib223 article-title: Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications publication-title: Hepatology (Baltimore, Md) – volume: 20 start-page: 708 year: 2023 end-page: 722 ident: bib284 article-title: Lifestyle interventions in nonalcoholic fatty liver disease publication-title: Nat Rev Gastroenterol Hepatol – volume: 100 start-page: 2231 year: 2015 end-page: 2238 ident: bib22 article-title: High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels publication-title: J Clin Endocrinol Metab – volume: 68 start-page: 707 year: 2018 end-page: 714 ident: bib448 article-title: A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort publication-title: J Hepatol – volume: 101 start-page: 422 year: 1996 end-page: 434 ident: bib238 article-title: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis publication-title: Am J Med – volume: 20 start-page: 2524 year: 2022 end-page: 25232 e2 ident: bib307 article-title: Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 Years: the framingham heart study publication-title: Clin Gastroenterol Hepatol – volume: 65 start-page: 1196 year: 2017 end-page: 1205 ident: bib251 article-title: An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis publication-title: Hepatology (Baltimore, Md) – volume: 16 start-page: 123 year: 2018 end-page: 131 e1 ident: bib345 article-title: Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis publication-title: Clin Gastroenterol Hepatol – volume: 78 start-page: 191 year: 2023 end-page: 206 ident: bib75 article-title: Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease publication-title: J Hepatol – volume: 400 start-page: 185 year: 2022 end-page: 235 ident: bib78 article-title: Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 publication-title: Lancet – volume: 18 start-page: 2305 year: 2020 end-page: 2314 e12 ident: bib130 article-title: Cost effectiveness of different strategies for detecting cirrhosis in patients with nonalcoholic fatty liver disease based on United States health care system publication-title: Clin Gastroenterol Hepatol – volume: 77 start-page: 596 year: 2022 end-page: 606 ident: bib202 article-title: Rare ATG7 genetic variants predispose patients to severe fatty liver disease publication-title: J Hepatol – volume: 66 start-page: 1486 year: 2017 end-page: 1501 ident: bib158 article-title: Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis publication-title: Hepatology (Baltimore, Md) – volume: 348 start-page: 607 year: 2000 end-page: 614 ident: bib464 article-title: Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain publication-title: Biochem J – volume: 71 start-page: 523 year: 2019 end-page: 533 ident: bib534 article-title: Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification publication-title: J Hepatol – volume: 18 start-page: 770 year: 2021 end-page: 786 ident: bib289 article-title: Dietary carbohydrates and fats in nonalcoholic fatty liver disease publication-title: Nat Rev Gastroenterol Hepatol – volume: 71 start-page: 379 year: 2019 end-page: 388 ident: bib297 article-title: The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content publication-title: J Hepatol – volume: 153 start-page: 1260 year: 2017 ident: bib99 article-title: Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 132 year: 2022 ident: bib135 article-title: Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease publication-title: J Clin Invest – volume: 76 start-page: 1013 year: 2022 end-page: 1020 ident: bib173 article-title: Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events publication-title: J Hepatol – volume: 14 start-page: 124 year: 2016 end-page: 131 e1 ident: bib123 article-title: Hepatocellular carcinoma in the absence of cirrhosis in United States Veterans is associated with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 35 start-page: 353 year: 2023 end-page: 358 ident: bib469 article-title: Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Eur J Gastroenterol Hepatol – volume: 39 start-page: 39 year: 2024 end-page: 48 ident: bib530 article-title: Measuring lipoprotein (a) for cardiovascular disease prevention - in whom and when? publication-title: Curr Opin Cardiol – volume: 103 start-page: 45 year: 2019 end-page: 56 ident: bib489 article-title: International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation publication-title: Transplantation – volume: 17 start-page: 1744 year: 2019 end-page: 1755 e11 ident: bib477 article-title: Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol – volume: 74 start-page: 775 year: 2021 end-page: 782 ident: bib206 article-title: Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores publication-title: J Hepatol – volume: 155 start-page: 1828 year: 2018 end-page: 18237 e2 ident: bib244 article-title: Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease publication-title: Gastroenterology – volume: 16 start-page: 1448 year: 2022 end-page: 1457 ident: bib483 article-title: The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database publication-title: Hepatol Int – volume: 71 start-page: 1940 year: 2020 end-page: 1952 ident: bib304 article-title: Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the multiethnic cohort publication-title: Hepatology (Baltimore, Md) – volume: 57 start-page: 3912 year: 2014 end-page: 3923 ident: bib349 article-title: Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dio xo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor beta agonist in clinical trials for the treatment of dyslipidemia publication-title: J Med Chem – volume: 69 start-page: 1599 year: 2019 end-page: 1613 ident: bib253 article-title: Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high-risk patients with cirrhosis publication-title: Hepatology (Baltimore, Md) – volume: 54 start-page: 1011 year: 2011 end-page: 1019 ident: bib375 article-title: A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis publication-title: J Hepatol – volume: 15 start-page: 1940 year: 2017 ident: bib395 article-title: A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis publication-title: Clin Gastroenterol Hepatol – volume: 14 start-page: 151 year: 2018 end-page: 159 ident: bib499 article-title: Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases publication-title: Surg Obes Relat Dis – volume: 11 start-page: 2442 year: 2019 ident: bib293 article-title: Effectiveness of intermittent fasting and time-restricted feeding compared to continuous energy restriction for weight loss publication-title: Nutrients – volume: 12 year: 2023 ident: bib73 article-title: Smoking increases the risk of hepatocellular carcinoma and cardiovascular disease in patients with metabolic-associated fatty liver disease publication-title: J Clin Med – volume: 11 year: 2014 ident: bib518 article-title: Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis publication-title: Plos Med – volume: 75 start-page: 786 year: 2021 end-page: 794 ident: bib182 article-title: Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 21 start-page: 1061 year: 2019 end-page: 1065 ident: bib522 article-title: Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients publication-title: Diabetes Obes Metab – volume: 75 start-page: 770 year: 2021 end-page: 785 ident: bib157 article-title: Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis publication-title: J Hepatol – volume: 158 start-page: 1611 year: 2020 end-page: 1625 e12 ident: bib121 article-title: Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Gastroenterology – volume: 42 start-page: 1731 year: 2022 end-page: 1750 ident: bib291 article-title: One size does not fit all; practical, personal tailoring of the diet to NAFLD patients publication-title: Liver Int – volume: 3 year: 2021 ident: bib114 article-title: Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort publication-title: JHEP Rep – volume: 48 start-page: 1117 year: 2018 end-page: 1127 ident: bib183 article-title: Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease publication-title: Aliment Pharmacol Ther – volume: 17 start-page: 1877 year: 2019 end-page: 18785 e5 ident: bib175 article-title: Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage publication-title: Clin Gastroenterol Hepatol – volume: 12 year: 2017 ident: bib36 article-title: Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States publication-title: PLoS One – volume: 375 start-page: 631 year: 2016 end-page: 643 ident: bib379 article-title: A placebo-controlled trial of obeticholic acid in primary biliary cholangitis publication-title: N Engl J Med – volume: 61 start-page: 2108 year: 2016 end-page: 2117 ident: bib134 article-title: Screening for nonalcoholic steatohepatitis in individuals with type 2 diabetes: a cost-effectiveness analysis publication-title: Dig Dis Sci – volume: 107 start-page: 253 year: 2012 end-page: 261 ident: bib179 article-title: Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma publication-title: Am J Gastroenterol – volume: 44 start-page: 1433 year: 2021 end-page: 1442 ident: bib405 article-title: Effects of cotadutide on metabolic and hepatic parameters in adults with overweight or obesity and type 2 diabetes: a 54-week randomized phase 2b study publication-title: Diabetes Care – volume: 70 start-page: 511 year: 2019 end-page: 521 ident: bib88 article-title: Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study publication-title: Hepatology (Baltimore, Md) – volume: 68 start-page: 1035 year: 2023 end-page: 1041 ident: bib501 article-title: Intragastric balloon in obese compensated nonalcoholic steatohepatitis cirrhosis patients is safe and achieves significant weight reduction at 6-months publication-title: Dig Dis Sci – reference: “The Oxford Levels of Evidence 2”. Oxford Centre for Evidence-Based Medicine. [Available from: – volume: 76 start-page: 456 year: 2022 end-page: 468 ident: bib442 article-title: Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery publication-title: Hepatology (Baltimore, Md) – volume: 384 start-page: 1113 year: 2021 end-page: 1124 ident: bib401 article-title: A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis publication-title: N Engl J Med – volume: 72 start-page: 581 year: 2023 end-page: 589 ident: bib186 article-title: Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis publication-title: Gut – volume: 154 start-page: 1706 year: 2018 end-page: 17018 e1 ident: bib250 article-title: Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis publication-title: Gastroenterology – volume: 71 start-page: 539 year: 2020 end-page: 548 ident: bib10 article-title: Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B publication-title: Hepatology (Baltimore, Md) – year: 2023 ident: bib229 article-title: Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study publication-title: Nutr Metab Cardiovasc Dis – volume: 102 start-page: 2950 year: 2017 end-page: 2961 ident: bib390 article-title: Liver safety of statins in prediabetes or T2DM and nonalcoholic steatohepatitis: post hoc analysis of a randomized trial publication-title: J Clin Endocrinol Metab – volume: 20 start-page: 2032 year: 2022 end-page: 20340 e6 ident: bib340 article-title: Coffee consumption is associated with lower liver stiffness: a nationally representative study publication-title: Clin Gastroenterol Hepatol – volume: 389 start-page: 998 year: 2023 end-page: 1008 ident: bib266 article-title: Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH publication-title: N Engl J Med – volume: 74 start-page: 1809 year: 2021 end-page: 1824 ident: bib426 article-title: Saroglitazar, a PPAR-α/γ agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial publication-title: Hepatology (Baltimore, Md) – year: 2024 ident: bib171 article-title: Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes publication-title: J Hepatol – volume: 8 year: 2013 ident: bib369 article-title: Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? publication-title: PLoS One – volume: 18 start-page: 1179 year: 2020 end-page: 11787 e6 ident: bib460 article-title: Resistance training increases muscle strength and muscle size in patients with liver cirrhosis publication-title: Clin Gastroenterol Hepatol – volume: 70 start-page: 1375 year: 2021 end-page: 1382 ident: bib18 article-title: Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort publication-title: Gut – volume: 12 start-page: 119 year: 2024 end-page: 131 ident: bib60 article-title: Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort publication-title: Lancet Diabetes Endocrinol – volume: 392 start-page: 1015 year: 2018 end-page: 1035 ident: bib77 article-title: Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet – volume: 33 start-page: e529 year: 2021 end-page: e534 ident: bib334 article-title: Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease publication-title: Eur J Gastroenterol Hepatol – volume: 4 year: 2021 ident: bib465 article-title: Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B-related cirrhosis and renal impairment publication-title: Health Sci Rep – volume: 17 start-page: 2776 year: 2019 end-page: 27784 e4 ident: bib274 article-title: Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 137 start-page: 1 year: 2002 end-page: 10 ident: bib19 article-title: Updated definitions of healthy ranges for serum alanine aminotransferase levels publication-title: Ann Intern Med – volume: 292 start-page: 177 year: 2022 end-page: 189 ident: bib23 article-title: Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease publication-title: J Intern Med – volume: 5 start-page: 362 year: 2020 end-page: 373 ident: bib168 article-title: FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study publication-title: Lancet Gastroenterol Hepatol – volume: 28 start-page: 1432 year: 2022 end-page: 1438 ident: bib417 article-title: Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study publication-title: Nat Med – volume: 21 start-page: 3314 year: 2023 end-page: 33121 e3 ident: bib198 article-title: Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 387 start-page: 332 year: 2022 end-page: 344 ident: bib204 article-title: Germline mutations in CIDEB and protection against liver disease publication-title: N Engl J Med – volume: 42 start-page: 987 year: 2023 end-page: 1024 ident: bib456 article-title: Practical guideline on obesity care in patients with gastrointestinal and liver diseases - joint ESPEN/UEG guideline publication-title: Clin Nutr – volume: 42 start-page: 864 year: 2022 end-page: 870 ident: bib210 article-title: Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: a case series publication-title: Liver Int – volume: 45 start-page: 846 year: 2007 end-page: 854 ident: bib138 article-title: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD publication-title: Hepatology (Baltimore, Md) – volume: 150 start-page: 1219 year: 2016 end-page: 12130 e6 ident: bib199 article-title: The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent publication-title: Gastroenterology – volume: 61 start-page: 75 year: 2014 end-page: 81 ident: bib195 article-title: Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma publication-title: J Hepatol – volume: 21 start-page: 970 year: 2021 ident: bib341 article-title: All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study publication-title: BMC Public Health – volume: 163 start-page: 1198 year: 2022 end-page: 1225 ident: bib433 article-title: AGA clinical practice guideline on pharmacological interventions for adults with obesity publication-title: Gastroenterology – volume: 78 start-page: 574 year: 2023 end-page: 583 ident: bib481 article-title: Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis publication-title: J Hepatol – year: 2017 ident: bib539 article-title: Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis publication-title: J Hepatol – volume: 13 start-page: 656 year: 2023 end-page: 665 ident: bib26 article-title: Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD - an umbrella overview of systematic review of meta-analysis publication-title: J Clin Exp Hepatol – volume: 66 start-page: 1031 year: 2017 end-page: 1036 ident: bib308 article-title: Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents publication-title: J Hepatol – volume: 74 start-page: 2241 year: 2021 end-page: 2250 ident: bib208 article-title: Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD publication-title: Hepatology (Baltimore, Md) – volume: 74 start-page: 1434 year: 2020 end-page: 1441 ident: bib103 article-title: Differences in the association of diet quality with body fat distribution between men and women publication-title: Eur J Clin Nutr – volume: 3 start-page: 456 year: 2017 end-page: 463 ident: bib252 article-title: MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma publication-title: JAMA Oncol – volume: 115 start-page: 1642 year: 2020 end-page: 1649 ident: bib237 article-title: Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms publication-title: Am J Gastroenterol – volume: 25 start-page: 641 year: 2019 end-page: 655 ident: bib273 article-title: Platelet GPIbalpha is a mediator and potential interventional target for NASH and subsequent liver cancer publication-title: Nat Med – volume: 29 start-page: 1380 year: 2017 end-page: 1384 ident: bib64 article-title: The association of nonalcoholic steatohepatitis and obstructive sleep apnea publication-title: Eur J Gastroenterol Hepatol – volume: 20 start-page: 12945 year: 2014 end-page: 12955 ident: bib532 article-title: Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors publication-title: World J Gastroenterol – volume: 70 start-page: 2085 year: 2021 end-page: 2095 ident: bib287 article-title: Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial publication-title: Gut – volume: 72 start-page: 1556 year: 2020 end-page: 1568 ident: bib311 article-title: Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 7 start-page: CD013157 year: 2021 ident: bib335 article-title: Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis publication-title: Cochrane Database Syst Rev – volume: 399 start-page: 61 year: 2022 end-page: 116 ident: bib1 article-title: The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality publication-title: Lancet – volume: 77 start-page: 1482 year: 2022 end-page: 1490 ident: bib172 article-title: Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD publication-title: J Hepatol – volume: 19 start-page: 2274 year: 2021 end-page: 22783 e5 ident: bib262 article-title: Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol – volume: 46 start-page: 1354 year: 2023 end-page: 1362 ident: bib52 article-title: High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold publication-title: Diabetes Care – volume: 394 start-page: 2012 year: 2019 end-page: 2024 ident: bib268 article-title: Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial publication-title: Lancet – volume: 75 start-page: 661 year: 2022 end-page: 672 ident: bib356 article-title: Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis publication-title: Hepatology (Baltimore, Md) – volume: 72 start-page: 2364 year: 2023 end-page: 2371 ident: bib128 article-title: Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial publication-title: Gut – volume: 337 start-page: 1705 year: 1997 end-page: 1714 ident: bib79 article-title: Alcohol consumption and mortality among middle-aged and elderly U.S. adults publication-title: N Engl J Med – volume: 39 start-page: 770 year: 2004 end-page: 778 ident: bib373 article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial publication-title: Hepatology (Baltimore, Md) – volume: 62 start-page: 1061 year: 2015 end-page: 1067 ident: bib94 article-title: Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study publication-title: J Hepatol – volume: 20 start-page: 283 year: 2022 end-page: 292 e10 ident: bib239 article-title: Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression publication-title: Clin Gastroenterol Hepatol – volume: 5 start-page: 739 year: 2020 end-page: 752 ident: bib329 article-title: Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Lancet Gastroenterol Hepatol – volume: 118 start-page: 1005 year: 2018 end-page: 1012 ident: bib72 article-title: Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project publication-title: Br J Cancer – volume: 10 start-page: 3409 year: 2013 end-page: 3423 ident: bib461 article-title: Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD) publication-title: Int J Environ Res Public Health – volume: 25 start-page: 1673 year: 2019 end-page: 1681 ident: bib524 article-title: Delayed sleeve gastrectomy following liver transplantation: a 5-year experience publication-title: Liver Transpl – volume: 78 start-page: 663 year: 2023 end-page: 671 ident: bib127 article-title: Time to focus on chronic liver diseases in the community: a review of primary care hepatology tools, pathways of care and reimbursement mechanisms publication-title: J Hepatol – volume: 30 start-page: 766 year: 2018 end-page: 773 ident: bib519 article-title: De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients publication-title: Eur J Gastroenterol Hepatol – volume: 2 start-page: 1093 year: 2023 end-page: 1102 ident: bib536 article-title: Validation of noninvasive markers for HCC risk stratification in 1389 patients with biopsy-proven NAFLD publication-title: Gastro Hep Adv – volume: 112 start-page: 18 year: 2017 end-page: 35 ident: bib21 article-title: ACG clinical guideline: evaluation of abnormal liver chemistries publication-title: Am J Gastroenterol – volume: 75 start-page: 284 year: 2021 end-page: 291 ident: bib70 article-title: Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort publication-title: J Hepatol – volume: 79 start-page: 1557 year: 2023 end-page: 1565 ident: bib397 article-title: Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver publication-title: J Hepatol – volume: 92 start-page: 947 year: 2011 end-page: 951 ident: bib509 article-title: Body composition and overweight of liver transplant recipients publication-title: Transplantation – volume: 9 start-page: 83 year: 2024 end-page: 91 ident: bib174 article-title: Implementation of a liver health check in people with type 2 diabetes publication-title: Lancet Gastroenterol Hepatol – volume: 3 year: 2021 ident: bib327 article-title: Non-alcoholic fatty liver disease: a patient guideline publication-title: JHEP Rep – volume: 13 start-page: 643 year: 2015 end-page: 654 ident: bib62 article-title: Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies publication-title: Clin Gastroenterol Hepatol – volume: 69 start-page: 1349 year: 2018 end-page: 1356 ident: bib333 article-title: Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 27 start-page: 1239 year: 2021 end-page: 1247 ident: bib502 article-title: Efficacy and safety of endoscopic balloon placement for weight loss in patients with cirrhosis awaiting liver transplantation publication-title: Liver Transpl – volume: 29 start-page: 76 year: 2021 end-page: 79 ident: bib118 article-title: International evidence for the effectiveness of the front-of-package nutrition label called Nutri-Score publication-title: Cent Eur J Public Health – volume: 78 year: 2023 ident: bib255 article-title: Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 79 start-page: 1374 year: 2023 end-page: 1384 ident: bib9 article-title: Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: nationwide multigenerational cohort study publication-title: J Hepatol – volume: 78 start-page: 684 year: 2023 end-page: 692 ident: bib214 article-title: A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis publication-title: J Hepatol – volume: 15 start-page: 502 year: 2019 end-page: 511 ident: bib440 article-title: Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis publication-title: Surg Obes Relat Dis – volume: 38 start-page: 210 year: 2023 end-page: 218 ident: bib454 article-title: Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: a randomized clinical trial publication-title: J Gastroenterol Hepatol – volume: 17 start-page: 1625 year: 2019 end-page: 16233.e1 ident: bib87 article-title: Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 49 start-page: 80 year: 2009 end-page: 86 ident: bib434 article-title: Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial publication-title: Hepatology (Baltimore, Md) – volume: 25 start-page: 1033 year: 2021 end-page: 1043 ident: bib215 article-title: PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date publication-title: Expert Opin Ther Targets – volume: 21 start-page: 2570 year: 2023 ident: bib357 article-title: MRI-AST (MAST) score accurately predicts major adverse liver outcome, hepatocellular carcinoma, liver transplant, and liver-related death publication-title: Clin Gastroenterol Hepatol – volume: 48 start-page: S350 year: 2008 ident: bib225 article-title: Visceral fat as a strong and independent risk factor of nonalcoholic fatty liver disease publication-title: J Hepatol – year: 2023 ident: bib410 article-title: Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes publication-title: Clin Gastroenterol Hepatol – volume: 116 start-page: 984 year: 2021 end-page: 993 ident: bib149 article-title: A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients publication-title: Am J Gastroenterol – volume: 28 start-page: 444 year: 2018 end-page: 450 ident: bib525 article-title: Laparoscopic sleeve gastrectomy for morbid obesity in patients after orthotopic liver transplant: a matched case-control study publication-title: Obes Surg – volume: 71 start-page: 808 year: 2020 end-page: 819 ident: bib57 article-title: Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 29 start-page: 2919 year: 2023 end-page: 2928 ident: bib362 article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial publication-title: Nat Med – volume: 77 start-page: 573 year: 2023 end-page: 584 ident: bib120 article-title: Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) – volume: 17 start-page: 1148 year: 2019 end-page: 11456 e4 ident: bib177 article-title: Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 18 start-page: 487 year: 2018 end-page: 493 ident: bib213 article-title: The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro publication-title: Pharmacogenomics J – volume: 5 start-page: 31 year: 2020 end-page: 41 ident: bib472 article-title: Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial publication-title: Lancet Gastroenterol Hepatol – volume: 116 start-page: 723 year: 2021 end-page: 732 ident: bib475 article-title: Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease publication-title: Am J Gastroenterol – volume: 21 start-page: 2026 year: 2023 end-page: 2039 ident: bib257 article-title: Noninvasive assessment of liver fibrosis in NAFLD publication-title: Clin Gastroenterol Hepatol – volume: 77 start-page: 256 year: 2023 end-page: 267 ident: bib145 article-title: The steatosis-associated fibrosis estimator (SAFE) score: a tool to detect low-risk NAFLD in primary care publication-title: Hepatology (Baltimore, Md) – volume: 65 start-page: 1758 year: 2022 end-page: 1769 ident: bib58 article-title: Phenotypic and genetic classification of diabetes publication-title: Diabetologia – volume: 35 start-page: 56 year: 2023 end-page: 70.e3 ident: bib283 article-title: Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial publication-title: Cell Metab. – volume: 19 start-page: 806 year: 2021 end-page: 815 e5 ident: bib185 article-title: Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease publication-title: Clin Gastroenterol Hepatol – volume: 60 start-page: 2008 year: 2014 end-page: 2016 ident: bib432 article-title: Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes publication-title: Hepatology (Baltimore, Md) – volume: 9 start-page: 218 year: 2024 end-page: 228 ident: bib8 article-title: Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study publication-title: Lancet Gastroenterol Hepatol – volume: 55 start-page: 913 year: 2006 end-page: 917 ident: bib165 article-title: Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy publication-title: Magn Reson Med – volume: 36 start-page: 150 year: 2002 end-page: 155 ident: bib47 article-title: Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? publication-title: Hepatology (Baltimore, Md) – volume: 165 start-page: 463 year: 2023 end-page: 472 e5 ident: bib53 article-title: Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study publication-title: Gastroenterology – volume: 74 start-page: 1611 year: 2021 end-page: 1644 ident: bib446 article-title: Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases publication-title: Hepatology (Baltimore, Md) – volume: 7 year: 2023 ident: bib312 article-title: American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease publication-title: Hepatol Commun – volume: 161 start-page: 1657 year: 2021 end-page: 1669 ident: bib124 article-title: Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 72 start-page: 401 year: 2020 end-page: 410 ident: bib270 article-title: Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis publication-title: J Hepatol – volume: 394 start-page: 2184 year: 2019 end-page: 2196 ident: bib381 article-title: Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial publication-title: Lancet – volume: 65 start-page: 1293 year: 2017 end-page: 1305 ident: bib455 article-title: Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study publication-title: Hepatology (Baltimore, Md) – reference: . – volume: 3 year: 2021 ident: bib314 article-title: Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD publication-title: JHEP Rep – volume: 76 start-page: 959 year: 2022 end-page: 974 ident: bib473 article-title: Baveno VII - renewing consensus in portal hypertension publication-title: J Hepatol – volume: 160 start-page: 1608 year: 2021 end-page: 1619 e13 ident: bib181 article-title: The association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 160 start-page: 1634 year: 2021 end-page: 16346 e7 ident: bib203 article-title: Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease publication-title: Gastroenterology – volume: 72 start-page: 2138 year: 2023 end-page: 2148 ident: bib16 article-title: Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis publication-title: Gut – volume: 21 start-page: 358 year: 2023 ident: bib323 article-title: Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 326 start-page: 2031 year: 2021 end-page: 2042 ident: bib439 article-title: Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis publication-title: JAMA – volume: 6 start-page: 550 year: 2022 end-page: 560 ident: bib38 article-title: Community socioeconomic deprivation predicts nonalcoholic steatohepatitis publication-title: Hepatol Commun – volume: 78 start-page: 1089 year: 2023 end-page: 1104 ident: bib488 article-title: Evaluation of recipients with significant comorbidity - patients with cardiovascular disease publication-title: J Hepatol – volume: 9 start-page: 897 year: 2011 end-page: 901 ident: bib503 article-title: Increased perioperative mortality following bariatric surgery among patients with cirrhosis publication-title: Clin Gastroenterol Hepatol – volume: 79 start-page: 888 year: 2023 end-page: 897 ident: bib406 article-title: A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 9 start-page: 428 year: 2011 end-page: 433 ident: bib234 article-title: Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma publication-title: Clin Gastroenterol Hepatol – volume: 357 year: 2017 ident: bib302 article-title: Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study publication-title: BMJ – volume: 19 start-page: 1240 year: 2021 ident: bib322 article-title: Physical activity, measured objectively, is associated with lower mortality in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol – volume: 20 start-page: 658 year: 2022 end-page: 673 ident: bib207 article-title: A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores publication-title: Clin Gastroenterol Hepatol – volume: 41 start-page: 356 year: 2022 end-page: 364 ident: bib109 article-title: Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: evidence from mediation analysis publication-title: Clin Nutr – volume: 355 start-page: 2297 year: 2006 end-page: 2307 ident: bib420 article-title: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis publication-title: N Engl J Med – volume: 76 start-page: 800 year: 2022 end-page: 811 ident: bib388 article-title: A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH publication-title: J Hepatol – volume: 19 start-page: 162 year: 2021 ident: bib254 article-title: Serum levels of α-fetoprotein increased more than 10 Years before detection of hepatocellular carcinoma publication-title: Clin Gastroenterol Hepatol – volume: 11 start-page: 295 year: 2013 end-page: 302 ident: bib474 article-title: Association between anthropometric parameters and measurements of liver stiffness by transient elastography publication-title: Clin Gastroenterol Hepatol – volume: 67 start-page: 1797 year: 2018 end-page: 1806 ident: bib245 article-title: Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: results from two prospective cohort studies publication-title: Hepatology (Baltimore, Md) – volume: 71 start-page: 156 year: 2022 end-page: 162 ident: bib226 article-title: Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis publication-title: Gut – volume: 75 start-page: 659 year: 2021 end-page: 689 ident: bib139 article-title: EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update publication-title: J Hepatol – volume: 76 start-page: 536 year: 2022 end-page: 548 ident: bib267 article-title: Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study publication-title: J Hepatol – volume: 340 year: 2010 ident: bib86 article-title: Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies publication-title: BMJ – volume: 39 start-page: 254 year: 2014 end-page: 269 ident: bib156 article-title: Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments publication-title: Aliment Pharmacol Ther – volume: 41 start-page: 225 year: 2021 end-page: 234 ident: bib285 article-title: Effects of mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression analysis of randomized controlled trials publication-title: Semin Liver Dis – volume: 374 start-page: 1321 year: 2016 end-page: 1331 ident: bib422 article-title: Pioglitazone after ischemic stroke or transient ischemic attack publication-title: N Engl J Med – volume: 44 start-page: 865 year: 2006 end-page: 873 ident: bib43 article-title: Long-term follow-up of patients with NAFLD and elevated liver enzymes publication-title: Hepatology (Baltimore, Md) – volume: 64 start-page: 1388 year: 2016 end-page: 1402 ident: bib3 article-title: EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 13 start-page: 63 year: 2021 end-page: 77 ident: bib313 article-title: Effect of exercise on hepatic steatosis: are benefits seen without dietary intervention? A systematic review and meta-analysis publication-title: J Diabetes – volume: 13 year: 2022 ident: bib63 article-title: Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: a population-based study publication-title: Front Endocrinol (Lausanne) – volume: 163 start-page: 1079 year: 2022 end-page: 10789 e5 ident: bib170 article-title: Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease: a systematic review and meta-analysis of individual participants publication-title: Gastroenterology – volume: 160 start-page: 1799 year: 2021 end-page: 1808 ident: bib498 article-title: AGA clinical practice guidelines on intragastric balloons in the management of obesity publication-title: Gastroenterology – volume: 73 start-page: 2196 year: 2021 end-page: 2205 ident: bib155 article-title: Transient versus two-dimensional shear-wave elastography in a multistep strategy to detect advanced fibrosis in NAFLD publication-title: Hepatology (Baltimore, Md) – volume: 9 start-page: 3682 year: 2019 ident: bib196 article-title: Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease publication-title: Sci Rep – volume: 5 year: 2022 ident: bib437 article-title: Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease publication-title: JAMA Netw Open – volume: 135 start-page: 1176 year: 2008 end-page: 1184 ident: bib418 article-title: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 378 start-page: 1096 year: 2018 end-page: 1106 ident: bib200 article-title: A protein-truncating HSD17B13 variant and protection from chronic liver disease publication-title: N Engl J Med – volume: 102 start-page: 727 year: 2018 end-page: 743 ident: bib523 article-title: International liver transplantation society consensus statement on immunosuppression in liver transplant recipients publication-title: Transplantation – volume: 70 start-page: 1946 year: 2021 end-page: 1953 ident: bib169 article-title: MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis publication-title: Gut – volume: 68 start-page: 1051 year: 2023 end-page: 1059 ident: bib325 article-title: Physical activity and risk of hepatocellular carcinoma: a systematic review and meta-analysis publication-title: Dig Dis Sci – volume: 147 start-page: 377 year: 2014 end-page: 384 e1 ident: bib386 article-title: No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial publication-title: Gastroenterology – volume: 47 start-page: 135 year: 2007 end-page: 141 ident: bib470 article-title: Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study publication-title: J Hepatol – volume: 159 start-page: 1290 year: 2020 end-page: 12301 e5 ident: bib443 article-title: Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis publication-title: Gastroenterology – volume: 385 start-page: 1559 year: 2021 end-page: 1569 ident: bib122 article-title: Prospective study of outcomes in adults with nonalcoholic fatty liver disease publication-title: N Engl J Med – volume: 98 year: 2019 ident: bib321 article-title: A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease publication-title: Medicine (Baltimore) – volume: 10 start-page: 284 year: 2022 end-page: 296 ident: bib51 article-title: A global view of the interplay between non-alcoholic fatty liver disease and diabetes publication-title: Lancet Diabetes Endocrinol – volume: 56 start-page: 1741 year: 2012 end-page: 1750 ident: bib485 article-title: Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events publication-title: Hepatology (Baltimore, Md) – volume: 57 start-page: 1357 year: 2013 end-page: 1365 ident: bib180 article-title: Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States publication-title: Hepatology (Baltimore, Md) – volume: 72 start-page: 372 year: 2023 end-page: 380 ident: bib29 article-title: Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals publication-title: Gut – volume: 56 start-page: 225 year: 2012 end-page: 233 ident: bib65 article-title: Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese publication-title: J Hepatol – volume: 60 start-page: 1873 year: 2017 end-page: 1882 ident: bib220 article-title: Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study publication-title: Diabetologia – volume: 72 start-page: 892 year: 2020 end-page: 905 ident: bib265 article-title: Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study publication-title: Hepatology (Baltimore, Md) – volume: 2 year: 2019 ident: bib260 article-title: Association of histologic disease activity with progression of nonalcoholic fatty liver disease publication-title: JAMA Netw Open – volume: 27 start-page: 1468 year: 2021 end-page: 1478 ident: bib521 article-title: Metabolic complications in liver transplantation recipients: how we can optimize long-term survival publication-title: Liver Transpl – volume: 57 start-page: 750 year: 2023 end-page: 762 ident: bib147 article-title: Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases publication-title: Aliment Pharmacol Ther – volume: 9 start-page: 701 year: 2018 end-page: 716 ident: bib366 article-title: Dietary antioxidants, circulating antioxidant concentrations, total antioxidant capacity, and risk of all-cause mortality: a systematic review and dose-response meta-analysis of prospective observational studies publication-title: Adv Nutr – volume: 67 start-page: 470 year: 2024 end-page: 482 ident: bib407 article-title: Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial publication-title: Diabetologia – volume: 5 start-page: 970 year: 2020 end-page: 985 ident: bib353 article-title: NIS4™ for non-invasive diagnosis of nonalcoholic steatohepatitis and liver fibrosis publication-title: Lancet Gastroenterol Hepatol – volume: 70 start-page: 522 year: 2019 end-page: 531 ident: bib261 article-title: Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the nonalcoholic steatohepatitis clinical research network treatment trials publication-title: Hepatology (Baltimore, Md) – volume: 7 start-page: 126 year: 2016 end-page: 135 ident: bib450 article-title: Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis publication-title: J Cachexia Sarcopenia Muscle – volume: 19 start-page: 1915 year: 2021 end-page: 19124 e6 ident: bib359 article-title: Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD publication-title: Clin Gastroenterol Hepatol – volume: 124 start-page: 130 year: 2012 end-page: 137 ident: bib466 article-title: Managing diabetes in patients with chronic liver disease publication-title: Postgrad Med – volume: 70 start-page: 531 year: 2019 end-page: 544 ident: bib34 article-title: Non-alcoholic fatty liver disease - a global public health perspective publication-title: J Hepatol – volume: 79 start-page: 287 year: 2023 end-page: 295 ident: bib14 article-title: Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons publication-title: J Hepatol – volume: 67 start-page: 2001 year: 2018 end-page: 2012 ident: bib256 article-title: Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science publication-title: Hepatology (Baltimore, Md) – volume: 68 start-page: 526 year: 2018 end-page: 549 ident: bib431 article-title: Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine publication-title: J Hepatol – volume: 120 start-page: 1640 year: 2009 end-page: 1645 ident: bib42 article-title: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity publication-title: Circulation – volume: 155 start-page: 107 year: 2018 end-page: 117 ident: bib102 article-title: Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 3 year: 2021 ident: bib540 article-title: External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population publication-title: JHEP Rep – volume: 176 start-page: 10 year: 2023 end-page: 21 ident: bib290 article-title: Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease : a randomized controlled trial publication-title: Ann Intern Med – volume: 80 start-page: 694 year: 2024 end-page: 701 ident: bib4 article-title: Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 79 start-page: 1542 year: 2023 end-page: 1556 ident: bib2 article-title: A multi-society Delphi consensus statement on new fatty liver disease nomenclature publication-title: J Hepatol – volume: 122 start-page: 1085 year: 2020 end-page: 1093 ident: bib117 article-title: Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies publication-title: Br J Cancer – volume: 46 start-page: 856 year: 2017 end-page: 863 ident: bib232 article-title: Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period publication-title: Aliment Pharmacol Ther – volume: 16 start-page: 2684 year: 2016 end-page: 2694 ident: bib513 article-title: Factors associated with major adverse cardiovascular events after liver transplantation among a national sample publication-title: Am J Transpl – volume: 114 start-page: 1574 year: 2019 end-page: 1586 ident: bib93 article-title: Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis publication-title: Am J Gastroenterol – volume: 60 start-page: 1278 year: 2011 end-page: 1283 ident: bib315 article-title: Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss publication-title: Gut – volume: 65 start-page: 2090 year: 2017 end-page: 2099 ident: bib533 article-title: Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review publication-title: Hepatology (Baltimore, Md) – volume: 65 start-page: 570 year: 2016 end-page: 578 ident: bib178 article-title: Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease publication-title: J Hepatol – volume: 2 start-page: 691 year: 2014 end-page: 700 ident: bib413 article-title: Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial publication-title: Lancet Diabetes Endocrinol – volume: 106 year: 2020 ident: bib511 article-title: Post-transplant obesity impacts long-term survival after liver transplantation publication-title: Metabolism – volume: 10 year: 2020 ident: bib427 article-title: Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study publication-title: Sci Rep – volume: 70 start-page: 1214 year: 2019 end-page: 1221 ident: bib209 article-title: Clinical utility of genomic analysis in adults with idiopathic liver disease publication-title: J Hepatol – volume: 6 year: 2023 ident: bib288 article-title: Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial publication-title: JAMA Netw Open – volume: 74 start-page: 2410 year: 2021 end-page: 2423 ident: bib54 article-title: Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study publication-title: Hepatology (Baltimore, Md) – volume: 149 start-page: 367 year: 2015 ident: bib280 article-title: Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 390 start-page: 559 year: 2024 end-page: 561 ident: bib363 article-title: Selective agonists of thyroid hormone receptor beta for the treatment of NASH publication-title: N Engl J Med – volume: 8 start-page: 816 year: 2023 end-page: 828 ident: bib480 article-title: Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis publication-title: Lancet Gastroenterol Hepatol – volume: 64 start-page: 433 year: 2016 end-page: 485 ident: bib497 article-title: EASL clinical practice guidelines: liver transplantation publication-title: J Hepatol – volume: 51 start-page: 237 year: 2022 end-page: 249 ident: bib104 article-title: Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the tianjin chronic low-grade systemic inflammation and health cohort study publication-title: Int J Epidemiol – volume: 29 start-page: 421 year: 2020 end-page: 428 ident: bib342 article-title: Inverse association of coffee with liver cancer development: an updated systematic review and meta-analysis publication-title: J Gastrointestin Liver Dis – volume: 366 start-page: 1279 year: 2005 end-page: 1289 ident: bib421 article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial publication-title: Lancet – volume: 401 start-page: 1786 year: 2023 end-page: 1797 ident: bib444 article-title: Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial publication-title: Lancet – year: 2024 ident: bib211 article-title: Prevalence and determinants of liver disease in relatives of Italian patients with advanced MASLD publication-title: Clin Gastroenterol Hepatol – volume: 45 start-page: 444 year: 2022 end-page: 450 ident: bib438 article-title: Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the Swedish obese subjects study publication-title: Diabetes Care – volume: 127 start-page: 1704 year: 2004 end-page: 1713 ident: bib146 article-title: Serum markers detect the presence of liver fibrosis: a cohort study publication-title: Gastroenterology – volume: 10 start-page: 632 year: 2016 end-page: 639 ident: bib235 article-title: Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis publication-title: Hepatol Int – year: 2024 ident: bib17 article-title: Metabolic syndrome traits increase the risk of major adverse liver outcomes in type 2 diabetes publication-title: Diabetes Care – volume: 145 start-page: 782 year: 2013 end-page: 789 e4 ident: bib176 article-title: Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 248 start-page: 863 year: 2008 end-page: 870 ident: bib494 article-title: Prolonged waiting times for liver transplantation in obese patients publication-title: Ann Surg – volume: 12 year: 2019 ident: bib337 article-title: Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Therap Adv Gastroenterol – volume: 75 start-page: 1164 year: 2021 end-page: 1176 ident: bib376 article-title: 24-Norursodeoxycholic acid reshapes immunometabolism in CD8(+) T cells and alleviates hepatic inflammation publication-title: J Hepatol – volume: 73 start-page: 625 year: 2021 end-page: 643 ident: bib403 article-title: Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH publication-title: Hepatology (Baltimore, Md) – volume: 33 start-page: 755 year: 2022 end-page: 768 ident: bib346 article-title: NAFLD and thyroid function: pathophysiological and therapeutic considerations publication-title: Trends Endocrinol Metab – volume: 72 start-page: 785 year: 2020 end-page: 801 ident: bib227 article-title: NAFLD as a driver of chronic kidney disease publication-title: J Hepatol – volume: 123 start-page: 681 year: 2020 end-page: 690 ident: bib528 article-title: A simple cut-off for waist-to-height ratio (0.5) can act as an indicator for cardiometabolic risk: recent data from adults in the Health Survey for England publication-title: Br J Nutr – volume: 65 start-page: 1770 year: 2022 end-page: 1781 ident: bib59 article-title: A novel diabetes typology: towards precision diabetology from pathogenesis to treatment publication-title: Diabetologia – volume: 79 start-page: 1302 year: 2023 end-page: 1316 ident: bib423 article-title: Treating NASH by targeting peroxisome proliferator-activated receptors publication-title: J Hepatol – volume: 25 start-page: 56 year: 2019 end-page: 67 ident: bib517 article-title: Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis publication-title: Liver Transpl – volume: 7 year: 2023 ident: bib243 article-title: Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis publication-title: Hepatol Commun – volume: 52 start-page: 472 year: 2010 end-page: 479 ident: bib374 article-title: High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial publication-title: Hepatology (Baltimore, Md) – volume: 5 start-page: 933 year: 2023 end-page: 944 ident: bib399 article-title: Gut hormone co-agonists for the treatment of obesity: from bench to bedside publication-title: Nat Metab – volume: 78 start-page: 471 year: 2023 end-page: 478 ident: bib49 article-title: A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes publication-title: J Hepatol – volume: 20 start-page: 35 year: 2021 ident: bib343 article-title: Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial publication-title: Nutr J – volume: 68 start-page: 485 year: 2018 end-page: 495 ident: bib505 article-title: Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy publication-title: Hepatology (Baltimore, Md) – volume: 71 start-page: 835 year: 2020 end-page: 848 ident: bib91 article-title: Risks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts publication-title: Hepatology (Baltimore, Md) – volume: 72 start-page: 1196 year: 2020 end-page: 1209 ident: bib193 article-title: Update on NAFLD genetics: from new variants to the clinic publication-title: J Hepatol – volume: 18 start-page: 2168 year: 2020 end-page: 21672 e2 ident: bib468 article-title: SGLT2 inhibitors in liver patients publication-title: Clin Gastroenterol Hepatol – volume: 331 start-page: 1287 year: 2024 end-page: 1297 ident: bib184 article-title: Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease publication-title: JAMA – volume: 57 start-page: 709 year: 2023 end-page: 722 ident: bib324 article-title: Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD) publication-title: Aliment Pharmacol Ther – volume: 3 start-page: 437 year: 2019 end-page: 447 ident: bib106 article-title: High-quality diets are associated with reduced risk of hepatocellular carcinoma and chronic liver disease: the multiethnic cohort publication-title: Hepatol Commun – volume: 13 start-page: 763 year: 2015 ident: bib188 article-title: Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases publication-title: Clin Gastroenterol Hepatol – volume: 67 start-page: 2141 year: 2018 end-page: 2149 ident: bib84 article-title: Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population publication-title: Hepatology (Baltimore, Md) – volume: 118 start-page: 1576 year: 2023 end-page: 1591 ident: bib309 article-title: Significant dose-response association of physical activity and diet quality with mortality in adults with suspected NAFLD in a population study publication-title: Am J Gastroenterol – volume: 5 year: 2023 ident: bib326 article-title: Physical activity is inversely associated with hepatic fibro-inflammation: a population-based cohort study using UK Biobank data publication-title: JHEP Rep – volume: 72 start-page: 1399 year: 2023 end-page: 1409 ident: bib355 article-title: Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis publication-title: Gut – volume: 71 start-page: 1198 year: 2020 end-page: 1212 ident: bib264 article-title: NGM282 improves liver fibrosis and histology in 12 Weeks in patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) – volume: 15 start-page: 425 year: 2018 end-page: 439 ident: bib276 article-title: Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease publication-title: Nat Rev Gastroenterol Hepatol – volume: 112 start-page: 740 year: 2017 end-page: 751 ident: bib141 article-title: Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis publication-title: Am J Gastroenterol – volume: 70 start-page: 577 year: 2019 end-page: 586 ident: bib105 article-title: Dietary patterns and risk of hepatocellular carcinoma among U.S. Men and women publication-title: Hepatology (Baltimore, Md) – volume: 73 start-page: 26 year: 2020 end-page: 39 ident: bib361 article-title: Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials publication-title: J Hepatol – volume: 47 start-page: 3037 year: 2022 end-page: 3050 ident: bib150 article-title: Liver fibrosis assessment: MR and US elastography publication-title: Abdom Radiol (NY) – volume: 52 start-page: 1387 year: 2020 end-page: 1398 ident: bib318 article-title: Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention publication-title: Aliment Pharmacol Ther – volume: 77 start-page: 607 year: 2022 end-page: 618 ident: bib402 article-title: Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: a randomised, open-label phase II trial publication-title: J Hepatol – volume: 346 year: 2013 ident: bib370 article-title: Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials publication-title: Bmj – volume: 76 start-page: 1362 year: 2022 end-page: 1378 ident: bib153 article-title: Impact of non-invasive biomarkers on hepatology practice: past, present and future publication-title: J Hepatol – volume: 18 start-page: 728 year: 2020 end-page: 735 e4 ident: bib537 article-title: GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis publication-title: Clin Gastroenterol Hepatol – volume: 15 start-page: 425 issue: 7 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib276 article-title: Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-018-0010-0 – volume: 70 start-page: 133 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib269 article-title: Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib publication-title: J Hepatol doi: 10.1016/j.jhep.2018.09.024 – volume: 192 start-page: E875 issue: 31 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib282 article-title: Obesity in adults: a clinical practice guideline publication-title: CMAJ doi: 10.1503/cmaj.191707 – volume: 283 start-page: 356 issue: 4 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib201 article-title: Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver publication-title: J Intern Med doi: 10.1111/joim.12719 – volume: 79 start-page: 1542 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib2 article-title: A multi-society Delphi consensus statement on new fatty liver disease nomenclature publication-title: J Hepatol doi: 10.1016/j.jhep.2023.06.003 – volume: 75 start-page: 661 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib356 article-title: Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32145 – volume: 10 issue: 1 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib427 article-title: Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study publication-title: Sci Rep doi: 10.1038/s41598-020-78342-x – volume: 5 start-page: 362 issue: 4 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib168 article-title: FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30383-8 – volume: 376 start-page: 1916 issue: 9756 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib389 article-title: Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis publication-title: Lancet doi: 10.1016/S0140-6736(10)61272-X – volume: 78 start-page: 663 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib127 article-title: Time to focus on chronic liver diseases in the community: a review of primary care hepatology tools, pathways of care and reimbursement mechanisms publication-title: J Hepatol doi: 10.1016/j.jhep.2022.10.010 – volume: 17 start-page: 1744 issue: 9 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib477 article-title: Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.04.062 – volume: 75 start-page: 284 issue: 2 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib70 article-title: Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort publication-title: J Hepatol doi: 10.1016/j.jhep.2021.02.034 – volume: 17 start-page: 95 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib56 article-title: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts publication-title: BMC Med doi: 10.1186/s12916-019-1321-x – volume: 402 start-page: 988 issue: 10406 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib143 article-title: Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study publication-title: Lancet doi: 10.1016/S0140-6736(23)01174-1 – volume: 35 start-page: 353 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib469 article-title: Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000002517 – volume: 144 start-page: e472 issue: 23 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib310 article-title: 2021 Dietary guidance to improve cardiovascular health: a scientific statement from the American heart association publication-title: Circulation doi: 10.1161/CIR.0000000000001031 – volume: 79 start-page: 829 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib496 article-title: A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials publication-title: J Hepatol doi: 10.1016/j.jhep.2023.03.014 – volume: 79 start-page: 1557 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib397 article-title: Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver publication-title: J Hepatol doi: 10.1016/j.jhep.2023.07.033 – volume: 66 start-page: 142 issue: 1 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib316 article-title: Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review publication-title: J Hepatol doi: 10.1016/j.jhep.2016.08.023 – volume: 118 start-page: 1005 issue: 7 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib72 article-title: Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project publication-title: Br J Cancer doi: 10.1038/s41416-018-0007-z – volume: 145 start-page: 782 issue: 4 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib176 article-title: Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.06.057 – volume: 76 start-page: 800 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib388 article-title: A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH publication-title: J Hepatol doi: 10.1016/j.jhep.2021.12.004 – volume: 79 start-page: 261 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib364 article-title: At the dawn of potent therapeutics for fatty liver disease - introducing the miniseries on promising pharmacological targets for NASH publication-title: J Hepatol doi: 10.1016/j.jhep.2023.04.003 – volume: 17 start-page: 1877 issue: 9 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib175 article-title: Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2018.12.031 – volume: 101 start-page: 2288 issue: 10 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib493 article-title: Liver transplantation in the obese cirrhotic patient publication-title: Transplantation doi: 10.1097/TP.0000000000001794 – volume: 3 start-page: 456 issue: 4 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib252 article-title: MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2016.3147 – volume: 104 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib487 article-title: Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: an updated meta-analysis and systematic review publication-title: Int J Surg doi: 10.1016/j.ijsu.2022.106752 – volume: 57 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib398 article-title: GLP-1 physiology informs the pharmacotherapy of obesity publication-title: Mol Metab doi: 10.1016/j.molmet.2021.101351 – volume: 21 start-page: 970 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib341 article-title: All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study publication-title: BMC Public Health doi: 10.1186/s12889-021-10991-7 – volume: 5 start-page: 933 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib399 article-title: Gut hormone co-agonists for the treatment of obesity: from bench to bedside publication-title: Nat Metab doi: 10.1038/s42255-023-00812-z – volume: 28 start-page: 1432 issue: 7 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib417 article-title: Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study publication-title: Nat Med doi: 10.1038/s41591-022-01861-9 – volume: 18 start-page: 1179 issue: 5 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib460 article-title: Resistance training increases muscle strength and muscle size in patients with liver cirrhosis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.07.058 – volume: 76 start-page: 469 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib463 article-title: Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32294 – volume: 161 start-page: 1657 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib124 article-title: Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.07.049 – volume: 25 start-page: 1033 issue: 12 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib215 article-title: PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date publication-title: Expert Opin Ther Targets doi: 10.1080/14728222.2021.2018418 – volume: 73 start-page: 26 issue: 1 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib361 article-title: Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials publication-title: J Hepatol doi: 10.1016/j.jhep.2020.02.027 – volume: 71 start-page: 823 issue: 4 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib258 article-title: Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD publication-title: J Hepatol doi: 10.1016/j.jhep.2019.04.019 – volume: 77 start-page: 918 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib76 article-title: Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2022.04.040 – volume: 301 start-page: 250 issue: 2 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib162 article-title: Quantification of liver fat content with CT and MRI: state of the art publication-title: Radiology doi: 10.1148/radiol.2021204288 – volume: 95 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib212 article-title: Advancing diagnosis and management of liver disease in adults through exome sequencing publication-title: EBioMedicine doi: 10.1016/j.ebiom.2023.104747 – volume: 18 start-page: 770 issue: 11 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib289 article-title: Dietary carbohydrates and fats in nonalcoholic fatty liver disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-021-00472-y – volume: 70 start-page: 172 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib449 article-title: EASL Clinical Practice Guidelines on nutrition in chronic liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2018.06.024 – volume: 117 start-page: 927 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib367 article-title: Dietary vitamin E intake is associated with a reduced risk of developing digestive diseases and nonalcoholic fatty liver disease publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000001726 – volume: 77 start-page: 1482 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib172 article-title: Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD publication-title: J Hepatol doi: 10.1016/j.jhep.2022.07.020 – volume: 79 start-page: 287 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib14 article-title: Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons publication-title: J Hepatol doi: 10.1016/j.jhep.2023.03.040 – volume: 20 start-page: 35 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib343 publication-title: Nutr J doi: 10.1186/s12937-021-00694-5 – volume: 64 start-page: 73 issue: 1 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib31 article-title: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.28431 – volume: 11 start-page: 2442 issue: 10 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib293 article-title: Effectiveness of intermittent fasting and time-restricted feeding compared to continuous energy restriction for weight loss publication-title: Nutrients doi: 10.3390/nu11102442 – volume: 72 start-page: 372 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib29 article-title: Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals publication-title: Gut doi: 10.1136/gutjnl-2022-327672 – volume: 32 start-page: 1872 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib441 article-title: Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis publication-title: Obes Surg doi: 10.1007/s11695-022-06011-1 – volume: 87 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib393 article-title: Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study publication-title: EBioMedicine doi: 10.1016/j.ebiom.2022.104392 – volume: 5 start-page: 1824 issue: 11 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib20 article-title: Definition of healthy ranges for alanine aminotransferase levels: a 2021 update publication-title: Hepatol Commun doi: 10.1002/hep4.1794 – volume: 75 start-page: 1235 issue: 5 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib259 article-title: Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32204 – volume: 9 start-page: 701 issue: 6 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib366 article-title: Dietary antioxidants, circulating antioxidant concentrations, total antioxidant capacity, and risk of all-cause mortality: a systematic review and dose-response meta-analysis of prospective observational studies publication-title: Adv Nutr doi: 10.1093/advances/nmy040 – volume: 19 start-page: 1240 issue: 6 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib322 article-title: Physical activity, measured objectively, is associated with lower mortality in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.07.023 – volume: 12 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib92 article-title: Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis publication-title: BMJ Open doi: 10.1136/bmjopen-2021-049767 – volume: 331 start-page: 1287 issue: 15 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib184 article-title: Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease publication-title: JAMA doi: 10.1001/jama.2024.1447 – volume: 35 start-page: 56 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib283 article-title: Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial publication-title: Cell Metab. doi: 10.1016/j.cmet.2022.12.001 – volume: 60 start-page: 1792 issue: 5 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib69 article-title: The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.27097 – volume: 46 start-page: 1230 issue: 10 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib233 article-title: Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey publication-title: J Gastroenterol doi: 10.1007/s00535-011-0431-9 – year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib144 article-title: Maf-5 predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction publication-title: Gastroenterology doi: 10.1053/j.gastro.2024.03.017 – volume: 72 start-page: 892 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib265 article-title: Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31108 – volume: 19 start-page: 1915 issue: 9 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib359 article-title: Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.09.044 – volume: 68 start-page: 485 issue: 2 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib505 article-title: Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29848 – volume: 57 start-page: 1357 issue: 4 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib180 article-title: Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.26156 – volume: 57 start-page: 1014 issue: 9 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib27 article-title: Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.17424 – volume: 8 issue: 9 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib369 article-title: Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? publication-title: PLoS One doi: 10.1371/journal.pone.0074558 – volume: 70 start-page: 1913 issue: 6 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib360 article-title: The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30664 – volume: 4 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib465 article-title: Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B-related cirrhosis and renal impairment publication-title: Health Sci Rep doi: 10.1002/hsr2.352 – volume: 112 start-page: 968 issue: 6 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib82 article-title: The relationship between different dimensions of alcohol use and the burden of disease-an update publication-title: Addiction doi: 10.1111/add.13757 – volume: 41 start-page: 1801 issue: 8 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib414 article-title: Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial) publication-title: Diabetes Care doi: 10.2337/dc18-0165 – volume: 44 start-page: 1433 issue: 6 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib405 article-title: Effects of cotadutide on metabolic and hepatic parameters in adults with overweight or obesity and type 2 diabetes: a 54-week randomized phase 2b study publication-title: Diabetes Care doi: 10.2337/dc20-2151 – volume: 70 start-page: 962 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib218 article-title: Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals publication-title: Gut doi: 10.1136/gutjnl-2020-322572 – volume: 28 start-page: 441 issue: 4 year: 2009 ident: 10.1016/j.jhep.2024.04.031_bib80 article-title: A healthy dose of scepticism: four good reasons to think again about protective effects of alcohol on coronary heart disease publication-title: Drug Alcohol Rev doi: 10.1111/j.1465-3362.2009.00052.x – volume: 97 issue: 13 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib35 article-title: Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000010214 – volume: 48 start-page: 1863 issue: 6 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib111 article-title: Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men publication-title: Int J Epidemiol doi: 10.1093/ije/dyz146 – volume: 163 start-page: 1198 issue: 5 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib433 article-title: AGA clinical practice guideline on pharmacological interventions for adults with obesity publication-title: Gastroenterology doi: 10.1053/j.gastro.2022.08.045 – volume: 5 issue: 10 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib437 article-title: Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.35003 – volume: 8 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib292 article-title: Ketogenic diets and chronic disease: weighing the benefits against the risks publication-title: Front Nutr doi: 10.3389/fnut.2021.702802 – volume: 103 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib242 article-title: Should patients with NAFLD/NASH Be surveyed for HCC? publication-title: Transplantation doi: 10.1097/TP.0000000000002361 – volume: 10 start-page: 3409 issue: 8 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib461 article-title: Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD) publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph10083409 – volume: 113 start-page: 391 issue: 2 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib305 article-title: Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial publication-title: Am J Clin Nutr doi: 10.1093/ajcn/nqaa332 – volume: 362 start-page: 1675 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib372 article-title: Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis publication-title: N Engl J Med doi: 10.1056/NEJMoa0907929 – volume: 366 start-page: 1279 issue: 9493 year: 2005 ident: 10.1016/j.jhep.2024.04.031_bib421 article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(05)67528-9 – volume: 47 start-page: 3037 issue: 9 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib150 article-title: Liver fibrosis assessment: MR and US elastography publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-021-03269-4 – volume: 17 start-page: 1148 issue: 6 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib177 article-title: Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2018.11.030 – volume: 337 start-page: 1705 issue: 24 year: 1997 ident: 10.1016/j.jhep.2024.04.031_bib79 article-title: Alcohol consumption and mortality among middle-aged and elderly U.S. adults publication-title: N Engl J Med doi: 10.1056/NEJM199712113372401 – volume: 71 start-page: 1940 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib304 article-title: Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the multiethnic cohort publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30967 – volume: 124 start-page: 130 issue: 4 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib466 article-title: Managing diabetes in patients with chronic liver disease publication-title: Postgrad Med doi: 10.3810/pgm.2012.07.2574 – volume: 13 start-page: 656 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib26 article-title: Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD - an umbrella overview of systematic review of meta-analysis publication-title: J Clin Exp Hepatol doi: 10.1016/j.jceh.2022.11.006 – volume: 78 start-page: 281 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib462 article-title: Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan publication-title: J Hepatol doi: 10.1016/j.jhep.2022.09.019 – volume: 340 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib86 article-title: Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies publication-title: BMJ doi: 10.1136/bmj.c1240 – volume: 46 start-page: 85 issue: 2 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib332 article-title: Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.14112 – volume: 78 start-page: 479 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib384 article-title: Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH publication-title: J Hepatol doi: 10.1016/j.jhep.2022.10.023 – volume: 11 start-page: 295 issue: 3 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib474 article-title: Association between anthropometric parameters and measurements of liver stiffness by transient elastography publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2012.09.025 – volume: 61 start-page: 1714 issue: 6 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib392 article-title: Statins are underutilized in patients with nonalcoholic fatty liver disease and dyslipidemia publication-title: Dig Dis Sci doi: 10.1007/s10620-015-4000-6 – volume: 20 start-page: 2032 issue: 9 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib340 article-title: Coffee consumption is associated with lower liver stiffness: a nationally representative study publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.09.042 – volume: 106 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib511 article-title: Post-transplant obesity impacts long-term survival after liver transplantation publication-title: Metabolism doi: 10.1016/j.metabol.2020.154204 – volume: 10 start-page: 393 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib404 article-title: Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(22)00070-5 – volume: 57 start-page: 3912 issue: 10 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib349 publication-title: J Med Chem doi: 10.1021/jm4019299 – volume: 64 start-page: 308 issue: 2 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib161 article-title: Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2015.10.009 – volume: 113 start-page: E3451 issue: 24 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib348 article-title: Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses publication-title: Proceedings of the National Academy of Sciences doi: 10.1073/pnas.1506113113 – volume: 46 start-page: 32 issue: 1 year: 2007 ident: 10.1016/j.jhep.2024.04.031_bib136 article-title: FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.21669 – volume: 165 start-page: 463 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib53 article-title: Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study publication-title: Gastroenterology doi: 10.1053/j.gastro.2023.04.025 – volume: 73 start-page: 175 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib107 article-title: Plant-based and animal-based low-carbohydrate diets and risk of hepatocellular carcinoma among US men and women publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31251 – volume: 69 start-page: 1599 issue: 4 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib253 article-title: Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high-risk patients with cirrhosis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30330 – volume: 41 start-page: 1532 issue: 7 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib286 article-title: Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial publication-title: Liver Int doi: 10.1111/liv.14818 – volume: 114 start-page: 1574 issue: 10 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib93 article-title: Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000000340 – volume: 71 start-page: 379 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib297 article-title: The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content publication-title: J Hepatol doi: 10.1016/j.jhep.2019.04.013 – volume: 124 start-page: 1 issue: 1 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib299 article-title: Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Br J Nutr doi: 10.1017/S0007114520000914 – volume: 72 start-page: 401 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib270 article-title: Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2019.09.018 – volume: 68 start-page: 1239 issue: 6 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib303 article-title: High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance publication-title: J Hepatol doi: 10.1016/j.jhep.2018.01.015 – volume: 374 start-page: 1321 issue: 14 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib422 article-title: Pioglitazone after ischemic stroke or transient ischemic attack publication-title: N Engl J Med doi: 10.1056/NEJMoa1506930 – volume: 120 start-page: 1640 issue: 16 year: 2009 ident: 10.1016/j.jhep.2024.04.031_bib42 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – volume: 71 start-page: 523 issue: 3 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib534 article-title: Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification publication-title: J Hepatol doi: 10.1016/j.jhep.2019.05.008 – volume: 79 start-page: 758 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib352 article-title: NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: a prospective derivation and validation study publication-title: J Hepatol doi: 10.1016/j.jhep.2023.04.031 – volume: 355 start-page: 2297 issue: 22 year: 2006 ident: 10.1016/j.jhep.2024.04.031_bib420 article-title: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis publication-title: N Engl J Med doi: 10.1056/NEJMoa060326 – volume: 9 start-page: 897 issue: 10 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib503 article-title: Increased perioperative mortality following bariatric surgery among patients with cirrhosis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2011.07.007 – volume: 20 start-page: 2451 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib160 article-title: Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.09.041 – volume: 71 start-page: 793 issue: 4 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib50 article-title: The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis publication-title: J Hepatol doi: 10.1016/j.jhep.2019.06.021 – volume: 159 start-page: 824 issue: 12 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib368 article-title: Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force publication-title: Ann Intern Med doi: 10.7326/0003-4819-159-12-201312170-00729 – volume: 18 start-page: 157 issue: 1 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib11 article-title: The impact of obesity and metabolic syndrome on alcoholic liver disease publication-title: Clin Liver Dis doi: 10.1016/j.cld.2013.09.006 – volume: 69 start-page: 1075 issue: 3 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib148 article-title: ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30163 – volume: 340 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib44 article-title: Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study publication-title: BMJ doi: 10.1136/bmj.c912 – volume: 5 start-page: 970 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib353 article-title: NIS4™ for non-invasive diagnosis of nonalcoholic steatohepatitis and liver fibrosis publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(20)30252-1 – volume: 57 start-page: 384 issue: 2 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib90 article-title: Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD) publication-title: J Hepatol doi: 10.1016/j.jhep.2012.03.024 – year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib211 article-title: Prevalence and determinants of liver disease in relatives of Italian patients with advanced MASLD publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2023.12.033 – volume: 18 start-page: 2305 issue: 10 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib130 article-title: Cost effectiveness of different strategies for detecting cirrhosis in patients with nonalcoholic fatty liver disease based on United States health care system publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.04.017 – volume: 77 start-page: 573 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib120 article-title: Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32633 – volume: 9 start-page: 83 issue: 1 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib174 article-title: Implementation of a liver health check in people with type 2 diabetes publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(23)00270-4 – volume: 3 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib540 article-title: External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population publication-title: JHEP Rep – volume: 1 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib205 article-title: Machine learning enables new insights into genetic contributions to liver fat accumulation publication-title: Cell Genom – volume: 71 start-page: 907 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib55 article-title: Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30858 – volume: 19 start-page: 806 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib185 article-title: Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.06.045 – volume: 60 start-page: 3142 issue: 10 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib236 article-title: Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience publication-title: Dig Dis Sci doi: 10.1007/s10620-015-3821-7 – volume: 66 start-page: 1031 issue: 5 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib308 article-title: Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents publication-title: J Hepatol doi: 10.1016/j.jhep.2016.12.025 – volume: 392 start-page: 1015 issue: 10152 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib77 article-title: Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(18)31310-2 – volume: 176 start-page: 10 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib290 article-title: Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease : a randomized controlled trial publication-title: Ann Intern Med doi: 10.7326/M22-1787 – volume: 68 start-page: 707 issue: 4 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib448 article-title: A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort publication-title: J Hepatol doi: 10.1016/j.jhep.2017.11.030 – volume: 177 start-page: 333 issue: 4 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib96 article-title: Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study publication-title: Am J Epidemiol doi: 10.1093/aje/kws252 – volume: 102 start-page: 727 issue: 5 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib523 article-title: International liver transplantation society consensus statement on immunosuppression in liver transplant recipients publication-title: Transplantation doi: 10.1097/TP.0000000000002147 – ident: 10.1016/j.jhep.2024.04.031_bib6 – volume: 67 start-page: 470 issue: 3 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib407 article-title: Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial publication-title: Diabetologia doi: 10.1007/s00125-023-06053-9 – volume: 393 start-page: 1597 issue: 10181 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib476 article-title: Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial publication-title: Lancet doi: 10.1016/S0140-6736(18)31875-0 – volume: 9 start-page: 3682 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib196 article-title: Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease publication-title: Sci Rep doi: 10.1038/s41598-019-39998-2 – volume: 7 issue: 7 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib243 article-title: Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis publication-title: Hepatol Commun doi: 10.1097/HC9.0000000000000183 – volume: 116 start-page: 984 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib149 article-title: A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000001059 – volume: 74 start-page: 1434 issue: 10 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib103 article-title: Differences in the association of diet quality with body fat distribution between men and women publication-title: Eur J Clin Nutr doi: 10.1038/s41430-020-0563-1 – volume: 75 start-page: 786 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib182 article-title: Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2021.05.008 – volume: 126 start-page: 1287 issue: 5 year: 2004 ident: 10.1016/j.jhep.2024.04.031_bib391 article-title: Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.02.015 – volume: 57 start-page: 750 issue: 7 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib147 article-title: Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.17385 – volume: 48 start-page: 557 issue: 2 year: 2008 ident: 10.1016/j.jhep.2024.04.031_bib457 article-title: Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.22367 – volume: 19 start-page: 162 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib254 article-title: Serum levels of α-fetoprotein increased more than 10 Years before detection of hepatocellular carcinoma publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.04.084 – volume: 20 start-page: 23 issue: 1 year: 2004 ident: 10.1016/j.jhep.2024.04.031_bib428 article-title: Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2004.02025.x – volume: 73 start-page: 625 issue: 2 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib403 article-title: Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31622 – volume: 56 start-page: 225 issue: 1 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib65 article-title: Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese publication-title: J Hepatol doi: 10.1016/j.jhep.2011.04.022 – volume: 70 start-page: 1946 issue: 10 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib169 article-title: MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis publication-title: Gut doi: 10.1136/gutjnl-2020-322976 – volume: 14 start-page: 124 issue: 1 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib123 article-title: Hepatocellular carcinoma in the absence of cirrhosis in United States Veterans is associated with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.07.019 – volume: 77 start-page: 256 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib145 article-title: The steatosis-associated fibrosis estimator (SAFE) score: a tool to detect low-risk NAFLD in primary care publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32545 – volume: 30 start-page: 380 issue: 2 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib116 article-title: Composite score of healthy lifestyle factors and risk of hepatocellular carcinoma: findings from a prospective cohort study publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-20-1201 – volume: 115 start-page: 1642 issue: 10 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib237 article-title: Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000000715 – volume: 46 start-page: 856 issue: 9 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib232 article-title: Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.14261 – volume: 22 start-page: 95 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib300 article-title: Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials publication-title: BMC Endocr Disord doi: 10.1186/s12902-022-01015-5 – volume: 33 start-page: e529 issue: 1S Suppl 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib334 article-title: Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000002158 – volume: 70 start-page: 2085 issue: 11 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib287 article-title: Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial publication-title: Gut doi: 10.1136/gutjnl-2020-323106 – volume: 78 start-page: 1199 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib510 article-title: Liver transplantation immunology: immunosuppression, rejection, and immunomodulation publication-title: J Hepatol doi: 10.1016/j.jhep.2023.01.030 – volume: 74 start-page: 1809 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib426 article-title: Saroglitazar, a PPAR-α/γ agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31843 – volume: 61 start-page: 75 issue: 1 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib195 article-title: Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2014.02.030 – volume: 75 start-page: 1476 issue: 6 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib240 article-title: Epidemiology and risk-stratification of NAFLD-associated HCC publication-title: J Hepatol doi: 10.1016/j.jhep.2021.08.012 – volume: 131 start-page: 193 issue: 1 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib46 article-title: Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults publication-title: Int J Cancer doi: 10.1002/ijc.26338 – volume: 137 start-page: 1 issue: 1 year: 2002 ident: 10.1016/j.jhep.2024.04.031_bib19 article-title: Updated definitions of healthy ranges for serum alanine aminotransferase levels publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-1-200207020-00006 – volume: 387 start-page: 332 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib204 article-title: Germline mutations in CIDEB and protection against liver disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2117872 – volume: 80 start-page: 694 issue: 5 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib4 article-title: Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2024.01.014 – volume: 54 start-page: 555 issue: 2 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib45 article-title: Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.24418 – volume: 23 start-page: 554 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib228 article-title: The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-023-03580-6 – volume: 163 start-page: 764 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib330 article-title: AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review publication-title: Gastroenterology doi: 10.1053/j.gastro.2022.06.023 – volume: 20 start-page: 1382 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib409 article-title: Glucagon-like peptide-1 receptor agonists and hepatic decompensation events in patients with cirrhosis and diabetes publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.07.010 – volume: 154 start-page: 1706 issue: 6 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib250 article-title: Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.01.064 – volume: 38 start-page: 2552 issue: 6 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib339 article-title: A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease publication-title: Clin Nutr doi: 10.1016/j.clnu.2018.11.030 – volume: 72 start-page: 1399 issue: 7 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib355 article-title: Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis publication-title: Gut doi: 10.1136/gutjnl-2022-328689 – volume: 77 start-page: 191 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib113 article-title: Cigarette smoking and liver diseases publication-title: J Hepatol doi: 10.1016/j.jhep.2022.01.016 – volume: 39 start-page: 254 issue: 3 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib156 article-title: Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12569 – volume: 64 start-page: 1388 issue: 6 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib3 article-title: EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2015.11.004 – volume: 24 start-page: 122 issue: 1 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib320 article-title: Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list publication-title: Liver Transpl doi: 10.1002/lt.24958 – volume: 65 start-page: 570 issue: 3 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib178 article-title: Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2016.04.023 – volume: 54 start-page: 1011 issue: 5 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib375 article-title: A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2010.08.030 – volume: 163 start-page: 1079 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib170 article-title: Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease: a systematic review and meta-analysis of individual participants publication-title: Gastroenterology doi: 10.1053/j.gastro.2022.06.073 – volume: 389 start-page: 998 issue: 11 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib266 article-title: Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH publication-title: N Engl J Med doi: 10.1056/NEJMoa2304286 – volume: 71 start-page: 808 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib57 article-title: Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31014 – volume: 14 issue: 9 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib396 article-title: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial publication-title: PLoS One doi: 10.1371/journal.pone.0221683 – volume: 79 start-page: 888 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib406 article-title: A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2023.05.013 – volume: 20 start-page: 283 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib239 article-title: Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.05.002 – volume: 20 start-page: 797 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib520 article-title: Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipients publication-title: Am J Transpl doi: 10.1111/ajt.15706 – volume: 156 start-page: 88 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib271 article-title: Factors associated with histologic response in adult patients with nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.09.021 – volume: 125 start-page: 29 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib365 article-title: Relationship between serum alpha-tocopherol and overall and cause-specific mortality publication-title: Circ Res doi: 10.1161/CIRCRESAHA.119.314944 – volume: 42 start-page: 864 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib210 article-title: Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: a case series publication-title: Liver Int doi: 10.1111/liv.15185 – volume: 76 start-page: 1013 issue: 5 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib173 article-title: Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events publication-title: J Hepatol doi: 10.1016/j.jhep.2021.12.031 – volume: 107 start-page: 862 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib317 article-title: The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab795 – volume: 3 start-page: 437 issue: 3 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib106 article-title: High-quality diets are associated with reduced risk of hepatocellular carcinoma and chronic liver disease: the multiethnic cohort publication-title: Hepatol Commun doi: 10.1002/hep4.1313 – volume: 13 start-page: 643 issue: 4 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib62 article-title: Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2014.04.014 – volume: 25 start-page: 641 issue: 4 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib273 article-title: Platelet GPIbalpha is a mediator and potential interventional target for NASH and subsequent liver cancer publication-title: Nat Med doi: 10.1038/s41591-019-0379-5 – volume: 33 start-page: 755 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib346 article-title: NAFLD and thyroid function: pathophysiological and therapeutic considerations publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2022.08.001 – volume: 76 start-page: 506 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib383 article-title: EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study publication-title: J Hepatol doi: 10.1016/j.jhep.2021.10.018 – volume: 29 start-page: 1380 issue: 12 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib64 article-title: The association of nonalcoholic steatohepatitis and obstructive sleep apnea publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000000973 – volume: 89 start-page: 1 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib98 article-title: Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease publication-title: Alcohol doi: 10.1016/j.alcohol.2020.07.010 – volume: 346 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib370 article-title: Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials publication-title: Bmj doi: 10.1136/bmj.f10 – volume: 148 start-page: 2102 issue: 9 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib108 article-title: Quality diet indexes and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study publication-title: Int J Cancer doi: 10.1002/ijc.33367 – volume: 21 start-page: 2026 issue: 8 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib257 article-title: Noninvasive assessment of liver fibrosis in NAFLD publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2023.03.042 – volume: 3 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib327 article-title: Non-alcoholic fatty liver disease: a patient guideline publication-title: JHEP Rep – volume: 46 start-page: 1081 issue: 4 year: 2007 ident: 10.1016/j.jhep.2024.04.031_bib385 article-title: A lipidomic analysis of nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.21763 – year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib17 article-title: Metabolic syndrome traits increase the risk of major adverse liver outcomes in type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc23-1937 – volume: 22 start-page: 7236 issue: 32 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib151 article-title: Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease – Where do we stand? publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i32.7236 – volume: 132 issue: 21 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib135 article-title: Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease publication-title: J Clin Invest doi: 10.1172/JCI162513 – volume: 7 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib312 article-title: American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease publication-title: Hepatol Commun doi: 10.1097/HC9.0000000000000108 – volume: 92 start-page: 947 issue: 8 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib509 article-title: Body composition and overweight of liver transplant recipients publication-title: Transplantation doi: 10.1097/TP.0b013e31822e0bee – volume: 48 start-page: 2137 issue: 14 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib531 article-title: Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies publication-title: Eur J Cancer doi: 10.1016/j.ejca.2012.02.063 – volume: 70 start-page: 5 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib5 article-title: Clinical practice guidelines of the European association for the study of the liver - advancing methodology but preserving practicability publication-title: J Hepatol doi: 10.1016/j.jhep.2018.10.011 – volume: 32 start-page: 3600 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib506 article-title: Combined sleeve gastrectomy with liver transplant in patients with obesity: a feasibility study publication-title: Obes Surg doi: 10.1007/s11695-022-06289-1 – volume: 20 start-page: 12945 issue: 36 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib532 article-title: Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i36.12945 – volume: 75 start-page: 46 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib306 article-title: Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial publication-title: J Hepatol doi: 10.1016/j.jhep.2021.02.027 – volume: 76 start-page: 536 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib267 article-title: Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study publication-title: J Hepatol doi: 10.1016/j.jhep.2021.10.029 – volume: 7 start-page: 126 issue: 2 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib450 article-title: Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12039 – volume: 390 start-page: 497 issue: 6 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib350 article-title: A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis publication-title: N Engl J Med doi: 10.1056/NEJMoa2309000 – volume: 62 start-page: 190 issue: 1 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib387 article-title: Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial publication-title: J Hepatol doi: 10.1016/j.jhep.2014.08.036 – volume: 894 start-page: 1 issue: i-xii year: 2000 ident: 10.1016/j.jhep.2024.04.031_bib40 article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation publication-title: World Health Organ Tech Rep Ser – volume: 326 start-page: 2031 issue: 20 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib439 article-title: Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis publication-title: JAMA doi: 10.1001/jama.2021.19569 – volume: 78 start-page: 501 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib100 article-title: Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort publication-title: J Hepatol doi: 10.1016/j.jhep.2022.11.013 – volume: 65 start-page: 1770 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib59 article-title: A novel diabetes typology: towards precision diabetology from pathogenesis to treatment publication-title: Diabetologia doi: 10.1007/s00125-021-05625-x – volume: 116 start-page: 723 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib475 article-title: Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000000994 – volume: 42 start-page: 931 issue: 5 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib416 article-title: The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients publication-title: Diabetes Care doi: 10.2337/dc18-1569 – volume: 184 start-page: 2537 issue: 10 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib33 article-title: Mechanisms and disease consequences of nonalcoholic fatty liver disease publication-title: Cell doi: 10.1016/j.cell.2021.04.015 – volume: 25 start-page: 56 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib517 article-title: Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis publication-title: Liver Transpl doi: 10.1002/lt.25338 – volume: 13 start-page: 63 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib313 article-title: Effect of exercise on hepatic steatosis: are benefits seen without dietary intervention? A systematic review and meta-analysis publication-title: J Diabetes doi: 10.1111/1753-0407.13086 – volume: 75 start-page: 770 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib157 article-title: Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis publication-title: J Hepatol doi: 10.1016/j.jhep.2021.04.044 – volume: 41 start-page: 225 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib285 article-title: Effects of mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression analysis of randomized controlled trials publication-title: Semin Liver Dis doi: 10.1055/s-0041-1723751 – volume: 72 start-page: 742 issue: 2 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib347 article-title: Thyroid hormone signaling and the liver publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31296 – volume: 103 start-page: 45 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib489 article-title: International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation publication-title: Transplantation doi: 10.1097/TP.0000000000002433 – volume: 67 start-page: 2141 issue: 6 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib84 article-title: Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29631 – volume: 51 start-page: 679 issue: 2 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib223 article-title: Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.23280 – volume: 149 start-page: 367 issue: 2 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib280 article-title: Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.04.005 – volume: 102 start-page: 2950 issue: 8 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib390 article-title: Liver safety of statins in prediabetes or T2DM and nonalcoholic steatohepatitis: post hoc analysis of a randomized trial publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2017-00867 – volume: 20 start-page: 2462 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib28 article-title: A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.09.021 – volume: 78 start-page: 191 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib75 article-title: Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2022.08.030 – volume: 375 start-page: 631 issue: 7 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib379 article-title: A placebo-controlled trial of obeticholic acid in primary biliary cholangitis publication-title: N Engl J Med doi: 10.1056/NEJMoa1509840 – volume: 71 start-page: 1198 issue: 4 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib264 article-title: NGM282 improves liver fibrosis and histology in 12 Weeks in patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30590 – volume: 65 start-page: 1293 issue: 4 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib455 article-title: Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.28992 – volume: 102 start-page: 1096 issue: 7 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib514 article-title: Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation publication-title: Transplantation doi: 10.1097/TP.0000000000002175 – volume: 72 start-page: 1196 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib193 article-title: Update on NAFLD genetics: from new variants to the clinic publication-title: J Hepatol doi: 10.1016/j.jhep.2020.02.020 – volume: 61 start-page: 1547 issue: 5 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib32 article-title: Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.27368 – volume: 60 start-page: 2008 issue: 6 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib432 article-title: Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.27199 – volume: 75 start-page: 1164 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib376 article-title: 24-Norursodeoxycholic acid reshapes immunometabolism in CD8(+) T cells and alleviates hepatic inflammation publication-title: J Hepatol doi: 10.1016/j.jhep.2021.06.036 – volume: 160 start-page: 1634 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib203 article-title: Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.12.023 – volume: 9 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib24 article-title: Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis publication-title: Sci Rep – volume: 4 start-page: e41 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib95 article-title: Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study publication-title: Lancet Public Health doi: 10.1016/S2468-2667(18)30230-5 – volume: 2 start-page: 691 issue: 9 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib413 article-title: Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(14)70120-2 – volume: 65 start-page: 2090 issue: 6 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib533 article-title: Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29055 – volume: 12 issue: 9 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib73 article-title: Smoking increases the risk of hepatocellular carcinoma and cardiovascular disease in patients with metabolic-associated fatty liver disease publication-title: J Clin Med doi: 10.3390/jcm12093336 – volume: 15 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib336 article-title: Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies publication-title: Gut Microbes doi: 10.1080/19490976.2023.2226922 – volume: 8 start-page: 511 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib411 article-title: Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(23)00068-7 – volume: 101 start-page: 422 issue: 4 year: 1996 ident: 10.1016/j.jhep.2024.04.031_bib238 article-title: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis publication-title: Am J Med doi: 10.1016/S0002-9343(96)00197-0 – volume: 76 start-page: 456 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib442 article-title: Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32358 – volume: 118 start-page: 98 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib39 article-title: Relationships between education and non-alcoholic fatty liver disease publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2023.07.039 – volume: 60 start-page: 110 issue: 1 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib231 article-title: Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team publication-title: J Hepatol doi: 10.1016/j.jhep.2013.08.011 – volume: 17 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib277 article-title: Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0263931 – volume: 20 start-page: 658 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib207 article-title: A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.05.056 – volume: 30 start-page: 1549 issue: 8 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib221 article-title: Measuring and estimating insulin resistance in clinical and research settings publication-title: Obesity (Silver Spring) doi: 10.1002/oby.23503 – volume: 117 start-page: 1614 issue: 10 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib459 article-title: Outcomes of exercise interventions in patients with advanced liver disease: a systematic review of randomized clinical trials publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000001883 – volume: 78 start-page: 574 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib481 article-title: Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis publication-title: J Hepatol doi: 10.1016/j.jhep.2022.10.030 – volume: 367 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib275 article-title: Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults publication-title: BMJ – volume: 44 start-page: 865 issue: 4 year: 2006 ident: 10.1016/j.jhep.2024.04.031_bib43 article-title: Long-term follow-up of patients with NAFLD and elevated liver enzymes publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.21327 – volume: 28 start-page: 528 issue: 5 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib125 publication-title: Endocr Pract doi: 10.1016/j.eprac.2022.03.010 – volume: 19 start-page: 436 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib500 article-title: AGA clinical practice update on bariatric surgery in cirrhosis: expert review publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.10.034 – volume: 29 start-page: 422 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib508 article-title: Combined liver transplantation and sleeve gastrectomy: report of a brief-interval staged approach publication-title: Liver Transpl doi: 10.1002/lt.26560 – volume: 17 start-page: 1625 issue: 8 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib87 article-title: Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2018.11.033 – volume: 378 start-page: 1096 issue: 12 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib200 article-title: A protein-truncating HSD17B13 variant and protection from chronic liver disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1712191 – volume: 70 start-page: 1214 issue: 6 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib209 article-title: Clinical utility of genomic analysis in adults with idiopathic liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2019.01.036 – volume: 52 start-page: 1387 issue: 8 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib318 article-title: Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15989 – volume: 49 start-page: 80 issue: 1 year: 2009 ident: 10.1016/j.jhep.2024.04.031_bib434 article-title: Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.22575 – volume: 73 start-page: 1368 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib535 article-title: aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2020.07.025 – volume: 112 start-page: 740 issue: 5 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib141 article-title: Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.453 – volume: 390 start-page: 559 issue: 6 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib363 article-title: Selective agonists of thyroid hormone receptor beta for the treatment of NASH publication-title: N Engl J Med doi: 10.1056/NEJMe2314365 – volume: 71 start-page: 539 issue: 2 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib10 article-title: Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30857 – volume: 96 issue: 17 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib131 article-title: Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000006585 – volume: 47 start-page: 135 issue: 1 year: 2007 ident: 10.1016/j.jhep.2024.04.031_bib470 article-title: Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study publication-title: J Hepatol doi: 10.1016/j.jhep.2007.02.013 – volume: 13 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib445 article-title: Effects of bariatric endoscopy on non-alcoholic fatty liver disease: a comprehensive systematic review and meta-analysis publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.931519 – volume: 155 start-page: 107 issue: 1 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib102 article-title: Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.03.038 – volume: 159 start-page: 1290 issue: 4 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib443 article-title: Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.06.006 – volume: 71 start-page: 835 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib91 article-title: Risks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30864 – volume: 32 issue: 5 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib491 article-title: Cardio-hepatic risk assessment by CMR imaging in liver transplant candidates publication-title: Clin Transpl doi: 10.1111/ctr.13229 – volume: 399 start-page: 61 issue: 10319 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib1 article-title: The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality publication-title: Lancet doi: 10.1016/S0140-6736(21)01701-3 – volume: 59 start-page: 1406 issue: 4 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib68 article-title: Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.26761 – volume: 70 start-page: 1375 issue: 7 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib18 article-title: Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort publication-title: Gut doi: 10.1136/gutjnl-2020-322786 – volume: 62 start-page: 615 issue: 7 year: 2008 ident: 10.1016/j.jhep.2024.04.031_bib81 article-title: Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis publication-title: J Epidemiol Community Health doi: 10.1136/jech.2007.065607 – volume: 74 start-page: 775 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib206 article-title: Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores publication-title: J Hepatol doi: 10.1016/j.jhep.2020.11.024 – volume: 115 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib278 article-title: The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Metabolism doi: 10.1016/j.metabol.2020.154455 – volume: 72 start-page: 2138 issue: 11 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib16 article-title: Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis publication-title: Gut doi: 10.1136/gutjnl-2023-330110 – volume: 79 start-page: 592 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib358 article-title: An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography publication-title: J Hepatol doi: 10.1016/j.jhep.2023.04.025 – volume: 10 start-page: 1342 issue: 12 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib241 article-title: Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2012.10.001 – volume: 38 start-page: 1917 issue: 11 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib453 article-title: Nutritional therapy for persistent cognitive impairment after resolution of overt hepatic encephalopathy in patients with cirrhosis: a double-blind randomized controlled trial publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.16266 – volume: 77 start-page: 1797 issue: 5 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib126 article-title: AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1097/HEP.0000000000000323 – volume: 68 start-page: 526 issue: 3 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib431 article-title: Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine publication-title: J Hepatol doi: 10.1016/j.jhep.2017.09.016 – volume: 36 start-page: 1470 issue: 6 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib296 article-title: Relationship between dietary patterns and non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.15363 – volume: 42 start-page: 218 issue: 2 year: 2005 ident: 10.1016/j.jhep.2024.04.031_bib97 article-title: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2004.10.005 – year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib229 article-title: Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study publication-title: Nutr Metab Cardiovasc Dis – volume: 17 start-page: 2776 issue: 13 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib274 article-title: Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.04.061 – volume: 78 start-page: 1089 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib488 article-title: Evaluation of recipients with significant comorbidity - patients with cardiovascular disease publication-title: J Hepatol doi: 10.1016/j.jhep.2023.03.023 – volume: 69 start-page: 878 issue: 4 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib478 article-title: Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis publication-title: J Hepatol doi: 10.1016/j.jhep.2018.05.019 – volume: 78 start-page: 914 issue: 5 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib424 article-title: Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase II randomized placebo-controlled trial (DESTINY-1) publication-title: J Hepatol doi: 10.1016/j.jhep.2023.02.004 – volume: 25 start-page: 538 issue: 4 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib504 article-title: Outcomes of sleeve gastrectomy in obese liver transplant candidates publication-title: Liver Transpl doi: 10.1002/lt.25406 – volume: 66 start-page: 1022 issue: 5 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib166 article-title: Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis publication-title: J Hepatol doi: 10.1016/j.jhep.2016.12.022 – volume: 106 start-page: 24 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib344 article-title: Coffee consumption has no effect on circulating markers of liver function but increases adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials publication-title: Nutr Res doi: 10.1016/j.nutres.2022.07.010 – volume: 14 issue: 9 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib319 article-title: Exercise does not independently improve histological outcomes in biopsy-proven non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Genes (Basel) doi: 10.3390/genes14091811 – volume: 330 start-page: 247 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib328 article-title: Accelerometer-derived "weekend warrior" physical activity and incident cardiovascular disease publication-title: JAMA doi: 10.1001/jama.2023.10875 – volume: 65 start-page: 1196 issue: 4 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib251 article-title: An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.28895 – volume: 18 start-page: 487 issue: 3 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib213 article-title: The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro publication-title: Pharmacogenomics J doi: 10.1038/tpj.2017.45 – volume: 39 start-page: 39 issue: 1 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib530 article-title: Measuring lipoprotein (a) for cardiovascular disease prevention - in whom and when? publication-title: Curr Opin Cardiol doi: 10.1097/HCO.0000000000001104 – volume: 68 start-page: 1051 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib325 article-title: Physical activity and risk of hepatocellular carcinoma: a systematic review and meta-analysis publication-title: Dig Dis Sci doi: 10.1007/s10620-022-07601-w – volume: 68 start-page: 1035 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib501 article-title: Intragastric balloon in obese compensated nonalcoholic steatohepatitis cirrhosis patients is safe and achieves significant weight reduction at 6-months publication-title: Dig Dis Sci doi: 10.1007/s10620-022-07596-4 – volume: 2 issue: 10 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib260 article-title: Association of histologic disease activity with progression of nonalcoholic fatty liver disease publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2019.12565 – volume: 6 start-page: 52 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib189 article-title: Variability of noninvasive MRI and biological markers in compensated cirrhosis: insights for assessing disease progression publication-title: Eur Radiol Exp doi: 10.1186/s41747-022-00303-y – volume: 70 start-page: 531 issue: 3 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib34 article-title: Non-alcoholic fatty liver disease - a global public health perspective publication-title: J Hepatol doi: 10.1016/j.jhep.2018.10.033 – volume: 63 start-page: 530 issue: 3 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib89 article-title: Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals publication-title: Gut doi: 10.1136/gutjnl-2013-305718 – volume: 21 start-page: 1061 issue: 4 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib522 article-title: Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients publication-title: Diabetes Obes Metab doi: 10.1111/dom.13619 – volume: 38 start-page: 518 issue: 2 year: 2003 ident: 10.1016/j.jhep.2024.04.031_bib137 article-title: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C publication-title: Hepatology (Baltimore, Md) doi: 10.1053/jhep.2003.50346 – volume: 56 start-page: 1741 issue: 5 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib485 article-title: Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.25855 – volume: 72 start-page: 785 issue: 4 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib227 article-title: NAFLD as a driver of chronic kidney disease publication-title: J Hepatol doi: 10.1016/j.jhep.2020.01.013 – volume: 21 start-page: 2570 issue: 10 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib357 article-title: MRI-AST (MAST) score accurately predicts major adverse liver outcome, hepatocellular carcinoma, liver transplant, and liver-related death publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2023.02.003 – volume: 50 start-page: 317 issue: 3 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib430 article-title: Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15331 – volume: 385 start-page: 1559 issue: 17 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib122 article-title: Prospective study of outcomes in adults with nonalcoholic fatty liver disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2029349 – volume: 78 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib255 article-title: Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2022.10.035 – volume: 78 start-page: 471 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib49 article-title: A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes publication-title: J Hepatol doi: 10.1016/j.jhep.2022.11.010 – volume: 51 start-page: 237 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib104 article-title: Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the tianjin chronic low-grade systemic inflammation and health cohort study publication-title: Int J Epidemiol doi: 10.1093/ije/dyab174 – volume: 20 start-page: 27 issue: 1 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib216 article-title: Inter-organ crosstalk during development and progression of type 2 diabetes mellitus publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-023-00898-1 – volume: 12 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib337 article-title: Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Therap Adv Gastroenterol doi: 10.1177/1756284819878046 – volume: 52 start-page: 472 issue: 2 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib374 article-title: High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.23727 – volume: 30 start-page: 348 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib67 article-title: Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Menopause doi: 10.1097/GME.0000000000002133 – volume: 70 start-page: 511 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib88 article-title: Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30226 – volume: 10 start-page: 245 issue: 4 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib74 article-title: Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies publication-title: J Evid Based Med doi: 10.1111/jebm.12270 – volume: 8 start-page: 20 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib13 article-title: Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(22)00317-X – volume: 8 start-page: 714 issue: 8 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib140 article-title: Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(23)00017-1 – volume: 18 start-page: 728 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib537 article-title: GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.11.012 – volume: 16 start-page: 198 issue: 2 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib71 article-title: Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.09.041 – volume: 28 start-page: 444 issue: 2 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib525 article-title: Laparoscopic sleeve gastrectomy for morbid obesity in patients after orthotopic liver transplant: a matched case-control study publication-title: Obes Surg doi: 10.1007/s11695-017-2847-7 – volume: 12 start-page: 131 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib224 article-title: The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications publication-title: Obes Facts doi: 10.1159/000497124 – volume: 15 start-page: 502 issue: 3 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib440 article-title: Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2018.12.002 – volume: 29 start-page: 34 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib486 article-title: Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium publication-title: Liver Transpl doi: 10.1097/LVT.0000000000000007 – volume: 14 start-page: 646 issue: 6 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib495 article-title: Listing practices for morbidly obese patients at liver transplantation centers in the United States publication-title: Exp Clin Transpl – volume: 34 start-page: 241 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib190 article-title: Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.14311 – volume: 159 start-page: 1985 issue: 5 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib132 article-title: Nashnet. Screening for nonalcoholic fatty liver disease in persons with type 2 diabetes in the United States is cost-effective: a comprehensive cost-utility analysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.07.050 – volume: 29 start-page: 172 issue: 2 year: 2009 ident: 10.1016/j.jhep.2024.04.031_bib429 article-title: Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2008.03869.x – volume: 74 start-page: 2410 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib54 article-title: Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31845 – volume: 6 start-page: 550 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib38 article-title: Community socioeconomic deprivation predicts nonalcoholic steatohepatitis publication-title: Hepatol Commun doi: 10.1002/hep4.1831 – volume: 4 start-page: 781 issue: 10 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib377 article-title: Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30184-0 – volume: 248 start-page: 863 issue: 5 year: 2008 ident: 10.1016/j.jhep.2024.04.031_bib494 article-title: Prolonged waiting times for liver transplantation in obese patients publication-title: Ann Surg doi: 10.1097/SLA.0b013e31818a01ef – volume: 79 start-page: 1110 issue: 5 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib382 article-title: Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2023.07.014 – volume: 385 start-page: 1547 issue: 17 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib425 article-title: A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH publication-title: N Engl J Med doi: 10.1056/NEJMoa2036205 – volume: 42 start-page: 1731 issue: 8 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib291 article-title: One size does not fit all; practical, personal tailoring of the diet to NAFLD patients publication-title: Liver Int doi: 10.1111/liv.15335 – volume: 122 start-page: 1085 issue: 7 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib117 article-title: Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies publication-title: Br J Cancer doi: 10.1038/s41416-020-0741-x – volume: 64 start-page: 433 issue: 2 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib497 article-title: EASL clinical practice guidelines: liver transplantation publication-title: J Hepatol doi: 10.1016/j.jhep.2015.10.006 – volume: 67 start-page: 2001 issue: 5 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib256 article-title: Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29607 – volume: 68 start-page: 1741 issue: 5 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib298 article-title: Ad libitum mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30076 – volume: 15 start-page: 1940 issue: 12 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib395 article-title: A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.04.016 – volume: 160 start-page: 1799 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib498 article-title: AGA clinical practice guidelines on intragastric balloons in the management of obesity publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.03.003 – volume: 39 start-page: 166 issue: 1 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib436 article-title: Determinants of diabetes remission and glycemic control after bariatric surgery publication-title: Diabetes Care doi: 10.2337/dc15-0575 – volume: 74 start-page: 1611 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib446 article-title: Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32049 – volume: 38 start-page: 210 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib454 article-title: Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: a randomized clinical trial publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.16035 – volume: 5 start-page: 31 issue: 1 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib472 article-title: Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30320-6 – volume: 21 start-page: 3314 issue: 13 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib198 article-title: Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2023.04.024 – volume: 10 start-page: 877 issue: 11 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib492 article-title: Cardiac stress testing and coronary artery disease in liver transplantation candidates: meta-analysis publication-title: World J Hepatol doi: 10.4254/wjh.v10.i11.877 – volume: 62 start-page: 1061 issue: 5 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib94 article-title: Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study publication-title: J Hepatol doi: 10.1016/j.jhep.2014.12.005 – volume: 69 start-page: 182 issue: 1 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib246 article-title: EASL clinical practice guidelines: management of hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2018.03.019 – volume: 150 start-page: 1160 issue: 5 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib471 article-title: Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.01.004 – volume: 384 start-page: 1113 issue: 12 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib401 article-title: A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis publication-title: N Engl J Med doi: 10.1056/NEJMoa2028395 – volume: 29 start-page: 76 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib118 article-title: International evidence for the effectiveness of the front-of-package nutrition label called Nutri-Score publication-title: Cent Eur J Public Health doi: 10.21101/cejph.a6239 – volume: 149 start-page: 119 issue: 1 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib48 article-title: Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.03.044 – volume: 16 start-page: 123 issue: 1 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib345 article-title: Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.08.014 – volume: 292 start-page: 177 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib23 article-title: Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease publication-title: J Intern Med doi: 10.1111/joim.13343 – volume: 77 start-page: 596 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib202 article-title: Rare ATG7 genetic variants predispose patients to severe fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2022.03.031 – volume: 69 start-page: 1349 issue: 6 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib333 article-title: Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2018.08.011 – volume: 71 start-page: 156 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib226 article-title: Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis publication-title: Gut doi: 10.1136/gutjnl-2020-323082 – volume: 6 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib288 article-title: Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2023.3513 – volume: 51 start-page: 1972 issue: 6 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib101 article-title: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.23527 – volume: 41 start-page: 1913 issue: 9 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib279 article-title: The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis publication-title: Clin Nutr doi: 10.1016/j.clnu.2022.06.037 – volume: 147 start-page: 377 issue: 2 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib386 article-title: No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.04.046 – volume: 76 start-page: 781 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib167 article-title: MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis publication-title: J Hepatol doi: 10.1016/j.jhep.2021.11.012 – volume: 160 start-page: 1608 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib181 article-title: The association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.12.003 – volume: 41 start-page: 356 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib109 article-title: Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: evidence from mediation analysis publication-title: Clin Nutr doi: 10.1016/j.clnu.2021.12.014 – volume: 5 issue: 1 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib326 article-title: Physical activity is inversely associated with hepatic fibro-inflammation: a population-based cohort study using UK Biobank data publication-title: JHEP Rep – volume: 66 start-page: 1486 issue: 5 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib158 article-title: Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29302 – volume: 73 start-page: 1023 issue: 5 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib191 article-title: Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2020.06.007 – volume: 73 start-page: 713 issue: 2 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib249 article-title: Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31309 – volume: 11 issue: 7 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib518 article-title: Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis publication-title: Plos Med doi: 10.1371/journal.pmed.1001680 – volume: 9 start-page: 428 issue: 5 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib234 article-title: Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2011.01.023 – volume: 20 start-page: 2524 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib307 article-title: Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 Years: the framingham heart study publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.11.001 – volume: 70 start-page: 522 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib261 article-title: Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the nonalcoholic steatohepatitis clinical research network treatment trials publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30418 – volume: 45 start-page: 846 issue: 4 year: 2007 ident: 10.1016/j.jhep.2024.04.031_bib138 article-title: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.21496 – volume: 7 start-page: 684 issue: 9 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib219 article-title: Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30187-1 – volume: 27 start-page: 1239 issue: 9 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib502 article-title: Efficacy and safety of endoscopic balloon placement for weight loss in patients with cirrhosis awaiting liver transplantation publication-title: Liver Transpl doi: 10.1002/lt.26074 – year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib410 article-title: Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes publication-title: Clin Gastroenterol Hepatol – volume: 155 start-page: 1828 issue: 6 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib244 article-title: Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.024 – volume: 79 start-page: 1374 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib9 article-title: Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: nationwide multigenerational cohort study publication-title: J Hepatol doi: 10.1016/j.jhep.2023.08.018 – volume: 48 start-page: 1117 issue: 10 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib183 article-title: Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.14990 – volume: 65 start-page: 1758 issue: 11 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib58 article-title: Phenotypic and genetic classification of diabetes publication-title: Diabetologia doi: 10.1007/s00125-022-05769-4 – volume: 135 start-page: 1176 issue: 4 year: 2008 ident: 10.1016/j.jhep.2024.04.031_bib418 article-title: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.06.047 – volume: 25 start-page: 1673 issue: 11 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib524 article-title: Delayed sleeve gastrectomy following liver transplantation: a 5-year experience publication-title: Liver Transpl doi: 10.1002/lt.25637 – volume: 36 start-page: 150 issue: 1 year: 2002 ident: 10.1016/j.jhep.2024.04.031_bib47 article-title: Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? publication-title: Hepatology (Baltimore, Md) doi: 10.1053/jhep.2002.33713 – volume: 6 start-page: 903 issue: 11 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib25 article-title: Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(21)00308-3 – volume: 57 start-page: 709 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib324 article-title: Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD) publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.17308 – volume: 75 start-page: 1491 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib37 article-title: High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32207 – volume: 158 start-page: 1611 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib121 article-title: Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.01.043 – volume: 43 start-page: 621 issue: 5 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib248 article-title: Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13505 – volume: 30 start-page: 766 issue: 7 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib519 article-title: De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000001105 – volume: 6 issue: 6 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib295 article-title: Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis publication-title: Cochrane Database Syst Rev – volume: 66 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib272 article-title: FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2023.102310 – volume: 394 start-page: 2184 issue: 10215 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib381 article-title: Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(19)33041-7 – volume: 38 start-page: 485 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib447 article-title: ESPEN guideline on clinical nutrition in liver disease publication-title: Clin Nutr doi: 10.1016/j.clnu.2018.12.022 – volume: 71 start-page: 983 issue: 5 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib263 article-title: Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease publication-title: Gut doi: 10.1136/gutjnl-2021-324264 – volume: 60 start-page: 1278 issue: 9 year: 2011 ident: 10.1016/j.jhep.2024.04.031_bib315 article-title: Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss publication-title: Gut doi: 10.1136/gut.2011.242073 – volume: 16 start-page: 2684 issue: 9 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib513 article-title: Factors associated with major adverse cardiovascular events after liver transplantation among a national sample publication-title: Am J Transpl doi: 10.1111/ajt.13779 – volume: 387 start-page: 679 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib400 article-title: Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study publication-title: Lancet doi: 10.1016/S0140-6736(15)00803-X – volume: 59 start-page: 51 issue: 1 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib351 article-title: Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.17734 – volume: 12 issue: 3 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib36 article-title: Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States publication-title: PLoS One doi: 10.1371/journal.pone.0173499 – volume: 20 start-page: 2393 issue: 10 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib281 article-title: Weight loss and weight regain in usual clinical practice: results from the TARGET-NASH observational cohort publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.01.023 – volume: 8 start-page: 816 issue: 9 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib480 article-title: Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(23)00150-4 – volume: 27 start-page: 49 issue: 1 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib61 article-title: Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes publication-title: Nat Med doi: 10.1038/s41591-020-1116-9 – volume: 41 start-page: 990 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib451 article-title: Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement publication-title: Clin Nutr doi: 10.1016/j.clnu.2021.11.014 – volume: 75 start-page: 659 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib139 article-title: EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update publication-title: J Hepatol doi: 10.1016/j.jhep.2021.05.025 – volume: 27 start-page: 1468 issue: 10 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib521 article-title: Metabolic complications in liver transplantation recipients: how we can optimize long-term survival publication-title: Liver Transpl doi: 10.1002/lt.26219 – volume: 3 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib114 article-title: Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort publication-title: JHEP Rep – volume: 8 start-page: 704 issue: 8 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib187 article-title: Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(23)00141-3 – volume: 29 start-page: 2919 issue: 11 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib362 article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial publication-title: Nat Med doi: 10.1038/s41591-023-02603-1 – volume: 100 start-page: 2231 issue: 6 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib22 article-title: High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2015-1966 – volume: 79 start-page: 842 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib119 article-title: Changing epidemiology, global trends and implications for outcomes of NAFLD publication-title: J Hepatol doi: 10.1016/j.jhep.2023.04.036 – volume: 40 start-page: 355 issue: 2 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib66 article-title: Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis publication-title: Liver Int doi: 10.1111/liv.14279 – volume: 165 start-page: 305 issue: 5 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib419 article-title: Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial publication-title: Ann Intern Med doi: 10.7326/M15-1774 – volume: 29 start-page: 421 issue: 3 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib342 article-title: Inverse association of coffee with liver cancer development: an updated systematic review and meta-analysis publication-title: J Gastrointestin Liver Dis – volume: 20 start-page: 1064 issue: 9 year: 2014 ident: 10.1016/j.jhep.2024.04.031_bib515 article-title: Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis publication-title: Liver Transpl doi: 10.1002/lt.23936 – volume: 25 start-page: 108 issue: 1 year: 1997 ident: 10.1016/j.jhep.2024.04.031_bib85 article-title: Excess weight risk factor for alcoholic liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.510250120 – volume: 357 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib302 article-title: Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study publication-title: BMJ – volume: 72 start-page: 581 issue: 3 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib186 article-title: Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis publication-title: Gut doi: 10.1136/gutjnl-2022-327777 – volume: 74 start-page: 2241 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib208 article-title: Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.32047 – volume: 29 start-page: 3564 issue: 7 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib163 article-title: Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis publication-title: Eur Radiol doi: 10.1007/s00330-019-06072-4 – volume: 45 start-page: 444 issue: 2 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib438 article-title: Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the Swedish obese subjects study publication-title: Diabetes Care doi: 10.2337/dc21-1335 – volume: 12 start-page: 119 issue: 2 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib60 article-title: Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(23)00329-7 – volume: 18 start-page: 2168 issue: 10 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib468 article-title: SGLT2 inhibitors in liver patients publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.05.021 – volume: 4 start-page: 731 issue: 9 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib512 article-title: Management of metabolic syndrome and cardiovascular risk after liver transplantation publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30181-5 – volume: 20 start-page: 708 issue: 11 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib284 article-title: Lifestyle interventions in nonalcoholic fatty liver disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-023-00800-4 – volume: 77 start-page: 607 issue: 3 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib402 article-title: Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: a randomised, open-label phase II trial publication-title: J Hepatol doi: 10.1016/j.jhep.2022.04.003 – volume: 29 start-page: 1418 issue: 11 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib452 article-title: Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis publication-title: Nutrition doi: 10.1016/j.nut.2013.05.016 – volume: 11 issue: 2 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib133 article-title: Cost-effectiveness analysis: risk stratification of nonalcoholic fatty liver disease (NAFLD) by the primary care physician using the NAFLD fibrosis score publication-title: PLoS One doi: 10.1371/journal.pone.0147237 – volume: 31 start-page: 2392 issue: 4 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib479 article-title: Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis publication-title: Eur Radiol doi: 10.1007/s00330-020-07223-8 – volume: 48 start-page: S350 year: 2008 ident: 10.1016/j.jhep.2024.04.031_bib225 article-title: Visceral fat as a strong and independent risk factor of nonalcoholic fatty liver disease publication-title: J Hepatol – volume: 35 start-page: 1284 issue: 11 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib142 article-title: Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000002641 – volume: 39 start-page: 86 issue: 1 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib331 article-title: NASH in lean individuals publication-title: Semin Liver Dis doi: 10.1055/s-0038-1677517 – volume: 32 start-page: 121 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib41 article-title: Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity publication-title: J Obes Metab Syndr doi: 10.7570/jomes23031 – volume: 158 start-page: 200 issue: 1 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib192 article-title: Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.09.008 – volume: 34 start-page: 2332 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib435 article-title: Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP publication-title: Surg Endosc doi: 10.1007/s00464-020-07555-y – volume: 71 start-page: 313 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib482 article-title: Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study publication-title: J Hepatol doi: 10.1016/j.jhep.2019.04.011 – volume: 72 start-page: 2364 issue: 12 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib128 article-title: Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial publication-title: Gut doi: 10.1136/gutjnl-2023-330269 – volume: 17 start-page: 988 issue: 17-18 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib378 article-title: Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis publication-title: Drug Discov Today doi: 10.1016/j.drudis.2012.05.012 – volume: 21 start-page: 358 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib323 article-title: Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.12.043 – volume: 2 start-page: 1093 issue: 8 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib536 article-title: Validation of noninvasive markers for HCC risk stratification in 1389 patients with biopsy-proven NAFLD publication-title: Gastro Hep Adv doi: 10.1016/j.gastha.2023.07.018 – volume: 29 start-page: 2656 issue: 10 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib354 article-title: Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis publication-title: Nat Med doi: 10.1038/s41591-023-02539-6 – volume: 20 start-page: 908 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib159 article-title: Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.12.016 – year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib171 article-title: Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes publication-title: J Hepatol doi: 10.1016/j.jhep.2024.03.023 – volume: 3 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib314 article-title: Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD publication-title: JHEP Rep – volume: 79 start-page: 1302 issue: 5 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib423 article-title: Treating NASH by targeting peroxisome proliferator-activated receptors publication-title: J Hepatol doi: 10.1016/j.jhep.2023.07.004 – volume: 77 start-page: 1335 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib12 article-title: The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review publication-title: Hepatology (Baltimore, Md) doi: 10.1097/HEP.0000000000000004 – volume: 107 start-page: 253 issue: 2 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib179 article-title: Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma publication-title: Am J Gastroenterol doi: 10.1038/ajg.2011.327 – volume: 150 start-page: 1219 issue: 5 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib199 article-title: The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.01.032 – volume: 55 start-page: 913 issue: 4 year: 2006 ident: 10.1016/j.jhep.2024.04.031_bib165 article-title: Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy publication-title: Magn Reson Med doi: 10.1002/mrm.20825 – volume: 73 start-page: 2196 issue: 6 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib155 article-title: Transient versus two-dimensional shear-wave elastography in a multistep strategy to detect advanced fibrosis in NAFLD publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31655 – volume: 118 start-page: 1576 issue: 9 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib309 article-title: Significant dose-response association of physical activity and diet quality with mortality in adults with suspected NAFLD in a population study publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000002222 – volume: 13 start-page: 363 issue: 2 year: 2013 ident: 10.1016/j.jhep.2024.04.031_bib507 article-title: Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease publication-title: Am J Transpl doi: 10.1111/j.1600-6143.2012.04318.x – volume: 44 start-page: 384 issue: 2 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib83 article-title: Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies publication-title: Alcohol Clin Exp Res doi: 10.1111/acer.14271 – volume: 36 start-page: 2616 issue: 8 Pt A year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib484 article-title: Management of patients with non-alcoholic steatohepatitis undergoing liver transplantation: considerations for the anesthesiologist publication-title: J Cardiothorac Vasc Anesth doi: 10.1053/j.jvca.2021.07.020 – volume: 66 start-page: 1968 issue: 6 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib490 article-title: A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: the CAR-OLT score publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29329 – volume: 2 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib526 article-title: NAFLD and liver transplantation: disease burden, current management and future challenges publication-title: JHEP Rep – volume: 20 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib338 article-title: The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies publication-title: Ann Hepatol doi: 10.1016/j.aohep.2020.08.071 – volume: 3 issue: 3 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib294 article-title: Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial publication-title: JHEP Rep – volume: 72 start-page: 1556 issue: 5 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib311 article-title: Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.31158 – volume: 136 start-page: 1601 issue: 5 year: 2009 ident: 10.1016/j.jhep.2024.04.031_bib394 article-title: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.01.053 – volume: 14 start-page: 151 issue: 2 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib499 article-title: Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2017.09.528 – volume: 400 start-page: 185 issue: 10347 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib78 article-title: Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 publication-title: Lancet doi: 10.1016/S0140-6736(22)00847-9 – volume: 10 start-page: 632 issue: 4 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib235 article-title: Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis publication-title: Hepatol Int doi: 10.1007/s12072-015-9679-0 – volume: 165 start-page: 1053 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib538 article-title: Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study publication-title: Gastroenterology doi: 10.1053/j.gastro.2023.06.027 – volume: 113 start-page: 1265 issue: 5 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib110 article-title: Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study publication-title: Am J Clin Nutr doi: 10.1093/ajcn/nqaa380 – volume: 24 start-page: 809 issue: 5 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib529 article-title: Relevance of body composition in phenotyping the obesities publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-023-09796-3 – volume: 164 start-page: 966 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib194 article-title: PNPLA3 genotype and diabetes identify patients with nonalcoholic fatty liver disease at high risk of incident cirrhosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2023.01.040 – volume: 42 start-page: 987 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib456 article-title: Practical guideline on obesity care in patients with gastrointestinal and liver diseases - joint ESPEN/UEG guideline publication-title: Clin Nutr doi: 10.1016/j.clnu.2023.03.021 – volume: 398 start-page: 262 issue: 10296 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib412 article-title: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications publication-title: Lancet doi: 10.1016/S0140-6736(21)00536-5 – volume: 76 start-page: 1362 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib153 article-title: Impact of non-invasive biomarkers on hepatology practice: past, present and future publication-title: J Hepatol doi: 10.1016/j.jhep.2022.03.026 – volume: 9 start-page: 218 issue: 3 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib8 article-title: Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(23)00443-0 – volume: 385 start-page: 956 issue: 9972 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib380 article-title: Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(14)61933-4 – volume: 112 start-page: 18 issue: 1 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib21 article-title: ACG clinical guideline: evaluation of abnormal liver chemistries publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.517 – year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib408 article-title: A phase 2 randomized trial of survodutide in MASH and fibrosis publication-title: N Engl J Med doi: 10.1056/NEJMoa2401755 – volume: 22 start-page: 169 issue: 2 year: 2002 ident: 10.1016/j.jhep.2024.04.031_bib467 article-title: Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs publication-title: Semin Liver Dis doi: 10.1055/s-2002-30102 – volume: 71 start-page: 495 issue: 2 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib371 article-title: Vitamin E improves transplant-free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30368 – volume: 60 start-page: 1873 issue: 10 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib220 article-title: Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study publication-title: Diabetologia doi: 10.1007/s00125-017-4340-1 – volume: 330 start-page: 537 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib112 article-title: Sugar-sweetened and artificially sweetened beverages and risk of liver cancer and chronic liver disease mortality publication-title: JAMA doi: 10.1001/jama.2023.12618 – volume: 13 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib63 article-title: Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: a population-based study publication-title: Front Endocrinol (Lausanne) – volume: 5 start-page: 739 issue: 8 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib329 article-title: Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(20)30077-7 – volume: 48 start-page: 696 issue: 7 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib230 article-title: Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.14937 – volume: 394 start-page: 2012 issue: 10213 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib268 article-title: Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial publication-title: Lancet doi: 10.1016/S0140-6736(19)32517-6 – volume: 27 start-page: 187 issue: 2 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib217 article-title: Metabolic syndrome and its association with nonalcoholic steatohepatitis publication-title: Clin Liver Dis doi: 10.1016/j.cld.2023.01.002 – volume: 39 start-page: 770 issue: 3 year: 2004 ident: 10.1016/j.jhep.2024.04.031_bib373 article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.20092 – volume: 123 start-page: 681 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib528 article-title: A simple cut-off for waist-to-height ratio (0.5) can act as an indicator for cardiometabolic risk: recent data from adults in the Health Survey for England publication-title: Br J Nutr doi: 10.1017/S0007114519003301 – volume: 6 issue: 1 year: 2024 ident: 10.1016/j.jhep.2024.04.031_bib164 article-title: Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: a meta-analysis publication-title: JHEP Rep – volume: 76 start-page: 959 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib473 article-title: Baveno VII - renewing consensus in portal hypertension publication-title: J Hepatol doi: 10.1016/j.jhep.2021.12.022 – volume: 72 start-page: 1062 issue: 6 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib115 article-title: Physical activity compared to adiposity and risk of liver-related mortality: results from two prospective, nationwide cohorts publication-title: J Hepatol doi: 10.1016/j.jhep.2019.12.022 – volume: 401 start-page: 1786 issue: 10390 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib444 article-title: Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(23)00634-7 – year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib539 article-title: Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis publication-title: J Hepatol – volume: 16 start-page: 1448 issue: 6 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib483 article-title: The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database publication-title: Hepatol Int doi: 10.1007/s12072-022-10414-8 – volume: 27 start-page: 430 issue: 3 year: 2012 ident: 10.1016/j.jhep.2024.04.031_bib458 article-title: Late evening snack: exploiting a period of anabolic opportunity in cirrhosis publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2011.06951.x – volume: 19 start-page: 2274 issue: 11 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib262 article-title: Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.08.061 – volume: 78 start-page: 684 issue: 4 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib214 article-title: A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2022.11.025 – volume: 71 start-page: 778 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib30 article-title: Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies publication-title: Gut doi: 10.1136/gutjnl-2021-324191 – volume: 71 start-page: 1141 issue: 6 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib129 article-title: Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia publication-title: J Hepatol doi: 10.1016/j.jhep.2019.08.019 – volume: 29 start-page: 2643 issue: 10 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib197 article-title: Interaction between estrogen receptor-alpha and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women publication-title: Nat Med doi: 10.1038/s41591-023-02553-8 – volume: 13 start-page: 763 issue: 4 year: 2015 ident: 10.1016/j.jhep.2024.04.031_bib188 article-title: Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2014.07.037 – volume: 46 start-page: 1354 issue: 7 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib52 article-title: High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold publication-title: Diabetes Care doi: 10.2337/dc22-2048 – volume: 70 start-page: 577 issue: 2 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib105 article-title: Dietary patterns and risk of hepatocellular carcinoma among U.S. Men and women publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.30362 – volume: 127 start-page: 1704 issue: 6 year: 2004 ident: 10.1016/j.jhep.2024.04.031_bib146 article-title: Serum markers detect the presence of liver fibrosis: a cohort study publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.08.052 – volume: 67 start-page: 1797 issue: 5 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib245 article-title: Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: results from two prospective cohort studies publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.29660 – volume: 10 start-page: 4277 issue: 9 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib154 article-title: Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease publication-title: Theranostics doi: 10.7150/thno.40249 – volume: 43 start-page: 298 issue: 2 year: 2020 ident: 10.1016/j.jhep.2024.04.031_bib415 article-title: Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial publication-title: Diabetes Care doi: 10.2337/dc19-0641 – volume: 130 start-page: 996 issue: 6 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib301 article-title: Association between ultra-processed foods consumption and risk of non-alcoholic fatty liver disease: a population-based analysis of NHANES 2011-2018 publication-title: Br J Nutr doi: 10.1017/S0007114522003956 – volume: 98 issue: 12 year: 2019 ident: 10.1016/j.jhep.2024.04.031_bib321 article-title: A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000014918 – volume: 153 start-page: 1260 issue: 5 year: 2017 ident: 10.1016/j.jhep.2024.04.031_bib99 article-title: Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.08.012 – volume: 348 start-page: 607 issue: Pt 3 year: 2000 ident: 10.1016/j.jhep.2024.04.031_bib464 article-title: Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain publication-title: Biochem J doi: 10.1042/bj3480607 – volume: 146 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib15 article-title: Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States publication-title: Metabolism doi: 10.1016/j.metabol.2023.155642 – volume: 51 start-page: 454 issue: 2 year: 2010 ident: 10.1016/j.jhep.2024.04.031_bib152 article-title: Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease publication-title: Hepatology (Baltimore, Md) doi: 10.1002/hep.23312 – volume: 7 start-page: CD013157 issue: 7 year: 2021 ident: 10.1016/j.jhep.2024.04.031_bib335 article-title: Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis publication-title: Cochrane Database Syst Rev – volume: 65 start-page: 281 issue: 4 year: 1968 ident: 10.1016/j.jhep.2024.04.031_bib7 article-title: [Principles and practice of mass screening for disease] publication-title: Bol Oficina Sanit Panam – volume: 108 start-page: 1192 issue: 5 year: 2023 ident: 10.1016/j.jhep.2024.04.031_bib222 article-title: Adipose tissue insulin resistance predicts the severity of liver fibrosis in patients with type 2 diabetes and NAFLD publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgac660 – volume: 61 start-page: 2108 issue: 7 year: 2016 ident: 10.1016/j.jhep.2024.04.031_bib134 article-title: Screening for nonalcoholic steatohepatitis in individuals with type 2 diabetes: a cost-effectiveness analysis publication-title: Dig Dis Sci doi: 10.1007/s10620-016-4044-2 – volume: 10 start-page: 284 issue: 4 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib51 article-title: A global view of the interplay between non-alcoholic fatty liver disease and diabetes publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(22)00003-1 – volume: 17 start-page: 65 issue: 1 year: 2022 ident: 10.1016/j.jhep.2024.04.031_bib516 article-title: Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting publication-title: Diagn Pathol doi: 10.1186/s13000-022-01247-y – volume: 69 start-page: 154 issue: 1 year: 2018 ident: 10.1016/j.jhep.2024.04.031_bib527 article-title: EASL clinical practice guidelines: management of alcohol-related liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2018.03.018
SSID	ssj0003094
Score	2.7704637
Snippet	Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	492
SubjectTerms	Humans Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - therapy Obesity - complications
Title	EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0168827824003295 https://dx.doi.org/10.1016/j.jhep.2024.04.031 https://www.ncbi.nlm.nih.gov/pubmed/38851997 https://www.proquest.com/docview/3065982421
Volume	81
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1600-0641 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003094 issn: 0168-8278 databaseCode: AIEXJ dateStart: 20210801 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1600-0641 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003094 issn: 0168-8278 databaseCode: AIEXJ dateStart: 20210701 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DSFeENdRLpOReABNmRK7ufix2ooAaRfRAn2LHMcRrUo6rek0eOKFX8Df4dfwSzgnttOOsnGRkKq0SePazfnsc2x_5xxCnrDCD7I8Vx4TUeh1IuiKWa5hqlInR9KoUlWdbCI-OEiGQ3HUan1zvjCnk7gsk7MzcfxfRQ3XQNjoOvsX4m5-FC7AZxA6HEHscPwjwfe6_YbCwOFkb_nkcHvXuUIeWf8oQAmGukL6u905sJRWRxP4oCtACgbDzj_OUA9i2z1p5QoGKwKlmmLk1wmyPNymDxqv-9CYPbfasGoDvwdlWJ1b2B9IZehCdTb5BnRTwzle5jG-kyOvPy-3Han47ahUSyye17L6NJrXX0xkvry4wToNe8uuuK143ZhF0CjxEmZS_7hR3CR-sWjlS0Nyx-Tas9o9NLG8VhSHWcMY74zhj-9gS-oAuFZBnQ_I3cf6sXqk33ImwjWyweJQwJi60X3ZG75qLAHuCxtb3rTXOm0ZfuHPNV1kGF008akNoMENct1KjXYN4m6Sli5vkav7lptxm3xB4H3__BUhZ94OqQMbdWCjC7DRaUkBbHQBNjotaAM2-muw0QZstAYbtWCjT2uoPbtD3jzvDXZfeDbJh6c6nAWelKFSvpZSxaAAlCgwQQPMgWFewbIE5wOZ9gvuy1gEQumMq1gVURH5iiW6YBm_S9bLaanvEerrKFCcFUJnyCcAQ4vFSkrOdUflKhJtErgnnCobAR8TsUxSR3UcpyiVFKWS-vDiQZtsN2WOTfyXS-_mTnCp82wGXZwCyi4tFTalrN1r7NnflnvssJGCUsCdPlnq6XyWcmRLJMj2aJNNA5qm9RwfqhDx_X-s9QG5tuipD8l6dTLXj8gVdVqNZidbZC0eJlu2I_wAeYPmbQ
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EASL%E2%80%93EASD%E2%80%93EASO+Clinical+Practice+Guidelines+on+the+management+of+metabolic+dysfunction-associated+steatotic+liver+disease+%28MASLD%29&rft.jtitle=Journal+of+hepatology&rft.au=Tacke%2C+Frank&rft.au=Horn%2C+Paul&rft.au=Wai-Sun+Wong%2C+Vincent&rft.au=Ratziu%2C+Vlad&rft.date=2024-09-01&rft.pub=Elsevier+B.V&rft.issn=0168-8278&rft.volume=81&rft.issue=3&rft.spage=492&rft.epage=542&rft_id=info:doi/10.1016%2Fj.jhep.2024.04.031&rft.externalDocID=S0168827824003295
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-8278&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-8278&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-8278&client=summon